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1. Abstract 
Hematopoietic stem cells (HSC) are precursors of all blood cells and primarily lo-
cated in the bone marrow (BM) of adults. They interact closely with a special BM 
microenvironment, referred to as stem cell niche, which regulates cell proliferation, 
self-renewal, differentiation and migration/mobilization. As a current hypothesis it 
is postulated that the impaired hematopoiesis of aged stem cells is a consequence 
of an altered interaction with their niche. With a newly developed experimental 
setup for intravital 2-photon microscopy the dynamics and spatial arrangement of 
young and aged primitive hematopoietic cells in the long bones of mice were in-
vestigated to reveal possible changes in cell-niche contact. Until now all micro-
scopic observations of BM-resident hematopoietic cells were obtained from cells 
located in a small bone marrow patch of the calvarium, although this compartment 
has known limitations with regard to HSC-biology. Transplanted hematopoietic 
progenitor cells (HPCs) and early hematopoietic progenitor cells (eHPCs) were 
found to be completely immobile in murine long bones but displayed a permanent 
protrusion movement of the cell surface. Moreover, eHPCs of aged animals were 
located more distant from the inner bone surface and this correlated with an in-
crease of the protrusion movement compared to eHPCs of young animals. This 
suggests a more quiescent microenvironment provided by the niche in areas close 
to the endosteum whereas cells that are located farther away from the inner bone 
surface are not longer in an extreme silent status.  
 
In the second part of the thesis the new intravital 2-photon microscopy method 
was used to analyze cell behavior of neutrophils as an example for differentiated 
blood cells in the murine bone marrow. Neutrophils are the most abundant and, 
arguably, most important leukocyte type of the vertebrate immune system. Their 
lack or dysfunction is always associated with severe consequences to health. In 
“danger situations” such as peripheral infections, the release of neutrophils from 
bone marrow can be dramatically increased within hours, a process termed dan-
ger mobilization. The granulocyte colony-stimulating factor G-CSF is known to play 
an important role in this process and already a single injection of G-CSF leads to a 
massive neutrophil mobilization into the peripheral blood. However, although re-
combinant G-CSF has been used in clinical hematology for more than 20 years to 
overcome the severe problems of neutropenic patients the underlying molecular 
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mechanisms by which danger mobilization is mediated on single cell level in the 
BM still remains unknown. Neutrophils show a rapid and strong increase of motility 
in murine long bones after G-CSF treatment although it is known, that they can not 
respond directly to this trigger. The chemokines KC and MIP-2 were found to play 
a key role in recruiting neutrophils to the circulation by forming a gradient that neu-
trophils are able to follow after detection by their specific surface receptor CXCR2. 
Megakaryocytes were identified as a source of KC and MIP-2 production in the 
bone marrow. Moreover it could be demonstrated that both chemokines were re-
leased in response to thrombopoietin (TPO) stimulation, one major activation trig-
ger for megakaryocytes. This factor might be released by a F4/80 positive sub-
population of macrophages that was identified to be positive for the G-CSF recep-
tor and was also able to produce TPO.  
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Figure 1  Bone constitution.  Bone consists of a compact bone 
structure, which encloses the central bone marrow cavity. It is 
divided in many round units (osteon), long cylinders which run 
parallel to the diaphysis. Each osteon contains a Haversian canal 
in which blood vessels and nerves are located. Haversian canals 
can communicate with each other, with the periosteum or the 
bone marrow cavity by diagonal proceeding Volkmann canals. 
Spongy bone, a porous network of trabeculae is mostly located 
between the compact bone and the bone marrow cavity. The 
bone is covered by connective tissue which is referred to as peri-
osteum at the outside of the bone and endosteum at the inner 
bone surface. 
 
source: http://en.wikipedia.org/wiki/File:Illu_compact_spongy_bone.jpg 
2. Introduction 
2.1 Bone and bone marrow: structure and function 
The main functions of bones are to constitute the supporting apparatus of the body 
and the starting point of muscles to protect various organs of the body and to pro-
duce and store minerals. Moreover, they are responsible for the production of red 
and white blood cells [Junquiera et al. 2005]. 
Bones are composed of a highly specialized tissue which consists of living and 
dead cells embedded in a mineralized organic matrix. In addition they are covered 
by a connective tissue 
membrane called peri-
osteum. Beneath the 
periosteum a dense 
zone, the compact 
bone or Substantia 
compacta is located 
which consists of the 
Haversian system, or 
osteon. Each osteon 
has concentric layers of 
mineralized matrix, 
which surround a cen-
tral canal that contains 
blood vessels and 
nerves to support the 
bone with nutritive sub-
stances. The central 
part of the bone is filled 
with the bone marrow. 
Between the marrow 
cavity and the compact bone, the trabecular bone tissue, also called cancellous or 
spongy bone can be found as an open porous network. It consists of rod- and 
plate-like structures built up by bone trabeculae and the empty space is engaged 
by blood vessels and marrow. The function of this tissue is, to reduce the weight of 
 2. Introduction 
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the bone [Schiebler 2005; Junquiera et al. 2005]. 
The bone substance is mainly built up by mononuclear bone-forming cells called 
osteoblasts. They form skin-like layers around bone structures and release colla-
gen type-I, calcium phosphate and carbonate. Osteoblasts are not able to prolifer-
ate but they build up the bone matrix which gets mineralized and filled up with cal-
cium over time. During this bone formation, also named ossification, a subset of 
osteoblasts undergoes a differentiation to osteocytes. These migrate into the bone 
as mature bone cells and, after reaching their final destination they become 
trapped and surrounded by bone matrix that they synthesize themselves. Osteo-
cytes are characterized by their multiple nuclei and build up extensions towards 
osteoblasts and other osteocytes in order to influence bone formation, matrix 
maintenance and calcium homeostasis. In contrast to bone formation, osteoclasts 
are the cell type which is responsible for bone removal, namely bone resorption. 
They are located on the surfaces of bone trabeculae in indentations called how-
ship-lacunae which they synthesize themselves by degradation of bone material. 
This degradation process is realized by a release of H+-ions into the microenvi-
ronment between osteoclasts and the bone material resulting in a strong acidifica-
tion of the small cavity. The organic constituents of the bone are drained by the 
acidic milieu and the resulting fragments are taken up by osteoclasts which de-
grade them subsequently [Schiebler 2005]. Because of their important role in regu-
lating the amount of bone tissue and their ability to remodel the bone structure by 
phagocytic functions, osteoclasts are indispensable for the maintenance of bone 
integrity and always ensure a perfect functional status of bones [Junquiera et al. 
2005; Schiebler 2005]. 
In almost any bone that holds cancellous tissue bone marrow can be found and 
according to unique characteristics it can be separated into two variants. The red 
bone marrow mainly consists of hematopoietic tissue which is responsible for the 
synthesis of all leukocytes, red blood cells and platelets. At birth almost the whole 
amount of BM consists of red BM but with age it gets more and more converted 
into the yellow type until only at specialized locations in the body functional hema-
topoiesis remains intact (e.g. the hip bone, breast bone, skull, ribs, vertebrae and 
shoulder blades and in the cancellous material of long bones). The main content of 
yellow BM are fat cells which serve as energy storage for the organism. This BM 
type is exclusively located in the center of long bones. Both BM variants are sup-
 2. Introduction 
 16 
plied with a distinct network of blood vessels which enter the bone through many 
different pores which are spread all over the bone surface [Junquiera et al. 2005; 
Schiebler 2005].  
 
Figure 2  Scheme of long bone architecture and the epiphyseal plate.  Long bones can be 
divided into a long diaphysis and two epiphyseal areas on each end. Over the period of time when 
the bone is growing an epiphyseal plate is located between both compartments, which is responsi-
ble for the linear growth of the bone. When the developmental bone growth is finalized the plate is 
replaced by the epiphyseal line. The epiphyseal plate can be divided into three major zones. The 
first one is a proliferation zone where chondrocytes divide heavily, leading to the bedding of new 
bone material. The hypertrophic cartilage zone consists of big apoptotic chondrocytes which are 
calcified step by step. The last zone is called osteogenic zone. This area is occupied by blood ves-
sels and stem cells, which differentiate to osteoblasts that then build up new bone matrix. Between 
epiphysis and diaphysis a reserve zone of hyaline cartilage is located which is extremely elastic but 
not supplied by any nerves or blood vessels.  
 
adapted from: http://en.wikipedia.org/wiki/File:Illu_long_bone.jpg and 
http://histology.leeds.ac.uk/bone/bone_ossify.php 
 
Among all other types of bone that can be found in a mammalian organism, long 
bones are one special variant and they are characterized by unique features. They 
consist of compact bone with just a small amount of marrow in the center and, as 
their name indicates, their shaft is much longer than wide. Long bones display a 
characteristic assembly with a cylindrical diaphysis and two bone ends called 
epiphysis. In children, an epiphyseal plate is located between the diaphysis and 
epiphysis, which is responsible for the longitudinal growth of the bone. In adults 
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this plate is replaced by an epiphyseal line. Long bones arise from cartilage which 
is exclusively composed of chondrocytes. This special compartment is then coated 
by a bone collar. To support the bone with blood vessels, the bone collar is perfo-
rated by osteoclasts so that the vessels can grow through to reach the cartilage. 
By this route mesenchymal stem cells reach the inside of the bone. The diaphysis 
grows in the direction to the epiphysis, simultaneously osteoclasts remove material 
from the bone center to form the bone marrow cavity between both epiphyseal 
plates [Schiebler 2005]. During this development the ossification of the diaphysis 
goes on and in the end all cartilage is ossified, except that in the epiphyseal plate 
which is needed for the subsequent longitudinal growth of the bone. In this pro-
cess the epiphyseal plate can be subdivided into three different zones. The first 
one is a proliferation zone in which the chondrocytes proliferate very fast. The hy-
pertrophic cartilage zone is characterized by big chondrocytes which undergo 
apoptosis and are then ossified. After this process, blood vessels and stem cells 
migrate into the ossified region and differentiate to osteoblasts that build new bone 
matrix which is also ossified by and by. When the growth process is completed, 
the longitudinal growth is finalized by replacing the epiphyseal plate with new bone 
matrix, leading to a complete closing of the compartment [Junquiera et al. 2005]. 
Between the epiphyseal plate and the epiphysis a broad bar of hyaline cartilage is 
located which displays the last reservoir of cartilage in the full-grown bone 
[Schiebler 2005] (Figure 2). 
 
2.2 The hematopoietic system  
The blood building system of an organism is referred to as hematopoietic system. 
All cellular blood components which are important for a normal blood count, either 
the mature cells or their progenitors are mainly produced in the red bone marrow 
by a process that is called hematopoiesis [Murphy K et al. 2008] 
 
2.2.1 Blood 
Blood is responsible for the supply of organs and muscles with oxygen and other 
nutrients. Nevertheless, blood is not only indispensable for the transport of sub-
stances through the body moreover it is also responsible for the evacuation of 
waste products. An average healthy adult has a blood volume of about 5 liters and 
approximately 1011 – 1012 new blood cells are produced daily to maintain the num-
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ber of all blood cells in the circulation. Blood cells can be divided into three major 
lineages: erythrocytes, lympho-cytes and myelocytes. The highest cell number in 
the vertebrate blood is provided 
by the oxygen carrying red 
blood cells or erythrocytes, 
which constitute about 43 % of 
the blood weight and 95 % 
weight of all blood cells. Lym-
phocytes are derived from 
common lymphoid progenitors 
and can be subdivided into two 
major groups, T-lymphocytes 
and B-lymphocytes. These cells 
are characterized by their ability 
to induce and modulate adap-
tive immune responses against 
foreign antigens (view 2.3) 
which makes them irreplacea-
ble fighters against all kinds of infections. Granulocytes, megakaryocytes and 
macrophages are the cells belonging to the third group, termed myelocytes. All 
three sub-types have the same myeloid progenitor cell in common and they exhibit 
many important functions in adaptive, as well in innate immunity [Junquiera et al. 
2005] [Murphy K et al. 2008]. 
Besides the blood cells, the blood plasma with a volume of around 55 % displays 
the second big blood component by weight. It contains many substances like pro-
teins (antibodies, hormones) or lipids which are transported with the blood flow 
throughout the whole body to locations where they are needed. One very im-
portant protein that is part of the blood plasma is fibrinogen. During the process of 
blood clotting it polymerizes to fibrin thereby providing an indispensable substance 
for the closure of an open wound [Schiebler 2005; Junquiera et al. 2005]. 
 
2.2.2 Hematopoietic stem cells 
All cellular blood components are derived from the same progenitor cells in the 
bone marrow which are called hematopoietic stem cells (HSCs). Because of their 
Figure 3  Blood composition and cell types of the 
blood.  The main compounds of the blood plasma and 
their functions are displayed on the left side. On the 
right side the different types of blood cells are listed 
with a brief description of their major functions. Addi-
tionally their average numbers in a healthy adult are 
demonstrated. 
 
adapted from: http://facweb.northseattle.edu/jlearn/ANP%20128/ 
Ch_10_Blood_Comp.htm 
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special and unique ability to produce all types of blood cells they are designated 
as pluripotent [Abramson et al. 1977; Dick et al. 1985; Keller et al. 1985; Jordan et 
al. 1990; Szilvassy et al. 1994]. They reside only in the red blood marrow which in 
adults is mainly located in ribs, vertebrae, breastbone, hips and the end of the fe-
murs. The population of pluripotent stem cells already develops in early embryos 
and renews itself mitotically while supporting the blood with all cellular compounds. 
 
 
Figure 4  All blood cells and cells of the immune system are produced by multipotential 
hematopoietic stem cells.  In the first step the stem cells differentiate into multipotent progenitor 
cells which then develop to progenitor cells either of the myeloid or lymphoid lineage in the bone 
marrow. In the end mature cells arise from a number of committed progenitors. The lymphoid line-
age consists of natural killer cells and T- and B-lymphocytes. T-cell progenitors migrate to the thy-
mus where they undergo further maturation. Afterwards T- cells as well as B-cells undergo further 
differentiation inside the lymph nodes like B-cells which develop into plasma cells after contact to 
an appropriate antigen. The myeloid progenitor cells differentiate to erythrocytes, megakaryocytes, 
mast cells and myeloblasts. Megakaryocytes are responsible for the production of thrombocytes 
(platelets) whereas the myeloblasts further develop to basophils, neutrophils, eosinophils and 
monocytes. Monocytes leave the bone marrow and enter body tissues to differentiate to macro-
phages. Mast cells also invade other tissues for further maturation. LT-HSC: long-term hematopoi-
etic stem cell; ST-HSC: short-term hematopoietic stem cell; MPP: multipotential progenitor; CFU: 
colony forming unit; GEMM: granulocyte, erythrocyte, monocyte, megakaryocyte; CMP: common 
myeloid progenitor; CLP: common lymphoid progenitor; MEP: megakaryocyte-erythrocyte progeni-
tor; GMP: granulocyte-macrophage progenitor; BFU: burst forming unit; 
 
source: http://contanatura.weblog.com.pt/arquivo/stem-cell.jpg 
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The hematopoietic stem cell which can be isolated from adult bone marrow or pe-
ripheral blood belongs to the group of adult stem cells and it is the best character-
ized somatic stem cell [Weissman 2000; Kondo et al. 2003]. Adult stem cells are 
present in most self-renewing tissues like skin, intestinal epithelium and the hema-
topoietic system. In contrast to embryonic stem cells which can, independent of 
their location, develop to all kinds of tissue, adult stem cells can only form cells of 
the tissue which they are derived from. They have the capacity to produce further 
stem cells of their own type, which indicates the ability of self-renewal. This gives 
rise to a distinct, mature and differentiated offspring which efficiently maintains or 
repairs host tissue [Osawa et al. 1996]. In addition to the ability of self-renewal and 
the fact that they are pluripotent it is generally expected that a hematopoietic stem 
cell fulfills a third criterion to be considered as stem cell and this is an extremely 
high potential of proliferation. An average adult has approximately 50 million HSC 
in his body, some of which can generate up to 1013 mature blood cells over a nor-
mal lifespan. In contrast mice possess just 10.000-15.000 HSCs but remarkably it 
has been shown that a single stem cell can reconstitute the entire lympho-
hematopoietic system of a mouse, following transplantation into an irradiated re-
cipient [Osawa et al. 1996; Morrison et al. 1995; Krause et al. 2001]. In cases of 
injury, this enormous proliferation potential is needed to rapidly compensate the 
blood loss. Under normal conditions up to 75 % of HSC reside quiescently in the 
bone marrow [Cheshier et al. 1999]. Just very few cells are constantly dividing to 
ensure the maintenance of the hematopoietic system. The exact process of this 
division remains unclear at present but it is commonly accepted that HSC divide 
asymmetrically in order to obtain a cell that is able to conserve a constant popula-
tion of quiescent long-term (LT) stem cells [Wilson et al. 2006a]. The second cell is 
believed to differentiate into a cell of the hematopoietic system. From all cells in 
the bone marrow just about 0.1 % are pluripotent stem cells. HSCs are character-
ized by a variety of surface markers. A lot of them have been identified during the 
last 20 years [Visser et al. 1990; Civin et al. 1993; Uchida et al. 1993], but just a 
few of them are routinely used for the characterization and isolation of HCS. The 
most important markers are c-kit, a receptor tyrosine-kinase recognizing the cyto-
kine SCF (stem cell factor) and Sca-1 which is a glycosylphosphatidylinositol(GPI)-
linked cell surface protein [Hanson et al. 2003] whose function is still unclear. It 
seems to have different roles in the normal HSC function like homing or lineage 
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development [Bradfute et al. 2005]. Studies on Sca-1 knock-out mice have identi-
fied an influence of the factor in HSC self-renewal [Ito et al. 2003] but there have 
also conflicting data been published [Bradfute et al. 2005]. Another important crite-
rion to identify a HCS is the absence of lineage markers. Every cell that orientates 
to a distinct cell lineage during maturation is provided with a unique set of surface 
markers. Based on this fact a common protocol for the isolation of HSCs is to re-
move all cell types that have underwent differentiation from a cell suspension by 
positive selection with an antibody cocktail consisting of all typical markers for their 
lineages. In mice a suitable AB cocktail contains the following antibodies: B220 
directed against B-cells, Gr-1 directed against neutrophils, Mac-1 directed against 
macrophages, CD5 directed against B- and T-cells, CD8a directed against cyto-
toxic T-cells and TER-119 directed against erythrocytes. The HSCs are designat-
ed to be completely unspecialized, so none of these markers should be detectable 
on them. It is now widely appreciated that the only valid test that defines a HSC is 
to demonstrate its capacity to completely and lastingly regenerate the lympho-
hematopoietic system following transplantation into lethally irradiated hosts [Szil-
vassy 2003]. As a critical test for HSC self-renewal serial transplantations are per-
formed to finally identify a real stem cell which can reconstitute recipients 4–6 
times [SIMINOVITCH et al. 1964; CUDKOWICZ et al. 1964]. 
A possibility to mobilize the usually quiescent HSC out of the bone marrow into the 
blood stream is the treatment of an organism with the granulocyte colony stimulat-
ing factor G-CSF, a glycoprotein that is involved in many processes of HSC ho-
meostasis (view 2.6). G-CSF probably induces the release of proteases leading to 
a degradation of chemokines like SDF-1 (CXCL12) which acts as the main an-
chorage for HSC in the bone marrow through the binding to its receptor CXCR4 
[Lapidot et al. 2002]. Treatment with G-CSF over several days leads to a strong 
increase of HSC in the peripheral blood which allows the isolation of HSC directly 
from this source. After transplantation HSC have the ability to return to the bone 
marrow of the recipient by specific migration, a behavior called “homing” [Nilsson 
et al. 2004]. Several cell surface adhesion molecules, including selectins and in-
tegrins are crucial for this HSC homing process (e.g. β1- integrins, the very late 
antigen 4 (VLA4) and VLA5 or the β2-Integrin “lymphocyte function-associated an-
tigen 1 (LFA-1)) [Papayannopoulou 2003; Lapidot et al. 2005]. The lack of one or 
more of these molecules leads to a strongly diminished or complete loss of the 
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HSCs’ possibility to home into bone marrow after transplantation. In principle, 
homing to the bone marrow is an unselective process which can be performed by 
all hematopoietic cells with almost the same frequency. The specialty of HSCs in 
contrast to other cell types is their ability to migrate through endothelial barriers 
into extra-vascular compartments of the bone marrow and in addition into distinct 
endothelial domains of the bone, which are designated as stem cell niche [Nilsson 
et al. 2004; Nilsson et al. 2005; Nilsson et al. 2003]. The concept of a distinct cell 
niche for the hematopoietic system was first established in 1978 [Schofield 1978]. 
The special three-dimensional microenvironment of this compartment is expected 
to regulate self-
renewal, differentiation 
and proliferation of 
HSCs in vivo [Curry et 
al. 1967]. Mediators 
which are secreted by 
cells of the endosteum, 
displaying the inner 
bone surface, recruit 
the cells to the niche. 
One crucial factor in-
volved in migration, 
mobilization and reten-
tion of HSCs is 
CXCL12 which is ex-
pressed by several 
types of bone marrow 
stromal cells, including 
osteoblasts and vascu-
lar endothelial cells 
[Ara et al. 2003; 
Ponomaryov et al. 2000]. CXCL12 binds to the CXC-chemokine receptor 4 
(CXCR4) which is expressed on the surface of HSCs and by this action it is be-
lieved that HSCs migrate directed and specifically to their niche [Wright et al. 
2002].  
Figure 5  Endosteal and vascular hematopoietic stem cell 
niche in the bone marrow.  Stem cells seem to reside at distinct 
places in the bone marrow that provide a special microenvironment 
to support stem cell quiescence and self-renewal. At these specific 
places called niche stem cells are in close contact, mainly to oste-
oblasts. If stem cells become more active it is believed that they 
enter a second niche in the bone marrow close to a blood vessel 
which is therefore termed vascular niche. This niche supports stem 
cell differentiation, proliferation and migration. 
 
source: http://www.regmed.uni-tuebingen.de/files/3the_stem_cell_niche_ 
338x252.jpg 
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Until now, two types of niches have been characterized in the bone marrow. A few 
stem cells can be found close to blood vessels. This microenvironment seems to 
support stem cell proliferation, differentiation and migration and is designated as 
vascular niche [Kiel et al. 2005; Kiel et al. 2006; Sugiyama et al. 2006]. In contrast, 
most of the stem cells reside in the endosteal niche. The main difference to the 
vascular niche is that this distinct area is located close to the endosteum where 
the cells reside in close vicinity to the bone what promotes stem cell quiescence 
and self-renewal [Wilson et al. 2006a]. In this compartment stem cells are attached 
to special stroma cells [Nilsson et al. 2001] or osteoblasts which mainly build up 
the endosteal stroma. These special osteoblasts are called “spindle-shaped oste-
oblasts” or SNO-cells and the strong adhesion and the resulting communication is 
known to play a crucial role in regulating stem cell fate [Zhang et al. 2003; Yin et 
al. 2006; Jung et al. 2005; Neiva et al. 2005]. Only the SNO-cells express the ad-
hesion molecule N-cadherin which is also expressed on hematopoietic stem cells 
and which seems to be a central molecule mediating the strong adhesion between 
both cell types [Zhang et al. 2003; Wilson et al. 2004]. Moreover, it was shown that 
SNO-cells also produce other adhesion molecules and cytokines which have a 
strong influence on stem cell behavior. In example angiopoietin 1 (ANG1) acti-
vates the tyrosine kinase receptor (TIE2) that is expressed on stem cells. TIE2 
increases the N-cadherin expression on stem cells resulting in a better adhesion to 
osteoblasts. Additionally the ANG1-TIE2 bond and the activated downstream 
pathway inhibits stem cell proliferation and keeps the cells in a resting status in 
vitro and in vivo [Fleming et al. 1993; Spangrude et al. 1990; Arai et al. 2004; 
Cheng et al. 2000]. Many other significant interactions between both cell types 
have been described in the last years. For example one important observation was 
that a depletion of osteoblasts leads to a reduction of the HSC number and inter-
estingly, this effect has been shown to be reversible [Visnjic et al. 2001; Visnjic et 
al. 2004]. This finding underlines the crucial influence of osteoblasts on hemato-
poietic stem cell regulation and the importance of their close interactions. Very 
recently it has been demonstrated that mesenchymal stem cells (MSCs) express-
ing high levels of nestin are an indispensable part of the stem cell niche. This 
study demonstrated that hematopoietic stem cells, after transplantation into lethal-
ly irradiated recipients, migrate into distinct areas close to MSCs whereas the de-
pletion of nestin positive MSCs clearly diminishes the number of homing HSCs. 
 2. Introduction 
 24 
Moreover, MSCs express high levels of SDF-1 which is supposed to be the main 
anchor that attach HSCs to the bone marrow by binding to CXCR4. These data 
imply a new kind of stem cell niche in which two different stem cell types interact 
very closely [Mendez-Ferrer et al. 2010]. 
 
2.2.3 Aging of hematopoietic stem cells 
By comparing stem cells from young and old organisms a big difference in cell ac-
tivity can be observed. These differences are not induced by the microenvironment 
in the niche but they are stem cell specific [Geiger et al. 2002; Geiger et al. 2005; 
Rossi et al. 2005]. As stem cells are responsible for the maintenance and renewal 
of all tissues it is assumed that the development of the individual’s aging process 
is related to an impaired activity of old stem cells. During their own aging they 
seem to loose their regenerative tissue repair activity and in addition their ability to 
react to replicative and oxidative stress. These facts limit the normal life-span of 
every organism [Geiger et al. 2002; van Zant et al. 2003; Sharpless et al. 2004; 
Torella et al. 2004].  
By FACS analysis [Morrison et al. 1996; Sudo et al. 2000] and in vitro experiments 
[de Haan et al. 1999] it has been clearly shown, that the number of stem cells in 
old mice is several-fold increased compared to young animals. This finding sug-
gests that not the number of cells is critical for aging but the quality of their action. 
A proof for this hypothesis are experiments which have shown that hematopoietic 
stem cells from old animals contributed just half as good to hematopoiesis in irra-
diated hosts than stem cells from young mice did [Morrison et al. 1996; Chen et al. 
2000]. Moreover, also their homing ability is impaired after transplantation [Liang 
et al. 2005] and they show a reduced capacity of self-renewal as well as an in-
creased apoptosis rate [Janzen et al. 2006]. Another difference between young 
and aged stem cells seems to be their adhesion to stromal cells within their niche 
which in turn could also influence their homing capacity. At least it was shown that 
an impaired adhesion can lead to elevated cell mobilization [Papayannopoulou 
2004; Semerad et al. 2005b; Thomas et al. 2002]. As Xing et al. found that old 
mice release more stem cells into the peripheral blood after G-CSF treatment than 
young mice [Xing et al. 2006] one could speculate that their interaction with stroma 
cells is somehow modified, leading to a facilitated detachment from stromal cells. 
In this context it is also not a big surprise that the aging of stem cells is accompa-
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nied by dramatic changes in the expression of different adhesion molecules like 
VLA4 or VCAM1 which are expressed much less in old cells whereas the expres-
sion of the adhesion molecule P-selectin and the α6 integrin is elevated in them 
[Xing et al. 2006; Rossi et al. 2005]. 
 
2.3 The mammalian immune system 
Every second living creatures are in danger of infections for example through bac-
teria or a viral disease and for that reason all organisms need to protect them-
selves against external, harmful influences to ensure their survival in the natural 
environment. During the last millions of years a complex system with distinct 
mechanisms has developed that is able to protect the organism from diseases 
very efficiently.  
The first line of defense against pathogens that induce disease to the host organ-
ism is displayed by physical barriers like skin or mucosa. If pathogens get over the 
physical barriers and start to proliferate within the body, other cellular mechanisms 
are needed to recognize and clear the infection. Therefore the immune system has 
evolved in a way that two major arms of immunity were established: the innate and 
the adaptive immune system [Murphy K et al. 2008]. The cells of innate immunity 
provide the first defense against microorganisms or toxins that successfully enter 
an organism and the following cell types are involved in these immunological re-
sponses: Phagocytes, including macrophages, neutrophils, dendritic cells as well 
as mast cells, eosinophils, basophils and natural killer cells which have different 
other opportunities to kill pathogens. Their responses are usually triggered when 
the microbes are identified by pattern recognition receptors (PRR) which detect 
components that are conserved on a broad spectrum of microorganisms. Alterna-
tively also injured or stressed cells are able to send out alert signals when they are 
damaged and many of these are recognized by the same receptors as those that 
recognize pathogens [McDonald et al. 2010]. In most cases macrophages are the 
first cells which get in contact with invading pathogens. They continuously mature 
from circulating monocytes and leave the blood vessels to invade all body tissues. 
The recognition of pathogens by the macrophage’s surface receptors leads to a 
fast phagocytosis of the invaders. Moreover, this process leads to a secretion of 
biologically active proteins like cytokines or chemokines (view 2.5). These proteins 
recruit another very important cell type of the innate immune system to the site of 
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inflammation, the neutrophil granulocyte, which can then unfold its full antimicrobi-
al repertoire (view 2.4). Innate immune defenses are non-specific, meaning these 
systems respond to pathogens in a vey general way and they are also not able to 
build up a distinct protective mechanism against any re-infection. However, the 
innate immune system removes the majority of invading microorganisms fast and 
effectively through mechanisms like phagocytosis. This way of action prevents the 
establishment of more severe infections [Murphy K et al. 2008].  
While innate immunity fights to remove an infection the adaptive immunity displays 
the next line of immune responses. The unique ability of the adaptive immunity is 
to recognize pathogens specifically and build up an immunological memory that 
provides a stronger protection against a re-infection. It is induced, when an imma-
ture dendritic cell (DC) recognizes and phagocytoses a pathogen. Thereby, the 
DC gets activated and migrates to the closest draining lymph node, where it pre-
sents specific antigens of the pathogen to naive lymphocytes, mainly T cells. As a 
result these cells differentiate into effector cells and react with strong proliferation 
to produce a high number of them [Murphy K et al. 2008].  
Different types of T effector cells are known so far. On the one hand cytotoxic T 
cells (CTLs) are characterized by expression of the cell surface marker CD8. The 
immunological role of CTLs is to eliminate infected or abnormal somatic cells di-
rectly. The recognition of these cells is mediated by presentation of pathogenic or 
tumor protein residues (peptides) in specific membrane bound glycoproteins, the 
major histocompatibility complex (MHC) class 1. Upon recognition of the somatic 
target cells by CTLs the effectors release the cytotoxins perforin, granzymes and 
granulysin thereby inducing the cell death cascade apoptosis of the pathogen 
[Russell et al. 2002]. They can also induce apoptosis in the target cell by triggering 
the apoptosis receptor FAS via the FAS-ligand (CD95 ligand) [Ju et al. 1995; Kagi 
et al. 1994]. The second type of T cells expresses the co-receptor CD4 on its sur-
face and it is known as T helper cell (TH-cell). Their main role is to mediate the ac-
tivity of other cell types, during an ongoing innate or adaptive immune response. In 
contrast to cytotoxic T cells, they are activated by recognition of a foreign peptide 
which is presented by a MHC molecule of class 2. TH-cells can be divided into dif-
ferent functional different sub-types. TH1-cells play an important role in the abate-
ment of intracellular bacterial infections which mainly reside in vesicles of macro-
phages, like the Mycobacterium tubercolosis causing tuberculosis infections. In 
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this setting TH1-cells induce the fusion of vesicles with the lysosomes of macro-
phages, which contain antimicrobial enzymes and substances that kill the bacteria. 
Moreover, they release cytokines which recruit cells of the innate arm of immunity 
to the site of infection. For the fight against extracellular pathogens TH2-cells are 
indispensable. After specific contact to an external antigen and activation by a 
TH2-cell, B cells differentiate into an effector-cell type called plasma cell. Their 
main function is to release specific antibodies which recognize foreign pathogenic 
antigens. One function of these agents is to bind and neutralize epitopes on the 
particular target which are crucial for their harmful activity. Moreover, pathogens 
are marked by antibodies to facilitate their recognition by phagocytes (opsoniza-
tion) [Murphy K et al. 2008]. 
Recently, an additional subset of T helper cells was identified and named as TH17-
cell because of their IL-17 production [Harrington et al. 2005; Park et al. 2005]. 
They are a subset of CD4-positive T cells and are involved in many T cell mediat-
ed autoimmune diseases like experimental autoimmune encephalomyelitis (EAE) 
demonstrated in IL-17 deficient animals which develop a milder form of EAE 
[Nakae et al. 2003]. 
Besides that, another special group of T cells is known which can be characterized 
by the production of the transcription factor forkhead box protein 3 (FOXP3). The 
function of these T regulatory cells (Tregs) is to arrange for the tolerance of self-
antigens by suppressing overreactions of the adaptive immune system to prevent 
the establishment of autoimmune diseases. For that they can e.g. release the im-
munosuppressive cytokines IL-10 and the transforming growth factor TGF-β. The 
deletion of Tregs leads to increased immune reactions against the own organism 
or for example against transplanted tissue [Murphy K et al. 2008]. 
After clearance of an infection most T effector cells undergo apoptosis except for a 
small population that subsequently forms memory cells. In case of a re-infection 
they can induce a much stronger and faster immune response against the specific 
antigen. This behavior builds the basis for all vaccinations [Murphy K et al. 2008]. 
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Figure 6  Neutrophil granulo-
cyte.  Wright Giemsa staining of 
blood smear. Neutrophils can be 
easily identified by their charac-
teristic segmented nucleus.  
 
source: http://www.oncolink.org/ 
coping/images/neutrophil.jpg 
2.4 Role of neutrophil granulocytes in the immune re-
sponse 
In addition to macrophages, neutrophils display the second major group of phago-
cytes in mammalians. Typical und unique for neutrophils is their characteristically 
formed nucleus which is, depending on the cell matu-
ration status, divided into 2-5 lobes. This feature is 
responsible for the name of the cell family neutrophils 
belong to together with basophils and eosinophils: the 
polymorphonuclear cells or PMNs. In human beings, 
neutrophils are the most abundant white blood cells. 
They constitute around 70 % of all leukocytes [Mur-
phy K et al. 2008] and have a very short life period, 
meaning that they undergo apoptosis after only 6 h 
in circulation independent of whether they have en-
countered a pathogen or not [Hoebe et al. 2004]. 
Neutrophils have three different strategies to directly 
attack microorganisms. The first is phagocyto-
sis,which involves the engulfment and elimination of pathogens in specialized 
phagolysosomal compartments. Secondly, neutrophils can release soluble antimi-
crobial molecules from their granules in close vicinity to the infection in a process 
called degranulation. The generation of neutrophil extracellular traps (NETs) is the 
third defense mechanism. In a just recently discovered cell death mechanism they 
release nuclear contents, composed of decondensed chromatin decorated with 
granula as well as with cytoplasmic proteins into the extracellular space. These 
structures trap various microbes and can kill them by high local concentrations of 
antimicrobial components [Bruns et al. 2010; Brinkmann et al. 2004; Brinkmann et 
al. 2007]. 
The major neutrophil population resides in the bone marrow of long bones but a 
small percentage always circulates with the blood flow to reach infected tissue 
very quickly. In cases of an infection the circulating PMNs are attracted inside the 
blood vessels to the emergency area and migrate from the blood flow into the in-
flamed tissue. This step is called extravasation.  
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Figure 7  Neutrophil adhesion and rolling on the vascular endothelium.  Reversible binding of 
neutrophils through selectins on the endothelium and its receptor sialyl-Lewis
x
 moiety (s-Le
x
) locat-
ed on the neutrophil surface induce a slowdown of neutrophils in the circulation. This results in a 
rolling of the cells on the endosteal surface and allows the forming of stronger bindings. 
 
source: http://0-www.ncbi.nlm.nih.gov.www.elgar.govt.nz/bookshelf/br.fcgi?book=imm&part=A203 
 
In the first step of this process TNFα stimulates the endothelial cells lining blood 
vessels to express the surface adhesion molecule P-selectin. Within a couple of 
hours a second surface adhesion molecule E-selectin is produced. Together, E- 
and P-selectin slow down the speed of leukocytes through the bloodstream by in-
ducing their rolling along the endothelium via s-Lex structures on the surface of the 
granulocyte [Murphy K et al. 2008]. 
 
 
Figure 8  Neutrophil migration through the vascular endothelium into infected tissue.  After 
rolling adhesion neutrophils form stronger bindings to ICAM-1 on the vascular endothelium through 
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their receptor LFA-1 that gets activated by contact with the chemokine IL-8. This adhesion com-
pletely stops the neutrophils and allows the migration through the vascular endothelium (extravasa-
tion) towards chemoattractants. 
 
source: http://0-www.ncbi.nlm.nih.gov.www.elgar.govt.nz/bookshelf/br.fcgi?book=imm&part=A203 
 
That allows other molecules to interact with the slowed leukocytes to stop them 
and promote their movement into the tissues. E- and P-selectin expression can 
also be stimulated by interleukin-1 (IL-1) and lipopolysaccharide (LPS) [Leeuwen-
berg et al. 1992]. Leukocyte rolling occurs due to the brief, reversible binding of E- 
and P-selectin with their complementary molecules, which are expressed on the 
surface of passing neutrophils. Tight adhesion to the rolling leukocyte is mediated 
by another molecule, the intercellular adhesion molecule 1 (ICAM- 1) whose ex-
pression is also induced by TNFα. ICAM-1 binds to both integrins LFA-1 and Mac-
1 on the surface of neutrophils and arrests the motion of the rolling leukocytes by 
strong adhesion to the endothelium. After stopping, the leukocyte is able to enter 
the tissues by secreting proteases to breach the endothelial basement membrane, 
a process known as diapedesis. Again, the integrins LFA-1 and Mac-1 play a ma-
jor role in this process, as well as adhesive interactions with the molecule PECAM 
(CD31). This protein is expressed on neutrophils and epithelial cells and the inter-
action allows the invasion of leukocytes through the endothelial cell layer [Murphy 
K et al. 2008]. The driving signal for the influx of PMNs comes from a pro-
inflammatory chemokine gradient, which is for example built up by Il-8, which in 
turn is released by macrophages after contact to a pathogen [Baggiolini et al. 
1994; Holmes et al. 1991; Strieter et al. 1992; Terashima et al. 1998]. 
 
2.5 Chemokines 
Chemokines are a subclass of cytokines which mainly act as chemoattractants for 
leukocytes. They activate different phagocytic leukocytes upon binding to G pro-
tein-coupled seven-transmembrane receptors [Murphy 1994] thereby guiding im-
mune cells straight and fast to the site of infection in order to ensure an efficient 
host defense against invading pathogens. All chemokines are relatively small mol-
ecules with a molecular mass between 6 and 14 kD and a homology of 20-50 % to 
each other [Le et al. 2004]. 
A great variety of cell types can produce chemokines. Some are permanently re-
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leased under homeostatic conditions, for example to regulate the constant migra-
tion of leukocytes or dendritic cells. Others are released in response to an inflam-
matory stimulus [Murphy K et al. 2008]. 
Until now over 50 mammalian chemokines and 19 different corresponding chemo-
kine receptors have 
been cloned and mo-
lecularly characterized 
[Murphy et al. 2000; Ho-
ruk 2001]. Based on their 
structural characteristics 
chemokines can be clas-
sified in four different 
groups [Murdoch et al. 
2000] representing simi-
lar spatial arrangements 
of the first two, closely 
paired cysteine residues of the particular chemokine (“C chemokines”, “CC chem-
okines”, “CXC chemokines” and “CX3C chemokine”). The chemokine receptor 
families are equally termed according to the group of chemokines they bind. 
Among these reside six “CXC receptors” (CXCR1-6), eleven “CC receptors” 
(CCR1-11), one “CX3C” (CX3CR1) and one “C receptor” (XCR1) [Le et al. 2004]. 
The subgroup of “CC chemokines” is characterized by two adjacent cysteines 
close to their amino terminus. They are also called “CC chemokine ligands” (CCL) 
and bind to CC chemokine receptors. This group mainly induces the migration of 
monocytes and other cell types such as NK cells or dendritic cells [Murphy K et al. 
2008]. The two N-terminal cysteines of “CXC chemokines” are separated by one 
additional amino acid. They can be divided into two different sub-groups: Those 
with a specific tripeptide structure motif of glutamic acid-leucine-arginine (ELR) 
located in front of the first cysteine of the CXC motif (designated as ELR-positive) 
and those without an ELR motif (ELR-negative) [Murphy et al. 2000]. ELR-positive 
“CXC chemokines” like interleukin-8 (IL-8), specifically mediate the migration of 
neutrophils and interact with the chemokine receptors CXCR1 and CXCR2. IL-8 is 
the human analogue for the murine chemokines keratinocyte chemoattractant 
(KC) and macrophage inflammatory protein-2 (MIP-2), which are all stimulators of 
Figure 9  Overview over the multiple roles of chemokines.  
Chemokines and their receptors play an important role in many 
different situations, under homeostatic as well as inflammation 
conditions [Le et al. 2004]. 
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neutrophils to leave the bloodstream and enter the surrounding tissue [Murphy K 
et al. 2008]. In contrast, ELR-negative chemokines tend to be chemo attractive for 
lymphocytes. 
 
 
 
Figure 10  Structure of chemokine classes.  Chemokines are distributed into four sub-groups, 
characterized by the first two cysteine residues. CXC chemokines can be divided in two subgroups, 
those with a specific tripeptide structure motif of glutamic acid-leucine-arginine (ELR) in front of the 
first cysteine and those without such a motif. 
 
source left: http://www.absoluteastronomy.com/topics/Chemotaxis 
source right: http://journals.prous.com/journals/dnp/19991201/html/dn120005/images/Coll1.gif 
 
Additionally, two more small groups of chemokines have been described so far. 
One is the termed “C chemokines” family which is characterized by one N-terminal 
cysteine and another almost C-terminally located one. Just two chemokines have 
been described in this sub-group, XCL1 (lymphotactin-α) and XCL2 (lymphotactin-
ß) which both attract T-cell precursors to the thymus. The only “CX3C chemokine” 
discovered until now, the fractalkine, displays the fourth group of chemokines. Ac-
cording to the other groups, three amino acids are located between both cysteines 
(CX3CL1). This chemokine has an interesting property as it is membrane bound 
and acts both as a chemoattractant as well as an adhesion molecule [Murphy K et 
al. 2008]. 
By examining the interaction of chemokines to their receptors, big differences can 
be observed. In some cases, chemokines can bind to only one specific receptor 
and vice versa it is also very common, that one certain receptor is just able to bind 
one specific, single chemokine, like the interaction of CXCR4 with CXCL12 (SDF-
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1) by which resting neutrophils are kept inside the BM cavities. However, there are 
also many other examples, where chemokines interact with more than one single 
receptor or receptors, that can bind different chemokines. For instance the chemo-
kine CCL7 that can bind to CCR1, 2 and 3 or the receptor CXCR1 which is able to 
bind the chemokines CXCL 2, 3, 5, 6, 7 and 8 [Le et al. 2004].  
As mentioned earlier inflammatory chemokines are indispensable for guiding im-
mune cells as response to microbial infections and agents that cause physical tis-
sue damage. As pioneer cells different leukocytes build up a chemokine gradient 
along the tissues and blood stream, so that immunocytes can orientate them-
selves at the increasing concentration of chemokines that guide them directly to 
the invading pathogens. Their release is often stimulated by pro-inflammatory cy-
tokines such as IL-1 [Le et al. 2004].  
Besides that, chemokines are involved in various other incidents. Notably, some 
chemokines are also known for their roles in cell and tissue development, for ex-
ample in vascularization or cerebellar development [Tachibana et al. 1998; Zou et 
al. 1998]. Moreover, they are able to promote angiogenesis [Strieter et al. 1992; 
Koch et al. 1992], play multiple roles in tumor growth [Wang et al. 1998; Murphy 
2001] and are also involved in different autoimmune diseases like asthma or mul-
tiple sclerosis [Murdoch et al. 2000]. However, each single chemokine and recep-
tor has a special position in the complex network of immune response and home-
ostasis to recruit almost every different cell type to the place, where it is needed. 
 
2.6 G-CSF 
The glycoprotein granulocyte colony-stimulating factor (G-CSF) is essential for 
many processes that are involved in neutrophil or stem cell homeostasis. 
An adult of average size produces approximately 120 million granulocytes per day, 
simply to replace the loss of short living neutrophils. This enormous production can 
be increased at least 10-fold under stress conditions and G-CSF is likely to play an 
important role in the basal regulation of neutrophil production as well as a primary 
regulatory factor controlling the neutrophil response to inflammatory stimuli. After 
its discovery (murine: 1980 [Burgess et al. 1980]; human: 1986 [Souza et al. 1986; 
Nagata et al. 1986c]) and further characterization, the enormous potential of G-
CSF for clinical applications was assessed very fast. In phase 1 clinical trials with 
cancer patients G-CSF was shown to be a potent well tolerated agent that could 
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Figure 11  Chrystal structure 
of recombinant human G-
CSF.  It consists of four main 
bundle helices termed A, B, C 
and D. [Hill et al. 1993b] 
increase the number of circulating neutrophils in a dose dependent manner 
[Morstyn et al. 1988; Gabrilove et al. 1988a; Gabrilove et al. 1988b]. For that rea-
son, G-CSF was recommended for approval in December 1990 by an advisory 
panel of the United States Food and Drug Admin-
istration (FDA) for commercial use in cancer 
chemotherapy. This has led to the final approval 
of this molecule in February 1991 [Demetri et al. 
1991]. Since this time G-CSF is heavily used in 
cancer patients to refill the neutrophil population 
very fast after chemotherapy. Administration of G-
CSF after cytotoxic chemotherapy was associated 
with significant reductions in the duration of se-
vere neutropenia and correspondently the in-
cidence of fever and hospitalizations with neutro-
penia and moreover the requirement for antibiotics 
strongly declined [Crawford et al. 1991]. Besides 
the mobilization of neutrophils from the BM into the 
blood G-CSF has been shown to activate the pro-
duction of neutrophil granulocytes and it also stimulates their survival, proliferation, 
differentiation, and function [von Vietinghoff et al. 2008; Metcalf 2008]. 
Interestingly this soluble mediator has not only effects on neutrophils but also on 
HPCs. It directly influences the production of the progenitors and moreover it ap-
pears to modulate the distribution of neutrophil and progenitor cells within the or-
ganism [Demetri et al. 1991]. With such a potential G-CSF is also intensively used 
in the clinics for the mobilization of hematopoietic stem cells into peripheral blood. 
In the past it was common for bone marrow transplantations that HSC were isolat-
ed from a big bone of the donor, typically the pelvis, through a needle that reaches 
the centre of the bone. This technique is referred to as bone marrow harvest and 
is performed under general anesthesia. With the availability of the stem cell growth 
factor G-CSF, most hematopoietic stem cell transplantation procedures are now 
performed using stem cells collected from the peripheral blood, rather than directly 
from the bone marrow. Collecting peripheral blood stem cells provides a bigger 
graft, does not require a general anesthesia to collect the graft and results in a 
shorter time to engraftment [Cutler et al. 2001]. 
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The mobilization of HPCs from their reservoir in the bone marrow into the circula-
tion is mediated by G-CSF but interestingly it could be shown, that G-CSF cannot 
act directly on the hematopoietic progenitor cells, because they do not express the 
G-CSF receptor [Thomas et al. 2002]. Moreover, although mature neutrophils do 
express the receptor for G-CSF [Avalos 1996], conflicting data are reported re-
garding to the direct role of G-CSF in recruiting neutrophils [Knapp et al. 2004] 
[Witowski et al. 2007]. How G-CSF acts on single cells in vivo in their natural envi-
ronment of long bones marrow, as well as the underlying mechanism of cell mobi-
lization are completely unknown.  
 
 
Figure 12  Neutrophil mobilization from bone marrow by G-CSF.  Neutrophils are attached in 
the bone marrow by expression of CXCR4 that binds to SDF-1. SDF-1 is strongly expressed by 
endosteal cells, mainly osteoblasts, in the bone marrow. G-CSF release induces neutrophil prote-
ases that cleave the SDF-1 CXCR4 binding and neutrophils are mobilized into the peripheral blood 
flow. 
 
source: http://www.rndsystems.com/dam_public/5827.jpg 
 
As G-CSF is so indispensable for the functionality of neutrophils and therefore for 
a crucial part of the innate immunity, it is produced by a variety of different cells, 
e.g. vascular endothelial cells [Zsebo et al. 1988], fibroblasts [Koeffler et al. 1987] 
and mesothelial cells [Demetri et al. 1989]. Also TH17-cells are able to produce G-
CSF. In response to an infection they leave the lymph node and migrate to the 
inflamed tissue, where they recruit neutrophils to the distinct place by releasing G-
CSF [Murphy K et al. 2008]. Nevertheless, the most important source of G-CSF is 
provided by cells of the monocyte/macrophage lineage [Demetri et al. 1991]. The 
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natural occurring human G-CSF exists in two forms, as 174 aa- and as 180 aa-
long protein [Hill et al. 1993a], whereas the more abundant and more active 
174 aa form has been used for the development of pharmaceutical products by 
recombinant DNA technology. Human G-CSF is encoded by a single gene [Naga-
ta et al. 1986a; Nagata et al. 1986c] that is located on chromosome 17 [Le Beau et 
al. 1987; Simmers et al. 1987]. Two different polypeptides are synthesized from 
the same gene by differential splicing of mRNA, in one form is shortened by three 
amino acids but both display the same G-CSF activity [Nagata et al. 1986b]. The 
murine G-CSF is located on chromosome 11 in a region that is homologous to the 
human chromosome 17 [Demetri et al. 1991]. Compared to the human G-CSF, the 
murine form is very similar [Tsuchiya et al. 1986]. The production of G-CSF can be 
induced in vitro by a variety of stimulatory agents, including LPS [Ernst et al. 1989; 
Vellenga et al. 1988], TNF-α [Koeffler et al. 1987], IL-1 [Zsebo et al. 1988; Fibbe et 
al. 1988], TPA [Koeffler et al. 1988; Demetri et al. 1989], GM-CSF [Vellenga et al. 
1988; Oster et al. 1989], IL-3 [Oster et al. 1989], IL-4 [Wieser et al. 1989] and IFN-
γ [Herrmann et al. 1986]. 
 
2.7 Megakaryocytes and Thrombopoietin  
Megakaryocytes are produced by megakaryoblasts and they are mainly located in 
the bone marrow. With a diameter of 35-150 µm they are the biggest cell type in 
this compartment. Normally, just a relatively small number resides in the bone 
marrow, but in cases of an infection the number can rapidly increase more than 
10-fold [Branehog et al. 1975]. These cells are characterized by many cell nuclei 
which posses a 16-fold set of chromosomes and their main function is to produce 
platelets. This is a thrombopoietin (TPO; see below) regulated process, triggered 
by the fusion of intracellular membranes leads to a constriction of single platelets 
and takes place in the Golgi-apparatus. Megakaryocytes can release between 
500-5000 platelets and after this cell disrupting event the remaining nucleus is re-
moved by macrophages [Junquiera et al. 2005]. Recently it was demonstrated that 
megakaryocytes release pro-platelets by extending cell elongations into micro 
vessels in the bone marrow. In these intravascular compartments pro-platelets are 
abrupted by shearing forces of the blood flow [Junt et al. 2007]. 
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Figure 13  Platelet production by megakar-
yocytes.  Megakaryocytes release platelets 
directly into the blood flow. Single platelets are 
constricted through the formation of new mem-
branes by a process that is triggered by throm-
bopoietin.  
 
adapted from http://www.rndsystems.com/cb_detail_ 
objectname_sp06_hspc.aspx 
TPO, the main trigger for megakaryocyte synthesis is produced in several organs, 
like the liver or the kidney induced by 
interleukin 6 (IL-6), but also from stromal 
cells in the bone marrow [Kaushansky 
2006]. Although TPO is very important 
for megakaryocyte production it was 
shown, that TPO is not the only stimulus 
for the so called megakaryocytopoiesis 
[Bunting et al. 1997]. Other molecules 
that are involved in this activity are GM-
CSF, IL-3, IL-6, IL-11, the chemokines 
SDF-1 and FGF-4 [Avecilla et al. 2004] 
and erythropoietin (EPO) [Deutsch et al. 
2006]. Nevertheless, TPO is also abso-
lutely essential for the formation of 
platelets which was clearly demonstrat-
ed in transgenic mice lacking TPO or 
the TPO receptor (Mpl). Although in the-
se animals the platelets look normal in 
morphology and are able to function properly, the number of circulating platelets in 
the animals is remarkably reduced by about 90 % [Murone et al. 1998]. 
 
2.8 Neutrophil mobilization 
The regulation of circulating neutrophil numbers and their localization inside the 
body are extremely critical parameters for efficient innate immune responses. It is 
absolutely essential, that neutrophils are able to reach all tissues of an organism 
very fast to immediately display their antimicrobial actions thereby preventing the 
local settlement and, furthermore the systemic dissemination of pathogens. Be-
sides constituting a huge storage for resting neutrophils, bone marrow plays a cen-
tral role in the regulation of their release into the blood stream under at least two 
different circumstances: on the one hand the homeostatic release of mature neu-
trophils that patrol through the blood in search of potential pathogens and on the 
other hand the emergency release of neutrophils in response to an acute inflam-
matory signal. The complex mechanisms of neutrophil release remain very unclear 
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at present. A variety of chemotactic factors, like the leukotriene B4, C5a and the 
chemokine interleukin (IL)-8, have been shown to induce a rapid blood neutrophilia 
after i.v. injection into rabbits or mice. It is possible that such factors are able to 
build up a chemotactic gradient across the sinusoidal endothelium which guides 
neutrophils from the bone marrow into the blood stream and further directly to the 
infected tissue [Jagels et al. 1992; Jagels et al. 1995; Terashima et al. 1998].  
As noted earlier, peripheral blood neutrophil counts can increase rapidly in re-
sponse to an infection or other stress triggers. Although, the downstream signals 
that regulate this response are mainly undefined, recent reports suggest that 
CXCR4 may play an important role in this context. CXCR4 is expressed by neu-
trophils as well as by many other hematopoietic cells and its ligand, SDF-1 
(CXCL12), is constitutively expressed at high levels in the bone marrow stroma 
[Suratt et al. 2004] or in nestin positive MSCs [Mendez-Ferrer et al. 2010]. If indi-
viduals are treated with G-CSF this results in a decrease of SDF-1 expression in 
the bone marrow and in the down-regulation of CXCR4 expression on neutrophils 
[Kim et al. 2006; Semerad et al. 2002; Semerad et al. 2005a; Levesque et al. 
2003a]. This observation suggests the hypothesis that disruption of the CXCR4-
SDF-1 bond might play a key step in mediating neutrophil release by G-CSF. Fur-
thermore, animals in which either SDF-1 or CXCR4 has been knocked out show a 
massive spreading of immature myeloid progenitor cells into the blood circulation 
[Ma et al. 1998] and additionally, a treatment of individuals with AMD3100, a se-
lective antagonist for CXCR4 leads to the development of peripheral neutrophilia 
in both mice and men [Hendrix et al. 2000], further supporting that CXCR4 is a 
crucial mediator of neutrophil mobilization. The same effect was observed by ad-
ministration of CXCR4-blocking antibodies [Liles et al. 2003; Broxmeyer et al. 
2005; Suratt et al. 2004]. A recent work has demonstrated that SDF-1 and CXCR4 
also play a key role in controlling neutrophil homeostasis [Link 2005].  
Yet, the mechanisms by which CXCR4 signaling leads to migration of neutrophils 
towards the bone marrow venous sinuses and into the circulation in response to 
treatment with G-CSF are not well defined. Based on their well-characterized role 
in other aspects of neutrophil biology, like in various infection models [Murphy 
1997], it was recently hypothesized that G-CSF may trigger ELR+ CXC chemo-
kines to induce neutrophil migration into the bone marrow vascular space, by act-
ing contrary to the CXCR4/CXCL12 axis [Eash et al. 2010]. Thereby, the ELR+ 
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CXC chemokines KC and MIP-2 seemed to be the major inducer of neutrophil mi-
gration and both are strongly expressed in infected tissues [Safirstein et al. 1991; 
Huang et al. 1992; Bozic et al. 1995; Rovai et al. 1998; Fahey, III et al. 1990]. 
They can be characterized by their specific influence on neutrophils and they are 
able to signal through CXCR1 and CXCR2 [Eash et al. 2010]. Furthermore, ELR+ 
chemokines are known to be potent neutrophil chemoattractants and activators in 
cases of exogenous administration [Burdon et al. 2005; Laterveer et al. 1995; 
Opdenakker et al. 1998; King et al. 2001; Burdon et al. 2008]. Like many genes of 
chemokines, the gene expression of KC and MIP-2 is inducible in multiple different 
cell types and in response to a variety of proinflammatory stimuli [Rovai et al. 
1998; Sherry et al. 1992; Ohmori et al. 1994b; Ohmori et al. 1994a]. Moreover, 
both chemokines are known to be expressed in a great variety of acute and chron-
ic inflammatory situations. They seem to be the essential activators of the occur-
ring immune response, which controls the kind and also the extent of the resulting 
inflammation [Safirstein et al. 1991; Huang et al. 1992; Rovai et al. 1998; Fahey, III 
et al. 1990; Dilulio et al. 1999; Kielian et al. 2001; Miura et al. 2001]. 
 
 
Figure 14  G-CSF and the both chemo-
kines KC and MIP-2 act together to mo-
bilize neutrophils from the bone marrow 
into the circulation.  G-CSF reduces the 
expression of CXCR4 on neutrophils which 
results in a diminished adhesion of neutro-
phils to the bone marrow via SDF-1. The 
chemokines KC and MIP-2 act on the 
CXCR2 receptor on neutrophils and guide 
the cells out of the bone marrow to the 
side of infection by building up a chemo-
kine gradient [Furze et al. 2008].  
 
KC (CXCL1) and MIP-2 (CXCL2) are both ligands of the receptor CXCR2 and are 
constitutively expressed in bone marrow endothelium. Interestingly also MIP-2 ex-
pression in endothelial cells is increased during G-CSF–induced neutrophil mobili-
zation [Eash et al. 2010].  
It was shown that G-CSF and the chemokines KC and MIP-2 act together to mobi-
lize and recruit neutrophils to infected tissue. In this concept, G-CSF down-
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regulates the expression of CXCR4 on neutrophils, which leads to a reduced re-
tention of the cells via the CXCR4/SDF-1 axis [Wengner et al. 2008]. In a very re-
cent study a important role of CXCR2 was spotlighted besides the known signifi-
cance of CXCR4 during G-CSF mobilization [Eash et al. 2010]. By the using 
CXCR2-/- mixed bone marrow chimeras an extended model to explain neutrophil 
mobilization from the bone marrow was established. Interestingly it could be 
shown that CXCR2 and CXCR4 act antagonistically to regulate neutrophil release. 
Moreover it was demonstrated that under basal conditions more chemokines are 
produced which are responsible for neutrophil adhesion, preferentially CXCL12, 
whereas under stress conditions KC and MIP-2 are heavily produced to exceed 
the level of retention signals and to direct a high number of neutrophils into the 
circulation. But this was only shown during long term experiments, where mice 
were treated with G-CSF repetitively over seven days [Eash et al. 2010]. 
 
2.9 Intravital 2-photon microscopy 
In the last years 2-photon microscopy became a heavily used technique to clarify 
open questions in the field of immunology. Despite multiple possibilities to analyze 
immune cell motility and interactions in vitro the most relevant method to analyze 
this behavior is to directly observe cells in their natural environment in different 
organs and tissue. The idea of intravital microscopy came up in the nineteen’s 
century, but multi-photon microscopy is a relatively recent approach [Williams 
B.Swaim 2010]. It is based on a concept of Maria Göppert-Mayer [Göppert-Mayer 
M. 1931] and was finally developed from Winfried Denk in 1990 [Denk et al. 1990]. 
The concept of this special microscopy technique is based on a long wavelength 
excitation that allows a deep tissue penetration. For that, a phenomenon is used 
which is called optical window. It describes the wavelengths between 800 – 1200 
nm where light have the ability to penetrate tissues with the maximum depth 
[Tromberg et al. 2000].  
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Figure 15  Generation of 3-D time lapse data with 
intravital 2-photon microscopy.  A tissue sample is 
raster scanned by a single laser beam. Several stacks 
of the same area are detected in a defined time period 
(15 s) and afterwards rendered to 3-D pictures [Su-
men et al. 2004]. 
 
Unfortunately, because of the low energy of a long wavelength one single photon 
is not able to excite a conventional fluorescent molecule. Two photons are needed 
to provide enough energy. But the probability that both photons are absorbed 
nearly simultaneously at the same fluorochrome is very low. To increase the pos-
sibility for such events, a femtosecond laser that pulses every 12.5 ns (80 MHz) 
which each pulse having a duration of just 100 fs is used generally to provide a 
high flux of photons. Normally, these lasers can emit a wavelength between 700 
and 1000 nm [Williams B.Swaim 2010]. To increase the fluorescence the laser is 
limited on a beam waist of < 1 µm what results in a  very compact focusing [Denk 
et al. 1990]. This leads to an excitation in only one single plane of the analyzed 
material. However, besides the long wavelength the extremely focused laser beam 
reduces photo bleaching and damage in the observed preparation which allows a 
relatively long microscopy period in the observed tissue [Williams B.Swaim 2010]. 
Additionally, besides the normal fluorescence also second harmonic generation is 
produced during 2-photon microscopy [P.A.Franken 1961]. This phenomenon oc-
curs when an intense laser beam induces fluorescent radiation of the double fre-
quency under distinct conditions, in this case during scanning special tissues like 
the collagen of muscles [Cox et al. 2003], bone [Kohler et al. 2009] or lung tissue 
[Bruns et al. 2010]. The wavelength of the second harmonic generation displays 
exactly the half wavelength of the incoming light and notably this kind of auto fluo-
rescence does not lead to any photo bleaching. Second harmonic generation is a 
useful tool for a better orientation in the tissue where 2-photon microscopy is per-
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formed [Friedl et al. 2007]. 
In the last years, several extremely interesting observations in the field of immu-
nology have been made by using 2-photon microscopy. This was supported by the 
generation of various new fluorescent dyes for cell and tissue staining. Additional-
ly, several transgenic mouse models were established that express fluorescent 
proteins under the control of distinct immune cells for example Lys-EGFP mice, 
that express enhanced GFP under the control of the lysosome M promoter, lead-
ing to green fluorescent neutrophils [Faust et al. 2000]. The tissues, mainly used 
for the 2-photon microscopy are the inguinal or popliteal lymph nodes and the 
bone marrow of the skull but in the last years with proceeding experience also 
other organs became feasible like the central nervous system (CNS), liver or 
spleen. With the unique possibility for very deep tissue penetration compared to 
single-photon excitation, depths of 450 µm in the lymph nodes and around 200 µm 
in the bone marrow can be reached. The further development of scan heads de-
creases the time that is needed to scan a single plane in an area observed by mi-
croscopy. This allows the acquisition of many planes in one preparation that can 
be rendered into 3-D stacks afterwards (Figure 15). Moreover, it is possible to de-
tect multiple imaging stacks from the same area that enable the creation of 3-D 
time lapse movies [Sumen et al. 2004]. Different parameters can be measured 
within the recorded data for example cell-cell interactions or contact times between 
different cell types, mainly between T cells and antigen presenting cells (APCs) 
like dendritic cells [Mempel et al. 2004a] or B cells. Another possibility is to deter-
mine the interaction of cells with their environment like leukocyte adhesion to en-
dothelial cells [Mempel et al. 2004c] or the interactions of hematopoietic stem cells 
with their niche [Mendez-Ferrer et al. 2010; Kohler et al. 2009]. Moreover, the mo-
tility and migration of cells is heavily studied. Examples are the homing and migra-
tion of T cells in the popliteal lymph note [Mempel et al. 2004a; von Andrian et al. 
2003] and B cell behavior in germinal centers of lymph nodes [Hauser et al. 2007]. 
Furthermore, leukocyte migration in blood vessels and tissues [Mempel et al. 
2004b] were analyzed.  
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2.10 Aim of the study 
In the last years, intravital 2-photon microscopy became more and more important 
to answer longstanding unresolved questions in living animals. It enables the anal-
ysis of cell migration in time-lapse recordings of 3D tissue reconstructions [Caha-
lan et al. 2002]. 
The bone marrow supports intense traffic of blood cells in the extra vascular space 
and at the interface with the intravascular compartment. Also the special microen-
vironment provided by the bone marrow is critical for the regulation of hematopoi-
etic cell behavior. For this reason the 2-photon microscopy is a very important ap-
proach to determine cell motility and interactions with the inner bone surface under 
different conditions. Unfortunately, the thickness of bone surrounding BM cavities 
in most anatomical locations renders these tissues inaccessible for in vivo imaging 
[Pannarale et al. 1997]. Until know there was just one model for bone marrow im-
aging available which visualizes the BM in the flat bones of murine skull. But for all 
in vitro studies with hematopoietic cells, these are isolated from murine long bones 
and also immunohistological stainings of bone marrow are performed on slices 
from long bones. To compare these data directly with results from 2-photon mi-
croscopy we concluded that the imaging should be performed in long bones. 
Moreover, it was recently shown, that skeletal progenitor cells from the calvaria 
are not able to form stem cell niches as efficiently as skeletal progenitor cells from 
fetal long bones [Chan et al. 2009]. For these reasons we established a complete-
ly new method for intravital 2-photon microscopy that allows the visualization of 
cells in the bone marrow of murine long bones.  
With this new approach we first wanted to analyze the motility and localization of 
hematopoietic progenitor cells and early hematopoietic progenitor cells with re-
spect to aging. Aged hematopoietic stem cells are impaired in supporting hemato-
poiesis and this is thought to be, at least in part, a consequence of the aging [Gei-
ger et al. 2002; van Zant et al. 2003; Rando 2006]. Multiple cellular and molecular 
mechanisms have been implemented in hematopoietic stem cell aging. However, 
it was recently postulated that aged in contrast to young primitive hematopoietic 
cells present with altered, less favorable interactions with the niche, which might in 
part explain impaired hematopoiesis in aged individuals. This hypothesis should 
be clarified by intravital 2-photon microscopy, with the idea, that the reduced ad-
hesion of HPCs and eHPCs might result in a larger distance of these cells to the 
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endosteal layer and maybe also in increased motility.  
The second part of the study focused on neutrophil behavior after G-CSF treat-
ment. This drug induces rapid neutrophil mobilization from the bone marrow into 
the circulation, but the underlying mechanisms are completely unknown. In the 
beginning the first view on neutrophils in the bone marrow of long bones under 
steady-state and G-CSF induced conditions should be realized. Afterwards the 
central question was how neutrophils react to G-CSF on the single-cell level direct-
ly after injection. Finally, the molecular mechanisms leading to the rapid release 
from bone marrow should be identified. Essentially, a detailed understanding of 
the role G-CSF plays in the process of neutrophil mobilization might deliver valua-
ble new insights, how this process could be improved in neutropenic patients to 
further minimize their risk for different, severe infectious diseases. 
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3. Materials and Methods 
3.1 Materials 
3.1.1 Mice 
Age- and sex-matched animals of 8 to 16 weeks of age were used for most exper-
iments. Experiments with old animals were performed with mice of 20-22 months 
of age. They were derived from the animal barrier facility at Cincinnati Children’s 
Hospital Medical Center (CCHMC) or obtained from aged rodent colonies of the 
National Institute on Aging (Harlan). 
C57Bl/6 mice were purchased from Harlan Winkelmann (Borchen), Charles River 
(Sulzfeld) or The Jackson Laboratory and subsequently housed in the animal bar-
rier facility at the Otto-von-Guericke University (OvGU, Magdeburg). Animals ex-
pressing an enhanced green fluorescent protein (EGFP) under the lysozyme-
promoter (Lys-EGFP mice) were provided by Thomas Graf (The Albert Einstein 
College of Medicine, USA). Animals expressing EGFP under the fractalkine recep-
tor CX3CR1 (CX3CR-EGFP mice) were provided by Steffen Jung (Weizmann In-
stitute, Israel). c-mpl ko mice (TPO-/-) were provided from Oliver Winter (Charitè 
Berlin). In these mice the receptor of TPO (c-mpl) is disrupted in embryonic stem 
cells by insertion  of a neomycin resistance marker [Gurney et al. 1994]. 
All animals were housed in a specific pathogen free (SPF) environment at the 
CCHMC barrier facility or at the OvGU facilities. 
 
3.1.2 Buffers and additives 
 Fetal calf serum (FCS) 
FCS (Integro) was heat-inactivated for 30 minutes at 56 °C before use. 
   
 PBS (Phosphate buffered saline)   
 136.9 mM NaCl 
 2.7 mM KCl 
 8.1 mM Na2HPO4 + 2 H2O 
 1.47 mM K2HPO4 
Dissolved in 1000 ml dist. H2O, pH 7.4, autoclaved. PBS was used unmodified or 
supplemented with 1 % FCS. 
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 Erythrocyte lysis buffer   
 0.15 mM NH4Cl 
 1 mM KHCO3 
 0.1 mM  Na-EDTA 
Dissolved in 500 ml dist. H2O, sterile filtered 
  
 Iscove`s Modified Dulbecco`s Medium (IMDM) 
IMDM  (Gibco) was supplemented with 2 % FCS or 10 % FCS. 
  
 Hanks buffered salt solution (HBSS) 
HBSS  (Gibco) was supplemented with 2 % FCS. 
 
3.1.3 Antibodies and fluorescent markers 
3.1.3.1 Antibodies for stem cell isolation (LIN-Cocktail) 
Specificity Source Isotype Clone 
Final conc.  
in LIN cocktail 
CD5 (Ly-1) Biotin 
BD-Biosciences 
(Heidelberg, 
Deutschland 
IgG2a, k 53-7.3 111.1 μg/ml 
B220 (CD45R) Biotin 
BD 
Biosciences 
IgG2a, k RA3-6B2 74.1 μg/ml 
Mac-1 (CD11b) Biotin 
BD 
Biosciences 
IgG2b, k M1/70 70 μg/ml 
CD8a (Ly-2) Biotin 
BD 
Biosciences 
IgG2a, k 53-6.7 111.1 μg/ml 
Gr-1 (Ly-6G/6C) Biotin 
BD 
Biosciences 
IgG2b, k RB6-8C5 63.7 μg/ml 
TER-119 (Ly-76) Biotin 
BD 
Biosciences 
IgG2b, k TER-119 70 μg/ml 
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3.1.3.2 Antibodies for stem cell isolation (FACS) 
Specificity Source Isotype Clone Final conc. 
Streptavidin FITC 
Isotype control 
BD 
Biosciences 
-- -- 6 µg/ml 
Streptavidin PE  
Isotype control 
BD 
Biosciences 
-- -- 3 µg/ml 
Streptavidin APC 
Isotype control  
BD 
Biosciences 
-- -- 6 µg/ml 
Streptavidin FITC 
Stem cell staining 
BD 
Biosciences 
  3.3 µg/ml 
c-Kit (CD117) APC 
Stem cell staining 
BD 
Biosciences 
IgG2b, k 2B8 1.25 µg/ml 
Sca-1 (Ly6A/E) PE 
Stem cell staining 
BD 
Biosciences 
IgG2a, k E13-161.7 1.25 µg/ml 
CD16/CD32 
BD 
Biosciences 
IgG2b, k 2.4G2 5 µg/ml 
7-Aminoactinomycin  
(7-AAD) 
Molecular 
Probes 
-- -- 5 μg/ml 
 
3.1.3.3 Antibodies for FACS analysis 
Specificity Source Isotype Clone Application Final conc. 
Gr-1 (Ly6G/6C) PE 
BD 
Biosciences 
IgG2b, k RB6-8C5 FACS 200 μg/ml 
F4/80 FITC 
BD 
Biosciences 
IgG2b, k BM8 FACS 200 μg/ml 
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3.1.3.4 Antibodies for mouse injections 
Specificity Source Isotype Clone Application 
Final conc. 
per mouse 
(20g) 
Anti KC antibody 
R&D Sys-
tems 
IgG2a 48415.111 
FACS and 2-
photon micros-
copy 
50 µg 
Anti MIP-2 anti-
body 
R&D Sys-
tems 
IgG2b 40605 
FACS and 2-
photon micros-
copy 
20 µg 
anti-Gr-1 anti-
body 
Bioxcell 
Rat 
IgG2b 
RB6-8C5 FACS  823 µg 
Rabbit CXCR2 
antiserum 
[Carlson et 
al. 2008b] 
-- -- 
FACS and 2-
photon mi-
croscopy 
-- 
Normal rabbit se-
rum 
[Carlson et 
al. 2008b] 
-- -- 
FACS and 2-
photon micros-
copy 
-- 
IgG2a Isotype con-
trol 
BD 
Biosciences 
-- -- 
FACS and 2-
photon micros-
copy 
50 µg 
IgG2b Isotype con-
trol 
BD 
Biosciences 
-- -- 
FACS and 2-
photon micros-
copy 
20 µg 
IgG Isotype control Acris -- - 
FACS and 2-
photon micros-
copy 
100 µg/ml 
 
3.1.3.5 Fluorescent dyes for in vivo imaging 
Specificity Source Application 
Carboxy Fluorescein Succinimidyl Ester 
(CFSE) 
Molecular Probes Cell staining 
Cell Tracker Orange (CTO) Molecular Probes Cell staining 
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Specificity Source Application 
Rhodamine-Dextran 40kD Sigma-Aldrich 
blood vessels 
staining 
 
3.2 Methods 
3.2.1 General Methods 
3.2.1.1 Mouse handling 
3.2.1.1.1 Intraperitoneal injection 
For intraperitoneal (i.p.) injections the relevant compounds were dissolved and 
diluted in sterile PBS to the desired concentration. A maximal volume of 500 μl 
was injected into the peritoneum using a fine dosage syringe with an integrated 
0.3 x 12 mm cannula (Braun Omnican F). 
 
3.2.1.1.2 Retroorbital i.v. injection 
Mice were slightly anaesthetized by isoflurane (CuraMed Pharma) inhalation. The 
antibodies, cells or dyes were injected into the retro-orbital sinus at a maximal vol-
ume of 200 μl sterile PBS using a fine dosage syringe with integrated 0.3 x 12 mm 
cannula (Braun Omnican F). 
 
3.2.1.1.3 Ketamin-Rompun narcosis 
For a mouse narcosis lasting up to 1 h, 1 ml Ketamin [50 mg/ml] and 0.5 ml 
Rompun [2 %] were mixed with 3.5 ml sterile NaCl and 100 μl per 10 g animal 
body weight were injected i.p. 
 
3.2.1.1.4 Bleeding 
Mice were slightly anesthetized by isoflurane inhalation and 75 µl blood were col-
lected by retro-orbital puncture with a capillary tube into a 1.5 ml test tube contain-
ing 20 µl Heparin-Sodium (168 U/ml final concentration) to avoid coagulation.  
 
3.2.1.2 Isolation of bone marrow cells 
Mice were killed by cervical dislocation. The hind limbs were disinfected with 70 % 
ethanol and the skin was removed. The paws were clipped and the thigh was sep-
arated from the shank by a cut through the knee joint. Now the muscles were care-
fully removed from the thigh with scissors and the femur was taken out of the hip. 
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The tibial muscles were relieved by down-pulling with the scissors and the ex-
posed bones were stored in PBS supplemented with 1 % FCS. Afterwards the 
bone marrow was flushed out of the bones with a 21G cannula connected to a 5 
ml syringe into a 50 ml test tube filled with 10 ml PBS + 1 % FCS. To get a single 
cell suspension it was resuspended carefully and the suspension was filtered 
through a cell strainer (100 µm pore diameter). 
To isolate bone marrow from old mice the fragile bones were pestled in 10 ml PBS 
+ 1 % FCS. After grinding the suspension was removed and filtered through a 100 
μm cell strainer (Falcon BD). In order to loose as little cells as possible the mortar 
was washed twice with 10 ml PBS + 1 % FCS and these fractions were pooled 
with the first filtrate. This alternative protocol was also used for some bone marrow 
isolations from young mice to increase the number of isolated cells. 
 
3.2.1.3 Isolation of splenocytes 
Mice were killed by cervical dislocation. The spleen was removed and stored in a 
50 ml tube containing 10 ml PBS + 1 % FCS. To get a single cell suspension, the 
organ was ground through a 100 μl cell strainer with the piston of a 5 ml syringe 
into a cell culture plate. The cell suspension was centrifuged (5 min, 400 x g, RT) 
and the supernatant was discarded. To eliminate red blood cells, the precipitated 
cells were resuspended in 5 ml erythrocyte lysis buffer per spleen. The cells were 
agitated with a pipette for 1 min, and then incubated for 5 min at RT. Administra-
tion of 40 ml PBS + 1 % FCS stopped the lysis reaction and the cells were centri-
fuged (5 min, 400 x g, RT). After washing in 50 ml PBS (5 min, 400 x g, RT) cells 
were resuspended in 5 ml PBS and the cell number was calculated (view 3.2.3). 
1∙107 cells were transferred to a 96 well plate for antibody staining. 
 
3.2.1.4 Estimation of cell numbers in a cell suspension 
For calculating the cell number in a suspension, an aliquot of 10 µl cell suspension 
was mixed 1:1 with trypan blue (0.4%) and transferred into a Neubauer counting 
chamber. Trypan blue stained cells were regarded as dead and excluded from 
counting.  
 
3.2.1.5 Fluorescence activated cell sorting (FACS) analysis  
To analyze blood samples the total volume of 75 μl (see 3.2.1.1.4) was transferred 
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into a 96 well plate and 150 µl erythrocyte lysis buffer were added to eliminate red 
blood cells. The solution was agitated with a pipette for 1 min, and incubated for 5 
min at room temperature (RT). After centrifugation (5 min, 400 x g, RT), the super-
natant was discarded and the erythrocyte lysis repeated twice as described above. 
Then the cells were washed once with 200 µl sterile PBS and used for FACS anal-
ysis  
For BM analysis the precipitated (5 min, 400 x g, RT) cells (view 3.2.1.2) were re-
suspended in 5 ml erythrocyte lysis buffer per two hind limbs. The suspension was 
agitated with a pipette for 1 min, and then stored for 5 min at RT. The reaction was 
stopped by administration of 40 ml PBS + 1% FCS. After a centrifugation step (5 
min, 400 x g, RT) the cells were washed in 50 ml PBS (5 min, 400 x g, RT) and 
resuspended in 1 ml PBS. Then the cell number was estimated and 1∙107 cells 
were transferred to a 96 well plate for antibody staining. 
For antibody staining, the precipitated cells from different sources were resus-
pended in 80 µl of the relevant antibody solution (in sterile PBS) and incubated for 
10 min at RT in the dark. Afterwards the cells were washed with 200 µl PBS (5 
min, 400 x g, RT), the supernatant was discarded and the cell pellet resuspended 
in 500 µl PBS. FACS-analysis was performed on a BD FACSCalibur and analyzed 
using DAKO’s “Summit” software. 
 
3.2.2 Stem cell specific methods 
3.2.2.1  Preparation of hematopoietic progenitor cells (HPCs) and early hema-
topoietic progenitor cells (eHPCs) 
Before use Dynabeads (Dynal) must be washed carefully. In the first step the en-
tire 5 ml of beads were transferred into a 15 ml test tube. Then 10 ml IMDM + 2 % 
FCS were added and the beads separated with a strong magnet (Dynal). After 3 
minutes the medium was removed with a 5 ml pipette and the tube taken out of the 
separator. The beads were resuspended in 10 ml IMDM + 2 % FCS before the 
tube was again applied to the separator for 3 minutes. After this step the medium 
was carefully removed. This washing procedure was repeated twice and finally the 
beads were resuspended in 5 ml IMDM + 2 % FCS and stored at 4 °C. The whole 
procedure was performed under sterile conditions. 
To isolate the HPCs and HSCs from a bone marrow derived cell suspension by 
FACS, most of the unwanted, mature cell types (LIN-positive cells) were eliminat-
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Figure 16  Enrichment of leukocytes.  A Ficoll gradient 
centrifugation can separate leukocytes from other bone 
marrow cells. A suspension of whole bone marrow cells is 
placed on Ficoll very carefully. The density of the Ficoll has 
to be lower than the density of leucocytes but higher than 
the density of erythrocytes.  
 
Adapted from http://edoc.hu-berlin.de/dissertationen/wentges-marek-
2004-12-13/HTML/chapter2.html 
ed by positive magnetic depletion. This step was based on an antibody cocktail, 
containing antibodies directed against the most common mature cell types, resid-
ing in the bone marrow (view 2.2.2).The isotype of all antibodies in this cocktail 
was rat immunoglobulin IgG2 and therefore the labeled cells were depleted by ad-
dition of sheep anti-rat IgG coated Dynabeads. 
In detail, bone marrow of 10 C57Bl/6 mice was isolated as described above (view 
3.2.1.2). After filtration the cells were centrifuged (5 min, 400 x g, RT), resuspend-
ed in 24 ml HBSS + 2 % FCS (RT) and the cell number was calculated (view 
3.2.1.2). 16 ml of Ficoll (1083, Sigma) were put in a 50 ml tube and carefully over-
layed with the cell suspen-
sion at room temperature. 
With the following centrifu-
gation (25 min, 600 x g, RT, 
without brake) a gradient 
was formed, which separat-
ed leukocytes from erythro-
cytes (Figure 16). The leu-
kocyte fraction was removed 
and transferred into a new 
50 ml tube. All next steps 
were done at 4 °C. To get 
rid of the Ficoll, the cells 
were washed twice with cold 
IMDM + 2 % FCS, first with 
50 ml, then with 25 ml (5 
min, 400 x g, 4 °C). The precipitated cells were resuspended in 3 ml IMDM + 2 % 
FCS and counted again. Per 1x108 cells, 112.4 µl LIN cocktail were added and 
agitated 25 min at 4 °C. Afterwards the cells were washed twice with 25 ml IMDM 
+ 2 % FCS (5 min, 400 x g, 4 °C). Dynabeads were added to the cell suspension 
in a four beads per cell ratio (concentration of bead stock: 4x108 beads/ml) and 
agitated 25 min at 4 °C. After this incubation step, the cells were transferred into a 
15 ml test tube and filled up with IMDM + 2 % FCS to a total volume of 8 ml. With 
the aid of a magnetic separator the bead bound LIN positive cells were precipitat-
ed. The supernatant containing the LIN negative cells was removed, transferred to 
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a new 15 ml tube and the separation was repeated at least three times. Precipitat-
ed beads were washed in 7 ml IMDM + 2 % FCS afterwards to obtain all unbound 
cells in the supernatant and this fraction was also separated three times. Both 
suspensions were combined in a 50 ml test tube and spun for 5 min at 400 x g at 4 
°C. Precipitated cells were then resuspended in 1 ml IMDM + 2 % FCS. After cal-
culating the cell number, 10 µl of the FC-block antibody mixture CD16/CD32 were 
added to the cells in order to avoid unspecific binding of the monoclonal antibodies 
which were subsequently used for the fluorescent based stem cell sort. After incu-
bation for 15 min at 4 °C with gentle shaking, three fluorescent dye coupled rea-
gents were added: 
 
Antibody Stock concentration Dilution Amount 
Strept.-FITC (fluorescein) 0.5 mg/ml 1:150 6.60 µl 
c-Kit APC-
(allophycocyanin) 
0.2 mg/ml 1:160 6.25 µl 
Sca-1-PE (phycoerythrin) 0.2 mg/ml 1:160 6.25 µl 
 
As all antibodies of the LIN-cocktail were biotinylated the streptavidin-FITC stain-
ing could be used as indicator for contaminating LIN positive cells. Additionally the 
eHPCs and HPCs were stained for their specific receptors with the monoclonal 
anti-c-Kit and anti-Sca-1 antibodies. The cells were agitated 20 min at 4 °C and 
then washed for the last time (5 min, 400 x g, 4 °C) in 25 ml IMDM + 2 % FCS. For 
the cell sorting the cells were resuspended in 500 l IMDM + 2 % FCS, supple-
mented with 7-Aminoactinomycin (7-AAD) [1 mg/ml]. This reagent specifically 
stained dead cells and thus allowed gating on living cells during the sort. In paral-
lel, 5 single color control stainings (FITC, APC, PE, 7-AAD, unstained) were pro-
duced from 10 μl each of the bone marrow cell suspension to adjust the FACS 
compensation settings. 
For the isolation of early progenitor and progenitor cells, a MoFlo cell sorter 
(DAKO) was used. A careful selection of the right cell populations was required to 
finally receive the correct cell types. In the first step a gating on living cells was 
realized using the 7-AAD signal (Figure 17 a)). Additionally this gate was com-
bined with the established and expected forward scatter (FSC)/side scatter (SSC) 
morphology (Figure 17 b)). Subsequently HPCs and eHPCs were indicated by the 
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fact, that eHPCs express the receptor c-Kit as well as the receptor Sca-1. In con-
trast, HPCs were positive for the c-Kit receptor but negative for Sca-1. This al-
lowed a separation of these two cell populations (Figure 17 c)). eHPCs and HPCs 
were sorted into 15 ml tubes filled with 1 ml IMDM + 10 % FCS respectively. After 
sorting both isolated cell populations were tested for their purity by FACS (Figure 
18). 
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Figure 17  Example of an early hematopoietic progenitor cells and hematopoietic progenitor 
cell isolation via cell sorting.  a) The first step was to eliminate dead cells by the 7-AAD signal. b) 
Secondly it was gated on cells with the right FSC/SSC morphology. c) Both desired cell populations 
were separated by their different expression of the surface receptors c-Kit and Sca-1 (R5: HPC, R6: 
eHPC). 
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Figure 18  Purity test of the isolated early hematopoietic progenitor cells and hematopoietic 
progenitor cell.  Clear populations of either a) HPCs (c-Kit
+
, Sca-1
-
) or b) eHPCs (c-Kit
+
, Sca-1
+
) 
were obtained. 
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3.2.3 Neutrophil specific methods 
3.2.3.1 Neutrophil mobilization with G-CSF 
The entire volume of a Neupogen® syringe (Amgen GmbH, 300 µg/0.5 ml or 480 
µg/0.5 ml) was flushed into a 1.5 ml test tube and stored at 4 °C. For neutrophil 
mobilization 100 µg G-CSF per kg animal weight, diluted in a volume of 100 µl 
sterile PBS was injected i.v. into the retro-orbital plexus. Control animals received 
100 µl pure PBS. Samples of blood or other organs were collected 2 h after mobi-
lization.  
 
3.2.3.2 Neutrophil mobilization with AMD3100  
To mobilize cells with AMD3100 (Sigma-Aldrich) 100 μl of a 1 mg/ml solution in 
H2O/PBS (1:4 v/v) were injected i.v. into the retro-orbital plexus. 2 h later 75 μl of 
peripheral blood were analyzed for neutrophil counts. Control animals received 
100 μl H2O/PBS. 
 
3.2.3.3 Neutrophil mobilization with thrombopoietin  
100 μl of 10 μg/ml murine thrombopoietin (R&D Systems) solution in PBS were 
injected i.v. into the retro-orbital plexus. 2 h later 75 μl of peripheral blood were 
analyzed for neutrophil counts. Control animals received 100 μl PBS. 
 
3.2.3.4 Anti KC and anti MIP-2 treatment for inhibition of neutrophil mobiliza-
tion  
For Inhibition of the chemokines KC and MIP-2 50 µg monoclonal anti-KC and 20 
µg anti-MIP-2 antibodies, diluted in PBS were administered in a total volume of 
100 µl per animal simultaneous. The injection route was either i.v. or i.p. at differ-
ent time points. Likewise, control animals received equivalent concentrations of 
IgG2a and IgG2b isotype controls the same way. 
 
3.2.3.5 Inhibition of neutrophil mobilization by blocking CXCR2 
To block CXCR2 in vivo, 100 μl of rabbit anti-CXCR2 antiserum were injected i.p. 
48 h before mobilization with G-CSF. Control animals received equal amounts of 
normal rabbit serum (NRS). For some experiments the antibody was titrated down 
to 10 μl, always diluted in sterile PBS to a total volume of 100 μl. 
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3.2.3.6 Antibody mediated neutrophil depletion  
For depletion of neutrophils, 100 µg of an anti-Gr-1 antibody (RB6-8C5, Bio X Cell, 
USA) were injected intraperitoneally in a total volume of 100 µl 48 h before onset 
of the experiment. Control animals were likewise treated with 100 µg of a control 
rat IgG. 
 
3.2.3.7 Acute peritonitis model 
An acute peritonitis was induced by injection of 500 µl 3 % thioglycollate broth 
(Sigma Aldrich) i.p. Control animals were treated with 500 µl PBS following the 
same protocol. After 2 h a peritoneal lavage was performed. Therefore mice were 
killed by cervical dislocation. 5 ml PBS + EDTA were injected into the peritoneum 
with a 20 G cannula attached to a 5 ml syringe. After one minute of belly massage 
the maximal possible volume of PBS cell suspension was drawn out of the perito-
neum using the same syringe. The cells were analyzed by FACS for the amount of 
Gr-1 positive cells. Additionally, bone marrow and peripheral blood were collected 
and analyzed for the occurrence of neutrophils. 
To inhibit the formation of an acute peritonitis 50 µg anti-KC and 20 µg anti-MIP-2 
antibodies were injected simultaneously in a total volume of 500 µl PBS i.p. 20 
minutes before induction of the peritonitis. Control animals received equivalent 
concentrations of anti-IgG2a and IgG2b-isotype controls in 500 µl PBS likewise. 
 
3.2.4 Intravital 2-photon microscopy 
3.2.4.1 Cell staining for 2-photon microscopy 
Cells were stained for in vivo microscopy either with CFSE [5 µM] or CTO [25 µM] 
in 1 ml PBS. After incubation at room temperature for 10 minutes in the dark, the 
staining was stopped by administration of 15 ml PBS + 1 % FCS. Before injection 
into mice, cells were washed once with PBS (5 min, 300 x g, RT). 
 
3.2.4.2 Blood vessel staining for 2-photon microscopy 
To visualize the blood vessels and blood flow during in vivo microscopy, 200 μl of 
Rhodamine-B-Isothiocyanate labeled 40kD dextran ([2 mg/ml], Sigma) in sterile 
PBS were injected retro-orbitally right before onset of the imaging. 
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3.2.4.3 Mouse narcosis and bone preparation 
The in vivo 2-photon microscopy was performed up to 12 h and so for the whole 
time period mice needed to be narcotized. To assure a deep narcosis, an intuba-
tion anesthesia with oxygen + 1 % isoflurane was chosen. In the beginning the 
mice were slightly anesthetized by a Ketamin-Rompun injection (view 3.2.1.1.3) to 
allow the intubation procedure. Then the animals were fixed with an elastic band at 
their teeth on a bevel (Figure 19 a) and b)). With a forceps the tongue was pulled 
to one side and a tracheal tubus was inserted very carefully into the trachea which 
was clearly detectable by the illumination with a goose neck lamp. Through the 
tubus animals were mechanically ventilated by a small animal respirator (MiniVent, 
Hugo Sachs, Germany) with a breathing rate of 250 per minute. Oxygen + Isoflu-
rane were mixed with a vaporizer (Univentor, Uno, Netherlands) and a volume of 
250 µl per breath was inhaled by the animal (Figure 19 c)). 
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a) 
 
b) 
 
c) 
 
Figure 19  Mouse fixation for intubation and narcosis.  a) The animal was fixed with its front 
teeth on a bevel. b) The throat was illuminated to facilitate the finding of the trachea, which was 
detectable as a small bright whole in the deeper part of the mouth. c) Setup for mouse narcosis. 
In the upper part of the picture the vaporizer can be seen, which mixed the isoflurane with pure 
oxygen. This anesthetic gas was transferred to a respirator (foreground) by which a defined gas 
volume and the breathing rate could be adjusted. 
 
To allow 2-photon microscopy in the lower legs of mice these bones had to be ex-
posed and moreover, their surface structure had to be thinned to allow microscop-
ic imaging in the marrow. Therefore the skin was cut carefully directly along the 
bone. The overlaying muscles were removed with a scalpel, thereby especially 
avoiding bigger blood vessel injury. By using an electric drill (Dremel) with a sul-
foxide grindstone (model 997, Dremel) the bone was thinned, constantly observed 
with a stereo microscope to not totally remove the covering bone layer. The resid-
ual bone surface was kept at 30-50 µm thickness (Figure 20 E)). While drilling the 
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procedure was interrupted about every 10 seconds and the bone was cooled and 
washed with PBS to avoid an overheating of the treated area. 
 
 
Figure 20  Overview of the mouse treatment and long bone preparation for intravital 2-
photon microscopy.  A) Fixation of the mouse in the imaging chamber. The animal is ventilated 
and thereby anesthetized through a tracheal tubus with a mechanical small animal respirator at 
depicted rates and volumes. The gross area of bone thinning and imaging is boxed and the approx-
imate position of the microscope lens is indicated with a dashed arrow. Imaging can be performed 
anywhere within the red (thinned) area of the tibia. All fluorescently marked cells detectable within 
this area are recorded by individual Z-stacks. B) A close-up micrograph of a mouse fixed for imag-
ing with the position of the tibia indicated (white arrow). C) Schematic overview how the hind leg 
bones are positioned in the animal shown in panel B). D) Enlargement of the tibial bone rotated 
90°clockwise with the area of preparation indicated by the red color. E) Virtual side view of the tibial 
bone in the area of imaging to demonstrate the process of careful bone thinning by an electric drill. 
The residual bone surface is kept at 30 to 50 μm of thickness. The figure on the right shows ren-
dered images of a bone with fluorescently labeled (green) cells below the bone surface. The typical 
XYZ dimensions of the area of imaging are depicted. F) To demonstrate the practicability of the 
transplantation/visualization technique, BM cells were stained with CFSE (green) or CTO (red) and 
transplanted together in equal numbers in recipient animals. Cells were visualized by 2-photon 
intravital microscopy in the region close to the endosteum in the tibia (brown auto fluorescence 
signal of the calcified bone) 16 hours post injection. 
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3.2.4.4 Two-Photon microscopy 
After preparation of the bone, the anesthetized animals were transferred into a 
laboratory made imaging chamber. This chamber was lined with silicon, in which 
the mice were fixed with needles (Figure 21). Additionally, the chamber was heat-
ed by an external water bath to keep the animals at a temperature of 37 °C. During 
microscopy, pre-warmed PBS 
was filled into the chamber until 
the legs were covered with the 
buffer. Besides the warming of 
the animal, the fluid acted as an 
immersion medium for the water 
dipping objective.  
 2-photon microscopy of stem 
cells was mainly performed us-
ing a customized 2-photon mi-
croscope (TrimScope; LaVision 
BioTec) with detection either by 
a charge-coupled device (CCD) 
camera (multifocal illumination) 
or an array of independent pho-
to-multiplier tubes (PMTs) detec-
tors (single-point illumination). 
Bone tissue was identified due to 
its strong auto fluorescence (with 
CCD camera) under unfiltered light conditions or using its second-harmonic (SHG) 
signal (with PMT).  
Two-photon microscopy of neutrophils was performed using a Zeiss LSM-710 mi-
croscope with simultaneous detection via external non-descanned-detectors 
(NDDs). Neutrophils were detected via GFP-fluorescence, blood vessels by injec-
tion of Rhodamine-B-Isothiocyanate labeled 40 kD dextran (Sigma) and bone by 
its second harmonic generation (SHG)-signal. Movies were recorded during 1 - 3 h 
after injection of stimuli for 60 minutes each. Several experiments were done in 
individual animals for up to 6 h. 
For imaging, a 300 x 300 µm area (LaVision BioTec) or a 423 x 423 µm area 
 
Figure 21  Intubated animal under the 2-photon mi-
croscope.  The Imaging chamber with an intubated and 
fixed mouse was placed under the 2-photon micro-
scope. Pre-warmed PBS was added afterwards. 
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(Zeiss) was scanned in 31 steps of 4 µm down to 120 µm depth using an illumina-
tion wavelength of either 800 or 880 nm (MaiTai TiSa-laser) detecting green (530 
nm) and red (580 nm) fluorescence, as well as unfiltered light or SHG (480-nm 
emission). This sequence was repeated every 60 seconds for a total of up to 60 
minutes. 
 
3.2.4.5 Data analysis 
3.2.4.5.1 Processing of data with the rendering software “Volocity ®” 
After recording sequences with the 2-photon microscope, the image raw data were 
imported into the 3D rendering software Volocity (Improvision, Perkin Elmer, UK). 
By use of this software suite brightness and contrast of the different channels were 
optimized. Afterwards the movies were exported as video sequences in a com-
pressed avi format for further analysis. 
 
3.2.4.5.2 Cell tracking 
The motility of cells inside the bone marrow was determined using the laboratory 
made “cell-tracker” software [Reichardt et al. 2007]. By following single cells with 
the mouse cursor over the complete movie sequence the software recorded differ-
ent parameters of cell motility, which could be further analyzed. If possible, three 
independent areas with 25-30 cells respectively were determined per microscopic 
experiment. 
 
3.2.4.5.3 Generation of “Kinetic overlays”  
Kinetic overlays were used as a helpful tool to display cell motility at different time 
points in one picture. Three sequenced pictures from an avi file were imported into 
Corel Photo-Paint X3. Each picture was divided into the three single RGB chan-
nels that were recorded during microscopy. Just the channel, representing the 
cells was maintained, the other channels were deleted. Then the three sequenced 
pictures were combined. 
 
3.2.4.5.4 Calculation of cell distance to the endothelial layer 
The measurement of cell distances to the endosteal layer (inner bone surface) 
was performed with the help of the Volocity software. The black levels of the SHG 
channel (bone) of a respective picture were reduced, so that the bone structure 
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was just detectable and appeared as thin layer. Then an x,y,z-calibrated grid was 
blend in this picture from which the distances of a cell to the endosteal wall could 
be estimated.  
 
 
Figure 22  Distance measurement between cell and bone.  A CFSE stained cell and the brown-
ish bone structure were displayed within a calibrated grid of small units. The bone signal was re-
duced until it was barely visible. This allowed the calculation of the distance between bone and cell. 
The yellow bar demonstrates a representative distance of 9 μm. 
 
3.2.4.5.5 Statistical analysis 
Data are shown as mean +/- SEM or median (in column scatter plots). Data were 
analyzed using GraphPad Prismsoftware using the unpaired Student’s t test. Dif-
ferences were significant when p < 0.05 ( p < 0.05 * , p < 0.01 ** and  p < 0.001 
***). 
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4. Results  
4.1 Part I: Localization and dynamics of young and aged 
hematopoietic progenitor cells and early hematopoi-
etic progenitor cells in the murine bone marrow re-
vealed by intravital 2-photon microscopy 
The aim of the first part of this thesis was to visualize hematopoietic progenitor 
cells and early hematopoietic progenitor cells in the bone marrow of murine long 
bones by intravital 2-photon microscopy and to analyze their behavior under dif-
ferent conditions. These observations were of great interest as stem cells of this 
origin are regularly taken for different immunological assays (i.e. in vitro generation 
of dendritic cells from bone marrow progenitors) but a clear characterization of 
these cells was still lacking. Until now, all microscopic approaches to characterize 
hematopoietic progenitors were done in the calvarium of mice, where a small spot 
of bone marrow is located. In different publications these microscopic data were 
combined with immunohistological stainings taken from bone marrow slices of the 
murine femur and tibia. Recent studies [Lo et al. 2009] revealed that both sources 
of bone marrow display a unique and distinguishable hematopoietic activity.  
Based on this innovative work we believed that it was necessary to study hemato-
poietic cell behavior in vivo at the same place from where cells for in vitro ap-
proaches are normally isolated. To realize the in vivo observation of early hemato-
poietic progenitor cells in long bones of mice, a completely new method for 2-
photon microscopy was established. 
 
4.1.1 Visualization of hematopoietic progenitor cells and early 
hematopoietic progenitor cells in long bones of mice 
To study the behavior of hematopoietic progenitor cells (HPC, L-S-K+, Lineage- 
Sca-1- c-Kit+) and early hematopoietic progenitor cells (eHPC, L-S+K+, Lineage- 
Sca-1+ c-Kit+) in the bone marrow, eHPCs and HPCs cells were isolated by cell 
sorting, stained with either CFSE or CTO and adoptively transferred into untreated 
recipients (view 3.2.1.1.2). The intravital cell imaging in the tibiae of anesthetized 
animals was performed between 18 – 36 h after transfer by use of our newly de-
veloped imaging technique (view 3.2.4.4).  
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a) 
 
b) 
 
    
c) 
 
d) 
 
Figure 23  3-D rendering of eHPCs.  The cells were isolated from 8 weeks old C57Bl/6 mice, adop-
tively transferred into untreated WT recipients and visualized by intravital 2-photon microscopy in the 
bone marrow of the anesthetized recipient animals 24 h after transfer. Cells were stained with either 
CTO (red) or CFSE (green). The bone structure was recorded by its auto fluorescence and delineated 
in a brown color. The pictures a) - d) represent characteristic images from 4 independent experiments. 
All pictures were recorded with a magnification of 200x. View also supplemental movies 1 – 4. 
 
4.1.2 Localization and dynamics of hematopoietic progenitor cells 
in long bones of mice 
This self-established intravital 2-photon model allowed us to further describe the 
localization of HPC cells and eHPCs in the tibial bone marrow. A small number of 
these cells were found in direct contact with the inner bone surface (Figure 25) 
whereas most cells were located farther away (Figure 24 and Table 1).  
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Figure 24  eHPCs (CFSE stained) with a certain 
distance to the brown structure of the inner 
bone surface.  3D rendering, of an intravital 2-
photon image, detected with a magnification of 
200x. 
Figure 25  eHPCs (CFSE stained) in direct 
contact to the brown structure of the inner 
bone surface.  3D rendering, of an intravital 2-
photon image, detected with a magnification of 
200x. 
 
After performing a more detailed analysis of cell distances we found that 11 % of 
transplanted eHPCs had direct contact to the endosteum in the tibia, whereas just 
4 % of HPCs were in direct contact to the endosteal layer (Table 1). In addition, 
eHPCs resided closer to the endosteum compared to HPCs (11 µm vs. 19 µm; 
Table 1).  
 
Table 1  Overview over all detected HPCs and eHPCs, isolated from young mice in the bone 
marrow of C57Bl/6 recipients.  Two populations were detected, one smaller part in direct contact 
to the endosteum, the bigger part still in close vicinity, but not in contact. In the right lane the mean 
distance of all analyzed cells to the endosteum was calculated. n = number of experiments 
 
Number of all 
analyzed cells 
Percentage of cells 
with distance to the 
endosteum 
Percentage of cells in 
direct contact to the 
endosteum 
Mean distance to 
the endosteum in 
m 
eHPCs 
(L
-
S
+
K
+
) from 
young mice 
44 
n = 6 
88.6 11.4 10.72 
HPCs 
(L
-
S
-
K
+
) from 
young mice 
93 
n = 6 
95.7 4.3 18.94 
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Figure 26  Localization of HPCs (L-S-K+) and eHPCs 
(L-S+K+), isolated from young mice, to the endosteal 
layer.  Distance of HPCs and eHPCs from the endoste-
um; each dot represents a single cell; black horizontal 
bars depict the average distance; and red/blue horizontal 
bars depict the standard deviation. eHPCs are located 
significantly closer to the endosteum, compared to HPCs. 
*p < .05. 
 
Regarding the cell motility of both progenitor cell types we found that they did not 
show any displacement. Instead, all observed cells displayed a “running on the 
spot” behavior and just a proceeding protrusion movement in the cell periphery 
was detectable. To exclude that the staining and transfer procedure was responsi-
ble for the resting behavior of eHPCs and HPCs, also whole bone marrow cells 
were isolated and stained with CFSE and CTO. 16 h after adoptive transfer a valid 
number of these cells displayed a clearly detectable motility in the bone marrow 
(data not shown). Dye exchange experiments were performed, to exclude label 
specific influences and no influences of the dye could be detected with respect to 
cell localization in the bone marrow. 
 
 
Figure 27  Comparison of eHPCs, stained 
with either CFSE or CTO.  To exclude an 
influence of the cell staining referring to the 
cell distance to the endosteal layer, five ran-
dom cells from every staining were chosen. 
No difference in the cell localization was de-
tectable. 
 
To describe the “running on the spot” behavior of HPCs und eHPCs, we mathe-
matically quantified the extent of cell protrusion movement over time with the help 
of our cooperation partners from the CCHMC. New algorithms were developed to 
calculate both the change in volume and the surface area of the observed cells 
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over time. This analysis was based on data obtained from 2-photon microscopy. It 
revealed that HPCs as well as eHPCs presented an active cell protrusion move-
ment indicated by absolute changes in cell volume between time points (Figure 28 
a)) as well as by the variance in change of the cell volume (Figure 28 b)) and the 
variance in the change of the cell surface area (Figure 28 c)). The variance is a 
measure of variability, representing the extent of the changes in volume or cell 
surface area per 1 minute. By this analysis a trend was uncovered for HPCs being 
more active with respect to changes in the cell surface area compared to eHPCs.  
 
a) 
 
b) 
 
c) 
Figure  28  CFSE-labeled HPCs (L
-
S
-
K
+
) or eHPCs (L
-
S
+
K
+
) after transplantation into recipient 
animals.  Tibiae from recipient animals were analyzed between 16 and 40 hours after transplanta-
tion. a) Quantification of cell protrusion movement, determined as the change in volume over time 
(interval of 1 minute) of transplanted HPCs and eHPCs. b) Average variance in the change in cell 
volume in a 1 minute time interval of HPCs and eHPCs. c) Average variance in the change of cell 
surface area in a 1 minute time interval of HPCs and eHPCs cells. All data were calculated for n = 
169 changes for HPCs and n = 92 changes for eHPCs, based on at least 3 independent experiments 
for each cell population. 
 
4.1.3 Dynamics of differentiated hematopoietic cells in the bone 
marrow 
Since we did not detect profound motility of HPC and eHPC in vivo it was neces-
sary to put this behavior into the perspective of other bone marrow-resident cells. 
To describe the motile behavior of differentiated hematopoietic cells in the bone 
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marrow a well established transgenic mouse model was used, in which macro-
phages and dendritic cells express a green fluorescent protein (GFP) under con-
trol of the fractalkine receptor CX3CR. Tibiae of the transgenic mice were pre-
pared and intravital 2-photon microscopy was immediately started. In the micro-
scopic pictures both cell types could be differentiated from each other by their cell 
morphology. Macrophages (Figure 29 a), white arrows) were round shaped and 
markedly smaller than dendritic cells which, in contrast, formed distinct cell clus-
ters and displayed the typical dendritic morphology (Figure 29 a), red arrows) with 
the typical veiled protrusions.  
 
a) 
 
b) 
 
c) 
 
d) 
 
Figure 29  Time-lapse intravital microscopy of BMDCs and macrophages in the tibia.  a) Visu-
alization of dendritic cells (red arrows) and macrophages (MCs, white arrows) in the vicinity of the 
endosteum in vivo using the CX3CR-GFP mouse model, in which these cell types are green. The 
brown color delineates the SHG signal of the calcified bone. b) Quantification of the velocity of den-
dritic cells and MCs in the BM (n = 65 cells per cell type, based on 3 independent experiments).  
c) Activity (meaning the percentage of cells that present with cell position changing migration) of 
dendritic cells and MCs in the BM, based on 3 independent experiments. d) Distance of BMDCs and 
MCs to the endosteum (vertical bars representing average). n = 65 cells per cell type, based on 3 
independent experiments. 
 
By analyzing the motility of the fluorescent cells, macrophages displayed a signifi-
cantly elevated cell velocity of 1.6 µl/min compared to dendritic cells showing a 
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velocity of just 0.9 µm/min (Figure 29 b)). Also activity was markedly higher in 
macrophages in comparism to DCs (Figure 29 c)). Moreover the distance of both 
cell types to the endosteal layer was evaluated. The distance was measured be-
tween the lower surface of the cell and the SHG-channel of the bone tissue, dis-
played with a yellow scale bar (view 3.2.4.5.4). All cells were found close to the 
endosteum, but rarely in direct contact. Notably, dendritic cells were found mark-
edly closer to the inner bone surface than macrophages (8.2 µm to 15.6 µm, Fig-
ure 29 d)), suggesting a correlation between close contact to the endosteal layer 
and cell motility.  
 
4.1.4 Altered localization and elevated dynamics of aged eHPCs 
Multiple cellular and molecular mechanisms have been suggested to describe 
hematopoietic stem cell aging. In this context is was recently postulated that aged 
stem cells compared to young ones present an altered, less favorable interaction 
with their stem cell niche [Xing et al. 2006]. This finding could in part explain im-
paired hematopoiesis in aged individuals, because there are hints, that the close 
interaction of stem cells to their niche is essential for normal hematopoiesis  [Gei-
ger et al. 2007].  By using an intravital 2-photon microscopy approach we aimed at 
directly testing this hypothesis. 
 
Table 2 Overview over all detected HPCs and eHPCs, isolated from aged mice in the bone 
marrow of C57Bl/6 recipients.  Two populations were detected, one smaller part in direct contact 
with the endosteum, the bigger part still in close vicinity, but not in contact. In the right lane the 
mean distance of all analyzed cells to the endosteum was calculated. n = number of individual an-
imals analyzed. 
 
Number of all 
analyzed cells 
Percentage of 
cells with dis-
tance to the en-
dosteum 
Percentage of 
cells in direct 
contact to the 
endosteum 
Mean distance to 
the endosteum in 
m 
eHPCs (L
-
S
+
K
+
) 
from aged mice 
50 
n = 3 
88 12 18.05 
HPCs (L
-
S
-
K
+
) 
from aged mice 
109 
n = 3 
79.8 20.2 12.38 
 
Interestingly, after transplantation of eHPCs and HPCs from aged mice into naïve 
 4. Results 
 70 
recipients, we found HPCs to be significantly closer located to the endosteal layer 
compared to eHPCs (12 µm compared to 18 µm). This was exactly opposite to the 
situation which we had observed in young mice before (19 µm compared to 11 
µm). Here the eHPCs were found in smaller distance to the endosteum. Further-
more, comparing the number of HPCs and eHPCs with direct contact to the en-
dosteal layer from young and aged mice, we found that both cell types from older 
animals were located closer to the endosteum than cells from young mice (table 1 
and table 2). 
Upon transfer, aged eHPCs, similar to young ones, were detected at solitary spots 
along the endosteum and were completely immobile (data not shown). Compared 
to young eHPCs, aged eHPCs were located at sites more distant from the endos-
teum. They displayed an average distance to the endosteum of 18.1 µm (Table 2) 
compared with 10.7 µm for young cells; Table 1 and Figure 26 a)). The maximum 
distance we observed for aged eHPCs was even over 50 µm. 
 
 
Figure 30  Distance comparison of eHPCs (L-
S+K+) isolated from aged versus young mice 
to the endosteal layer.  eHPCs were isolated 
either from young or aged mice and the dis-
tance to the endosteal layer was calculated. 
Each dot represents a single cell; black horizon-
tal bars depict the average distance. eHPCs 
from young mice are located significantly closer 
to the endosteum, compared to eHPCs from 
aged mice. *p < .05. 
 
Moreover, interestingly, aged eHPCs presented a significantly increased protru-
sion movement compared to young eHPCS, indicated by increased changes in 
cell volume between time points (Figure 31 a)), a clearly increased average vari-
ance in cell volume change and also an elevated average of the cell surface area 
(Figure 31 b)). 
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a) 
 
b) 
 
c) 
Figure 31  HSCs from aged mice (20- to 24-month-old animals) were fluorescently labeled 
(CFSE or CTO) and transplanted into young recipient animals.  Tibiae from recipient animals 
were analyzed between 16 and 40 hours after transplantation. a) Quantification of cell protrusion 
movement, determined as the change in volume over time (interval of 1 minute) of transplanted L
-
S
-
K
+
 and L
-
S
+
K
+
 cells. b) Average variance in the change in cell volume in a 1 minute time interval 
of L
-
S
-
K
+
 and L
-
S
+
K
+
 cells. c) Average variance in the change of the cell surface area in a 1 mi-
nute time interval of L
-
S
-
K
+
 and L
-
S
+
K
+
 cells. All data were calculated for n = 44 for young L
-
S
-
K
+
 
cells and n = 50 for aged L
-
S
+
K
+
 cells, based on at least 3 independent experiments for each cell 
population. 
 
To further characterize the localization of eHPCs we transplanted young and aged 
cells into animals with YFP labeled osteoblasts (Col1a1-GFP) [Kalajzic et al. 
2002]. By analysis of the microscopic data in this model we found that neither 
young nor aged eHPCs (n = 20 for both cell types) were directly associated with 
osteoblasts which are located along the endosteal layer of long bones. 
 
4.1.5 Summary - Part I 
Our novel approach of intravital 2-photon microscopy allows the first view on cells 
residing in the bone marrow of murine long bones. We were able to visualize 
adoptively transferred HPCs and eHPCs in close vicinity to the endosteal layer. 
Some cells were found in direct contact to the endosteum and they displayed ac-
tive interactions with their microenvironment but we could not clarify, to which spe-
cific cells of the endosteum they establish the close contact. However, most cells 
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were located farther away from the inner bone surface. No HPC or eHPC show 
any motility although we could demonstrate by intravital microscopy that other 
more mature hematopoietic cells like dendritic cells or macrophages are motile in 
the same microenvironment. Instead of motility, all cells displayed an active pro-
trusion movement that we determined with new algorisms that could analyze the 
changes in cell volume and cell surface area. On the basis of these calculations 
we found a tendency of HPCs to be more active than eHPCs. Then we focused on 
the differences between eHPCs from aged and young mice. We found eHPCs to 
be located more distantly from the endosteal layer compared to eHPCs from 
young animals. Moreover, cells from old animals revealed a significantly increased 
protrusion activity. These data suggest that cells in close contact to the inner bone 
surface are more quiescent than cells with more distance to the endosteum. 
This part of the work was published in Blood 2009 [Kohler et al. 2009]. 
 
 
4.2 Part II: Analysis of G-CSF mediated neutrophil emer-
gency release from the bone marrow of murine long 
bones 
In many infection models, neutrophils are rapidly mobilized from the bone marrow 
into the peripheral blood from where they are then recruited to sites of acute infec-
tion. At these places they play an important role in the immunological fight against 
invading pathogens. In many different studies it has been shown that G-CSF is 
crucial for this emergency release [Metcalf et al. 1996; Shahbazian et al. 2004; 
Knapp et al. 2004; Cataisson et al. 2006; Gregory et al. 2007] but the underlying 
mechanisms how G-CSF induces acute neutrophil mobilization still remain largely 
unknown. This lack of knowledge is highly noteworthy because of the fact that the 
mobilizing features of G-CSF have been used in clinical applications for more than 
20 years to reconstitute neutropenic patients. 
In order to clarify how neutrophils react in response to a systemic G-CSF trigger 
on the single cell level in vivo and to investigate the immediate cell-intrinsic pro-
cesses induced by this treatment we used our established technical approach of 
intravital 2-photon microscopy in the long bones of mice. 
 
 4. Results 
 73 
4.2.1 Visualization of the inner bone surface and blood staining 
for 2-photon microscopy 
In the beginning of this project we expanded our method of intravital 2-photon mi-
croscopy in murine long bones. After the preparation a remaining bone layer of 
about 30 - 50 µm was maintained to ensure a closed bone marrow cavity, unaf-
fected by external influences (Figure 32 b)). By the use of new advanced micros-
copy hardware, a much more detailed view into the bone marrow cavity with a 
drastically increased optical resolution was possible. For the first time the remark-
ably structured endosteal surface of the tibia was visible, with a lot of indentations 
(Figure 32 a)). This structure could also be much better presented in an angular 
perspective and it was reminiscent of a crisp bread slice (Figure 32 b)). A closer 
look on the invaginations revealed, that they formed small craters and some of 
them ended up in tiny canals which completely crossed the remaining bone layer 
(Figure 32 c) – f)). 
Additionally, a blood vessel staining with rhodamine-dextran was included in all 
imaging approaches. This was important to determine the expected release of 
neutrophils from the bone marrow into the blood flow. Immediately after retro-
orbital injection of the dye the vessels could be seen during 2-photon acquisition 
with a filter detecting wavelengths between 565 – 610 nm. This fact also served to 
demonstrate an intact blood supply of the bones during our investigations. Bigger 
vessels were found in deeper regions of the marrow. With closer distance to the 
endosteum the vessels became thinner and just beneath the inner bone surface 
they strongly branched into a filamentous network and lined the entire bone struc-
ture (Figure 32 g)). Moreover, it was conspicuous that blood vessels crossed the 
bones through the observed canals, indicating a consistent blood exchange with 
the environmental tissue (Figure 32 h)). 
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a) 
 
b) 
 
c) 
 
d) 
 
e) 
 
f) 
 
g) 
 
h) 
 
Figure 32  Visualization of bone structure and blood vessels.  a) Top view on the inner bone sur-
face of murine long bones, detected by its SHG signal. b) An angular view revealed a crisp bread-like 
structure of the inner bone surface, with lots of indentations. c) – f) A closer look on the small invagina-
tions revealed that some end up in small channels which cross the entire bone layer g) A blood vessel 
staining with rhodamine-dextran showed an intimately connected network of vessels close to the en-
dosteal layer. h) A view from the outside on the bone surface after blood vessel staining demonstrated, 
that many pores constitute channels for blood vessels. View supplemental movie 5. 
 4. Results 
 75 
4.2.2 G-CSF treatment induces rapid neutrophil mobilization into 
the peripheral blood 
In order to specify the kinetics of neutrophil mobilization for further analysis we 
started with assessing the neutrophil number in the peripheral blood after a single, 
retro orbital injection of G-CSF. A volume of 75 µl blood was taken repetitively 
from the same animals by retro-orbital puncture at different time points after G-
CSF injection (4 h, 8 h, 12 h, 16 h, 25 h). These blood aliquots were analyzed by 
FACS for the percentage of Gr-1 positive cells. 0 h reflected a first sample collec-
tion immediately before the injection. A constant increase of neutrophils in the pe-
ripheral blood from around 15 % up to over 40 % was measured in the samples 
taken within the first 12 h. At later time points (25 h after injection) the cell number 
slightly decreased to about 28 %. Unfortunately, there was no significant differ-
ence between G-CSF and PBS treated animals (Figure 33 a)). One explanation for 
this observation could be that the repeated bleeding procedure as such was re-
sponsible for neutrophil mobilization also in the control animals. To exclude this 
effect the number of blood drawings was reduced to only two collections right be-
fore G-CSF or PBS injection and 12 h after the treatment (Figure 33 b)). Again, 
there was no significant difference in the measured numbers of Gr-1 positive cells, 
comparing G-CSF and PBS injected mice. The measured percentages at the two 
time points assembled around 20 % and the highest neutrophil number was even 
found in the blood sample which was taken before G-CSF treatment. Moreover, 
there was a high standard deviation in the samples which were collected before 
injection of either agent. It was known from the literature that female, 8 weeks old 
C57Bl/6 mice which were used for the experiments should constantly carry 7.35 % 
(percent of total white blood cells) circulating neutrophils in their peripheral blood 
under unstimulated conditions [http://phenome.jax.org]. By this number it became 
clear that neutrophils in the analyzed animals were already pre-mobilized by the 
blood drawing procedure and that this protocol had to be optimized. 
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From now on the animals were housed as calmly as possible and all unnecessary 
transports were avoided to exclude any side effects of mouse treatment on the 
neutrophil behavior. To completely avoid repetitive bleeding we decided to focus 
on a time point 2 h after administration of the mobilizing agent for blood withdraw-
al. This time point was chosen according to published reports [Wengner et al. 
2008] showing that 2 h after triggering neutrophils with G-CSF a first peak of mobi-
lized cells in the blood should be detectable. 
To clarify the impact of an injection on neutrophil mobilization into the blood we 
then tested different injection routes. Double retro orbital injections (i.v.) with PBS 
followed by G-CSF led to a strong neutrophil mobilization into the blood flow after 
2 h. Interestingly we found that a double injection of only PBS mobilized the cells 
just as well as a single treatment with G-CSF. A single i.v. injection of PBS led to 
the lowest increase of Gr-1 positive cells in the blood, but also this single control 
injection recruited neutrophils compared to a completely untreated animal (Figure 
34 a)). These same four injection conditions were then repeated for an i.p. route 
and an i.v. administration into the tail vein. Strong neutrophil mobilization into the 
peripheral blood could be observed ranging from 40 % to 70 % (Figure 34 b) and 
c)) in all settings. In a last experiment retro orbital and i.p., single or double injec-
tions of PBS were compared. An additional mouse group was only pricked on the 
two injection time points without any injection. This should clarify how sensitive the 
cells reacted on external interferences unavoidable in conjunction with the planned 
experiments. The analysis of this prick-test clearly demonstrated, that all kinds of 
a) 
 
b) 
 
Figure 33  Neutrophil mobilization into peripheral blood after a single i.v. injection of G-
CSF.  a) Kinetics of the increase in neutrophil cell number in the peripheral blood upon mobiliza-
tion with G-CSF or with PBS as unmobilized control after repetitive bleeding. b) To reduce repeti-
tive blood drawing and thereby minimizing the pre-mobilizating effect of this procedure just 2 time 
points per injected animal were considered. n = 3 – 4 animals were analyzed for each time point. 
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repeated mouse treatment activated neutrophils and led to their recruitment into 
the peripheral blood (Figure 34 d)).  
 
a) 
 
b) 
 
 
c) 
 
d) 
 
    
Figure 34  Neutrophil mobilization caused by different injection methods.  Different application 
routes led to an unspecific mobilization of neutrophils. The 2
nd
 treatment was performed 20 minutes 
after the 1
st
 one. Upon a) retro orbital i.v. injection, b) i.p. injection or c) i.v. injection into the tail vein 
of different PBS/G-CSF combinations the recruitment of neutrophils into the peripheral blood was 
assessed. d) For the prick test a 27 G cannula was pierced into either the peritoneum or behind the 
eye without any injection. 2 h after the last treatment 75 µl blood were drawn from each animal and 
analyzed for the number of circulating neutrophils by Gr-1 specific FACS analysis. n = 1 – 2 animals 
were analyzed for each condition. 
 
By comparing the different injections and combinations it became obvious that the 
injection route and the frequency of treatments had a strong influence on the num-
ber of peripheral blood neutrophils. Based on these results we redefined our neu-
trophil mobilization protocol for G-CSF.  
First of all the animals were handled much more carefully now throughout all pro-
cedures. The retro orbital injection was chosen as optimal protocol, because it in-
duced the lowest mobilization of neutrophils with PBS as a “trigger”. Furthermore 
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G-CSF was injected once, 2 h before investigation of the mobilization status and 
blood withdrawal was reduced to one terminal time point. With these changes im-
plemented the results became much more consistent (Figure 35 a) and c)) and a 
very reproducible and clear mobilization of neutrophils into peripheral blood was 
measureable. Besides the neutrophil Gr-1 high positive cell population, a second, 
Gr-1 intermediate cell type was detected by FACS analysis. This population was 
identified as macrophage type by an anti-F4/80 antibody staining (Figure 35 b)). 
Also the number of these cells was strongly increased after G-CSF mobilization 
(Figure 35 d)). 
a) 
 
b) 
 
c) 
 
d) 
 
Figure 35  Neutrophil mobilization into peripheral blood upon G-CSF injection.  a) 2 h after 
retro orbital G-CSF injection blood was collected and analyzed for the percentage of Gr-1 high 
neutrophils and Gr-1 intermediate cells that were recruited into the peripheral blood. Control ani-
mals received an equal volume of PBS. b) The Gr-1 low cells were identified to be macrophages 
by antibody staining with F4/80 c) Statistical analysis of neutrophil recruitment. The mobilization 
experiment was repeated in 6 unrelated animals. d) Statistical analysis of macrophage recruit-
ment. N = 6 animals were analyzed in this experiment. The result was representative for three 
independently performed experiments. 
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4.2.3 Dramatic increase of neutrophil motility in the bone marrow 
after G-CSF injection 
The strong and rapid mobilization of neutrophils into peripheral blood suggested 
that this phenomenon could also have a detectable impact on the single cell be-
havior in the bone marrow, which is known as the main reservoir for mature neu-
trophils. To test this hypothesis our well established protocol for intravital 2-photon 
microscopy in murine long bones was used. The visualization of neutrophils was 
realized by using a transgenic mouse model, in which EGFP was expressed under 
control of the neutrophil specific lysozyme M promoter (LYS-EGFP mice) [Faust et 
al. 2000]. Therefore most of the mature neutrophils were fluorescently tagged in 
these animals. Rhodamine-dextran and likewise G-CSF were injected i.v. right 
before start of the preparation procedure to ensure that both substances reach the 
vasculature of the bone marrow simultaneously shortly before the onset of imag-
ing. The fluorescently labeled dextran was used to visualize blood flow in the ani-
mals and thereby to provide an internal life status control. Control animals re-
ceived PBS instead of G-CSF. After about 30 minutes of preparation the image 
acquisition was started to record three time sequences of about 30 minutes at 
three different areas. So in total a time period of 1-3 h after G-CSF administration 
was investigated. 20-30 cells per sequence were then analyzed for their velocity 
and activity.  
In the PBS injected mice around 35 % of neutrophils were motile, denoted in ac-
tivity. The velocity was measured to be at a population mean of 1.8 µm/min. How-
ever, after systemic G-CSF administration a dramatic increase in the overall motili-
ty of neutrophils was observed. Their velocity rose to a mean of 3.6 µm/min with 
some cells migrating at velocities >15 µm/min (Figure 36 a)). The migratory activity 
of the neutrophil population escalated to a mean of almost 60 % of living cells 
reaching almost 80% in some animals (Figure 36 b)). This observation was under-
lined by performing a kinetic overlay of three pictures of a movie sequence where 
localization changes are marked in color (Figure 36 c)). With this analysis it could 
be seen very easily that cells displayed a clearly higher motility after G-CSF treat-
ment than cells from mice treated with PBS.  
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a) 
 
 
c) 
 
b) 
 
Figure 36  Influence of G-CSF injection on the migratory behavior of individual neutrophils 
in the bone marrow.  a) and b) The overall cell velocity and activity of neutrophils significantly 
increased in the tibial BM 1-3 h after triggering with G-CSF. n = 11 animals were analyzed after G-
CSF administration, n = 4 animals were analyzed after PBS treatment. c) A kinetic overlay of three 
sequential pictures also demonstrated a higher motility of neutrophils in mice which were treated 
i.v. with G-CSF. The changes of cell localization from picture to picture were marked with different 
colors. View supplemental movie 5 (2 h after PBS treatment) and 6 (2 h after G-CSF treatment). 
View supplemental movie 6 and 7. 
 
Additionally we found a stronger tendency of neutrophils to leave the BM via blood 
vessels upon stimulation with G-CSF compared to PBS controls. The vessels of 
G-CSF treated animals appeared somehow destroyed, which could be caused by 
a massive influx of mobilized cells (Figure 36 c)). This invasion process of the vas-
culature by neutrophils could be observed in our intravital microscopy set-up. Cells 
entering the vasculature appear yellow because of the spectral overlap of green 
fluorescent cell bodies and the blood vessels stained in red (Figure 37). After ad-
ministration of G-CSF an accumulation of neutrophils was observed in several dis-
tinct areas of the image. Regarding these observations we speculated that the 
cells swarm to defined vascular egression sites along the vessels, where a bottle-
neck arises. This could result in such an accumulation because not all cells were 
able to leave the marrow at the distinct exits coincidentally (Figure 37).  
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Figure 37  Neutrophils leave the BM into the 
vasculature upon stimulation with G-CSF.  
White arrowheads indicate single egression 
events. More or less all cells when motile showed 
a trend to migrate to distinct bottlenecks, where a 
swarm formation could be observed indicated by 
black arrows. View supplemental movie 8. 
 
4.2.4 Long term behavior of neutrophils upon G-CSF stimulation  
After characterization of the immediate early cell response towards G-CSF trigger-
ing we went on to analyze neutrophil activity and velocity over a time span of 6 h 
upon a single G-CSF injection in the same animals. 0 h after G-CSF administration 
the cell velocity remained at a level of unmobilized animals (1.7 µm/min) but al-
ready 1 h after mobilization the neutrophil velocity suddenly peaked at 4.5 µm/min. 
After 2 h the velocity started to slightly decrease to 3 µm/min after 4 h. Then a se-
cond peak of increasing cell velocity could be observed at around 5 h (Figure 38) 
after which the velocity constantly decreased until all cells stopped moving at 
around 12 h after experimental onset, probably due to the very long narcosis of the 
animals (data not shown).  
As a control, one mouse was injected with G-CSF and directly killed by cervical 
dislocation. In the first 2 h hours the neutrophil velocity was comparable to a living 
animal but then it strongly decreased and after 4-5 h there was no cell motility de-
tectable anymore (Figure 38, red dots). This observation proofed, that the other 
animals were definitely alive during the imaging procedure and that cells were ob-
viously provided with all substances they needed for survival and motility. But 
there was still the question, how long neutrophils in a prepared and narcotized an-
imal were able to exhibit their normal cell behavior like in an unopened mouse. A 
decrease in cell motility after several hours was expected, due to the narcosis, the 
cooling of the animal and the diminished blood pressure and blood glucose level 
because of a lacking nutrient supply. To answer this question, we injected animals 
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once with G-CSF but started the preparation and imaging 6 h, 12 h and 16 h after 
the treatment in individual mice. We found a constant level of 2 - 2.5 µm/min veloc-
ity at the indicated time points, showing that neutrophils stay in an activated status 
up to 16 h after a single G-CSF injection (Figure 38).  
 
Figure 38  Long term development of neutrophil velocity upon stimulation with G-CSF.  2-
photon acquisition was performed on BM neutrophils upon a single injection of G-CSF where on 
the left side of the graph individual animals were observed over 6 h. For comparison the 6 h, 12 h 
and 16 h time point was also investigated in animals which were freshly prepared after each time 
interval (right hand side). n = 4 mice unrelated were analyzed over 6 h, at time point 0 h just two 
animals and at time point 1 h just three animals could be measured for technical reasons. The red 
dots revealed the cell velocity in mice which received one G-CSF injection and where then killed 
immediately. n = 6 unrelated animals were prepared and analyzed 6 h after G-CSF injection, n = 3 
unrelated animals were prepared and analyzed 12 h and 16 h after G-CSF injection. 
 
Comparable results were obtained by analyzing the cell activity. This value peaked 
1 - 2 h after G-CSF administration and like seen with the velocity, also again after 
5 h. Comparable to the velocity, the activity almost doubled from 35 % in unmobi-
lized animals to over 60 % in G-CSF treated mice after 1 h (Figure 39). Interesting-
ly in contrast to the velocity the activity directly increased after mobilization at time 
point 0 h, suggesting that an elevated activity might be a hallmark of cells which 
have been disassociated from their stromal connections usually holding them back 
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in the bone marrow. In the control groups with individual mice for every time point 
also the activity stayed increased but, surprisingly, there was a third peak of neu-
trophil activity present after 12 h (Figure 39). 
 
 
Figure 39  Long term development of neutrophil activity upon stimulation with G-CSF.  In-
travital 2-photon microscopy was performed on BM neutrophils following a single injection of G-
CSF where on the left side of the graph individual animals were observed over 6 h. In comparison 
the 6, 12 and 16 hour time point was also investigated in animals which were freshly prepared after 
each time interval (right hand side). n = 4 mice were analyzed over 6 h, at time point 0 h just two 
animals and at time point 1 h just three animals could be measured for technical reasons. The red 
dots revealed the cell activity in mice which received one G-CSF injection and where then killed 
immediately. n = 6 unrelated animals were prepared and analyzed 6 h after G-CSF injection, n = 3 
unrelated animals were prepared and analyzed 12 h and 16 h after G-CSF injection. 
 
Taken together the acquired activity and velocity data suggested that it was possi-
ble to investigate a prepared and anesthetized animal for a maximum of 6 h in a 
constantly running 2-photon experiment. After this time interval the neutrophil mo-
tility dramatically went down and did not show normal activated cell behavior any-
more like in freshly prepared animals. 
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4.2.5 Monocyte mobilization with G-CSF in CX3CR-EGFP mice  
To verify if G-CSF only leads to an increased neutrophil motility in the bone mar-
row or if also other cell types like macrophages are affected we performed 2-
photon microscopy in the long bones of a transgenic mouse line which expressed 
EGFP under control of the fractalkine receptor CX3CR1 (CX3CR-EGFP mice). 
These animals possess green fluorescent macrophages and dendritic cells [Jung 
et al. 2000]. Both cell types could be clearly divided from each other by their very 
different cell morphology. A kinetic overlay after movie acquisition already strongly 
suggested that compared to an unmobilized mouse (Figure 40 b)), no increase in 
cell motility of CX3CR-expressing cells was detectable upon G-CSF treatment of 
the animals (Figure 40 a)). For technical reasons it was not possible to detect the 
bone signal in the control animal which received PBS (Figure 40 b)). 
 G-CSF  PBS 
a) 
 
b) 
 
 
 
 
 
Figure 40  Macrophages and dendritic cells did not display altered cell motility upon stimula-
tion with G-CSF.  CX3CR-EGFP mice were injected either with G-CSF or PBS. Intravital 2-photon 
microscopy was performed 1-3 h after injection.  A kinetic overlay of three sequenced pictures dis-
played no increase in cell motility of both morphotypes (DCs and macrophages) after a) G-CSF 
treatment compared to b) PBS injection. View supplemental movie 9. 
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These findings were then validated by measuring the velocity and activity of mac-
rophages 2 h after G-CSF treatment. Interestingly we found that the velocity of 
macrophages was decreased 2-fold from 1.6 µm/min to 0.8 µm/min after stimula-
tion with G-CSF. The same tendency could be observed for the activity of these 
cells, although not reaching the level of statistical significance (Figure 41). 
  
Figure 41  Analysis of macrophage motility with intravital 2-photon microscopy.  Macro-
phages show no mobilization after an injection of G-CSF when analyzed for a) cell velocity and 
b) cell activity. The movies were recorded 1-3 h after G-CSF injection or after treatment with PBS 
control. n = 3 animals were analyzed independently for each condition. 
 
4.2.6 Inhibition of G-CSF-induced neutrophil mobilization 
In the next step we aimed at clarifying the molecular mechanisms which were cru-
cial for the observed rapid neutrophil mobilization in response to a systemic 
G-CSF application. It is well known from several inflammation models [Kobayashi 
2006; McColl et al. 1999; Gordon et al. 2005; Lally et al. 2005], that the proinflam-
matory chemokines KC (CXCL1) and MIP-2 (CXCL2) mediate a remarkable re-
cruitment of neutrophils to sites of inflammation. To find out if KC or MIP-2 were 
also relevant mediators in case of a G-CSF induced neutrophil mobilization, mon-
oclonal anti-KC and anti-MIP-2 antibodies were used to block neutrophil release 
from the bone marrow into the peripheral blood.  
To demonstrate that the anti-KC and anti-MIP-2 antibodies worked in terms of 
blocking a neutrophil recruitment, a recently published model of acute peritonitis 
was used [Wengner et al. 2008]. The combined administration of both antibodies 
upon induction of the peritonitis led to a significant reduction of neutrophil counts in 
the peripheral blood and there was also a considerable but not significant neutro-
phil decrease in the peritoneal lavage detectable (Figure 42 a) and b)).  
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a) 
 
b) 
 
Figure 42  Administration of anti-KC and anti-Mip-2 antibodies blocked neutrophil mobi-
lization in a mouse model of acute peritonitis.  Anti-KC and anti-MIP-2 antibodies were 
injected 20 minutes before thioglycollate treatment. Neutrophil counts in either a) the blood or 
b) peritoneal lavage were assessed 2 h after induction. Control mice received PBS twice in the 
same time period instead. n = 5 animals were analyzed for every condition. 
 
Afterwards we used these antibodies in our model of G-CSF mediated neutrophil 
mobilization. Both antibodies were injected simultaneously i.p. 18 h - 48 h before 
G-CSF administration to avoid a pre-stimulation of neutrophils (Figure 33 and 34). 
2 h later peripheral blood was collected and analyzed for the percentage of circu-
lating neutrophils. Control animals received unspecific antibodies of the same iso-
type and PBS after 48 h as vehicle control for G-CSF. However, FACS analysis 
showed no significant reduction of circulating neutrophils 2 h after treatment with 
anti KC/MIP-2 in the blood of mice (Figure 43).  
 
a) 
 
b) 
 
Figure 43  No reduction of G-CSF induced neutrophil mobilization after anti-KC and anti-MIP-2 
treatment.  Mice were injected i.p. with anti-KC and anti MIP-2 antibodies 16 h or 46 h before G-CSF 
treatment. 2 h later blood was collected and the FACS analysis was performed. n = 4 – 6 animals 
were analyzed for every condition. 
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In addition to the FACS analysis the antibodies were also tested in a 2-photon mi-
croscopy approach. Animals were treated with anti KC and anti MIP-2 in the same 
way as for the recruitment experiments and the in vivo behavior of cells was ob-
served in the tibial BM. The development of neutrophil motility in response to sys-
temic G-CSF matched the FACS results. Despite the antibody treatment there was 
only a very slight decrease in the activity of cells, which was not statistically signifi-
cant and also the neutrophil velocity remained at almost the same level as com-
pared to control-treated animals (Figure 44).  
 
a) 
 
b) 
 
c) 
 
 
 
Figure 44  Intravenous treatment of mice with anti-KC and anti-Mip2 antibodies does not alter 
neutrophil mobilization on a single cell level.  18 h after before G-CSF mobilization anti-KC and 
anti-MIP-2 antibodies were injected. Despite antibody administration neither a) the velocity nor b) 
the neutrophil activity was significantly reduced. c) This result was also confirmed by a kinetic over-
lay. n = 3 - 4 animals were analyzed independently. View supplemental movie 10. 
 
Although we were not able to inhibit neutrophil mobilization from the BM by appli-
cation of anti-KC and anti Mip-2 antibodies our cooperation partner (Nancy Hogg, 
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London, UK) was able to detect a peak of KC appearance in the peripheral blood 
45 min. after G-CSF injection by an enzyme-linked immunosorbent assay (ELISA, 
data not shown). This suggested that at least KC was released as a consequence 
of G-CSF treatment and thus might play a role in neutrophil mobilization. 
 
4.2.7 Inhibition of neutrophil recruitment into the peripheral blood 
after CXCR2 antiserum treatment 
As an alternative to inhibit the chemo-attractive action of KC and Mip-2 we then 
focused on blocking the surface receptor for both chemokines, the CXC receptor 2 
which is highly expressed on neutrophil granulocytes [Bozic et al. 1994]. For the 
experiments a polyclonal CXCR2 antiserum was employed which had been shown 
before to potently inhibit neutrophil recruitment to an inflamed central nervous sys-
tem (CNS) [Carlson et al. 2008a; Hosking et al. 2009]. 100 µl CXCR2 antiserum 
were injected i.p. 48 h before G-CSF administration and blood was taken for anal-
ysis another 2 h later. Control animals received the same volume of normal rabbit 
serum (NRS).  
 
a) 
 
 
c) 
 
b) 
 
 
d) 
 
Figure 45  Administration of an anti-CXCR2 antiserum entirely blocks neutrophil recruitment 
to the peripheral blood.  a) Antiserum treatment of mice 48 h before G-CSF injection dramatically 
decreased neutrophil counts in the blood b) compared to the administration of an unspecific immune 
serum (NRS). c) A statistical analysis revealed the strong significance. d) The mobilization of mac-
rophages is not inhibited by anti-CXCR2, rather it slightly increase their number. n = 6 animals were 
analyzed for each condition. The result was representative for three independently performed exper-
iments. 
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Following this protocol we observed an almost complete inhibition of neutrophil 
entry into the blood flow upon G-CSF stimulation by FACS analyses (Figure 45 a) 
and b)). A statistical analysis of these data also revealed a dramatic decrease of 
neutrophil numbers in the circulation after CXCR2 antiserum treatment in contrast 
to control animals which received NRS (Figure 45 c)). Additionally it was conspic-
uous that the number of macrophages expressing intermediate levels of Gr-1 was 
not affected by the antiserum treatment. 
 
a) 
 
b) 
 
c) 
 
  
d) 
 
e) 
 
Figure 46  The baseline level of neutrophil counts in the peripheral blood was strongly re-
duced upon administration of low doses of CXCR2 antiserum.  a) A 10
th
 of the usually admin-
istered antiserum volume, injected 48h before G-CSF treatment still reduced the basal circulating 
neutrophil counts to nadir, when analyzed 2 h after G-CSF mobilization b) in contrast to control 
animals which received the NRS. c) Neutrophils from animals that received the low dose antise-
rum could be effectively recruited to the blood flow by G-CSF treatment in some cases. d) Statisti-
cal analysis of neutrophil behavior under low dose antiserum conditions. e) Statistical analysis of 
macrophage behavior under low dose antiserum conditions. n = 6 animals were analyzed for each 
condition. 
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To further confirm its specific effect on neutrophils the amount of antiserum was 
titrated down in non G-CSF mobilized animals. A small volume of just 10 µl 
CXCR2 antiserum led to an almost complete reduction of neutrophil counts (to 
about 1 %) in the peripheral blood (Figure 46 a) and d)). In control animals which 
were treated with 10 µl of NRS the normal baseline of around 8 % circulating neu-
trophils was retained (Figure 46 b) and d)). These results suggested that the CXC 
receptor 2 might not only play a role in the emergency release of neutrophils but 
also in regulating the normal baseline of this cell type in peripheral blood. Howev-
er, a mobilization of neutrophils with G-CSF to at least intermediate but not signifi-
cant levels was possible at these low doses of anti-CXCR2 serum (Figure 46 c) 
and d)).  
Notably, also in these experiments the number of macrophages was not affected 
by the CXCR2 antiserum. Macrophages could still be mobilized by G-CSF after 
administration of 10 µl antiserum and without G-CSF stimulus the number of mac-
rophages stayed on the normal baseline level regardless if antiserum was admin-
istered or not (Figure 46 e)).  
 
4.2.8 Inhibition or depletion after CXCR2 treatment? 
A very critical point for the analysis was to demonstrate that the anti-CXCR2 se-
rum really bound the receptor thereby blocking the release of neutrophils from BM 
and not only depleted all neutrophils in the system. To verify the mode of action 
mice were mobilized with G-CSF after treatment with either 100 µl CXCR2 antise-
rum (Figure 47 a)), 100 µl NRS (Figure 47 b)) or 100 µl of a monoclonal anti-Gr-1 
antibody (RB6-8C5) which is well known to completely eliminate Gr-1 positive cells 
in living mice (Figure 47 c)) [Stegemann et al. 2009]. 2 h after mobilization the 
number of Gr-1 positive cells in the peripheral blood and bone marrow was as-
sessed. The anti-Gr-1 antibody treatment led to an almost complete depletion of 
neutrophils in the circulation compared to the anti-CXCR2 serum administration, 
where a reduction to around 0.5 % cells could be observed. Notably, the difference 
between both remaining neutrophil populations was highly significant (Figure 47 
d)). Moreover not only neutrophils but also the number of macrophages was clear-
ly reduced upon anti-Gr-1 treatment in contrast to the CXCR2 antiserum, which 
had no influence on macrophage numbers in the peripheral blood (Figure 47 d) 
and e)). 
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a) 
 
b) 
 
c) 
 
 
 
d) 
 
e) 
 
Figure 47  The anti-CXCR2 serum specifically eliminates neutrophils from blood.  Animals 
were treated with either a) 100 µl CXCR2 antiserum, b) 100 µl NRS or c) 100 µl RB6-8C5 and 48 
h afterwards stimulated with G-CSF. d) Statistical analysis of blood neutrophil numbers in these 
groups. e) Statistical analysis of blood macrophage numbers in these groups. n = 3 – 6 animals 
were analyzed for each condition. 
 
Importantly, within the bone marrow no reduction of Gr-1 positive cells was detect-
able 48 h upon CXCR2 antiserum treatment. The neutrophil counts in these ani-
mals almost remained the same compared to NRS treated mice (Figure 48 a) and 
b)). In contrast, the administration of an anti-Gr-1 antibody led to a massive 10 fold 
decimation of neutrophils also in the BM 48 h later (Figure  48 c) and d)).  
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a) 
 
 
b) 
 
 
c) 
 
 
d) 
 
e) 
 
Figure 48   Did anti-CXCR2 serum deplete Gr-1 positive cells?  48 h after treatment wit 
with either a) NRS, b) CXCR2 antiserum or c) anti Gr-1 bone marrow samples were taken 
and analyzed for the amount of Gr-1 positive cells. d) Statistical analysis of the neutrophil 
number in the bone marrow after the different treatments. e) 12 h after treatment with ei-
ther NRS, CXCR2 antiserum or anti Gr-1 spleen samples were taken and analyzed for the 
amount of Gr-1 positive cells. n = 3 animals were analyzed for every condition. 
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These results give an indication that the CXCR2 antiserum did not eliminate Gr-1 
positive neutrophils and macrophages from the BM and so maybe also not from 
the blood like the depleting anti-Gr-1 antibody did. To further proof the depleting 
ability of the CXCR2 antiserum, the number of neutrophils 12 h after CXCR2 anti-
serum treatment was determined in the spleen in comparison to the positive deple-
tion with anti Gr-1 and NRS. Notably, in this organ the number of neutrophils was 
strongly but not significantly reduced after anti Gr-1 whereas after CXCR2 antise-
rum application the number was stronger decreased (Figure 48 e)). Because of 
these conflicting data it is still not completely clear how the CXCR2 antiserum in-
fluences neutrophils in the peripheral blood. 
 
4.2.9 Influence of CXCR2 antiserum treatment on neutrophil be-
havior in vivo 
Next the question arose if the mobilization-inhibitory effect of CXCR2 antiserum 
was detectable on the migratory activity of individual neutrophils in the BM in vivo. 
Therefore mice were treated as before in the FACS experiments and 2-photon 
microscopy was started 30 min after G-CSF injection for 3 h. In every experiment 
three different areas per tibia were investigated consecutively and 20 - 30 cells 
were analyzed per sequence.  
In control mice which just received NRS before G-CSF triggering the cells dis-
played a very active morphology and also the typical cluster formation of mobilized 
neutrophils (Figure 49 a)). Unfortunately in this experiment it was not possible to 
detect the bone structure by technical reasons. In contrast neutrophils of mice 
which received the CXCR2 antiserum looked more roundish and quiescent (Figure 
49 b)). A kinetic overlay clearly underscored that neutrophils were highly motile in 
the NRS group (Figure 49 c)), whereas cell motility after CXCR2 antiserum treat-
ment was strongly reduced (Figure 49 d)). This was also supported by single cell 
tracking showing a highly significant decrease of neutrophil velocity after CXCR2 
antiserum administration and also a slightly but not significantly diminished cell 
activity, compared to NRS injection (Figure 49 e) and f)). 
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 NRS + G-CSF  CXCR2 antiserum + G-CSF 
a) 
 
b) 
 
c) 
 
d) 
 
e) 
 
f) 
 
Figure 49  Influence of CXCR2 antiserum treatment on neutrophil single cell behavior.  a) 30 
min after G-CSF stimulation 2-photon microscopy was carried out in tibial BM of NRS or b) CXCR2 
antiserum treated Lys-EGFP mice. c) Kinetic overlay of NRS or d) CXCR2 antiserum sequences.  
e) Statistical analysis of neutrophil velocity under both conditions. f) Statistical analysis of neutrophil 
activity under both conditions. n = 5 animals were analyzed independently. View supplemental mov-
ie 11. 
 
To further proof the influence of CXCR2 in neutrophil mobilization we looked for 
CXCR2 knock out mice. Our cooperation partners from the University of California 
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which also provided us with the CXCR2 antiserum housed these animals in their 
facility and we asked them to inject G-CSF to the mice. Importantly, CXCR2 ko 
mice could not mobilize neutrophils into the circulation (data not shown) underlin-
ing the important role of CXCR2 during this process. 
 
4.2.10 Triggering of neutrophil motility with the CXCR4 antagonist 
AMD 3100 
In several studies it was shown that the neutrophil surface receptor CXCR4 is re-
sponsible for the tethering of neutrophils in the bone marrow by its binding to 
CXCL12 and that the down regulation of CXCL12 and CXCR4 by G-CSF leads to 
their mobilization into the blood stream [Levesque et al. 2003b; Petit et al. 2002; 
Kim et al. 2006; Semerad et al. 2005b]. To investigate the impact of CXCR2 inhibi-
tion in this system we disrupted the CXCR4-CXCL12 binding by administration of 
the CXCR4 antagonist AMD3100 [De Clercq et al. 1992] in the presence or ab-
sence of an additional CXCR2 antiserum treatment. 
 
 
Figure 50  Neutrophil mobilization into the 
blood stream after AMD3100 treatment.  a) 
Statistical analysis of neutrophil recruitment into 
peripheral blood 2 h after application of 
AMD3100. NRS or CXCR2-antiserum was in-
jected 48 h before. n = 3 – 4 animals were ana-
lyzed for each condition. 
 
 
First of all we found that a treatment of mice with AMD3100 48 h after NRS appli-
cation increased the number of circulating neutrophils to over 20 % when blood 
was collected 2 h after AMD3100 injection (Figure 50) which is even stronger 
compared to G-CSF which just led to around 15 % neutrophils in the peripheral 
blood. This effect could be inhibited by injection of AMD3100 in the presence of 
the CXCR2 antiserum, thereby suggesting that without CXCR2 triggering neutro-
phils might be loosened from their CXCL12 anchor but are not able to subsequent-
ly enter the blood stream.  
This was also confirmed when we evaluated the AMD3100 influence on the single 
cell behavior in vivo by 2-photon microscopy. AMD 3100 treatment led to a mobili-
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zation of neutrophils within 1 - 2 h in the majority of mice which was comparable to 
the situation under G-CSF conditions with respect to activity (Figure 51 d)). A ki-
netic overlay displays the situation in the same animal 1 - 2 h after AMD3100 in-
jection (Figure 51 a)) and before AMD3100 treatment (Figure 51 b)) as an internal 
control. Interestingly, the velocity was not increased compared to non mobilized 
mice, which might further confirm the idea that cells are only detached from the 
endosteum after AMD3100 (Figure 51 c)) but not induced to migrate faster due to 
the absence of additional CXCR2 ligands. 
 
a) 
 
b) 
 
c) 
 
d) 
 
Figure 51  Impact of AMD3100 administration on neutrophil mobilization in vivo.  a) Kinetic 
overlay of 2-photon microscopy sequences after AMD3100 mobilization and b) before AMD 3100 
injection reveal a strong increase of cell motility after treatment. c) Analysis of cell velocity and d) 
activity in mice treated with AMD3100 in comparison to the situation 1 – 2 h after G-CSF and PBS. 
Data were measured in 3 - 7 independently analyzed animals. View supplemental movie 12. 
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4.2.11 Thrombopoietin (TPO) as mediator of neutrophil mobiliza-
tion  
Taken together our results suggested that G-CSF did not act directly on neutro-
phils to induce their mobilization. To clarify the underlying mechanisms leading to 
the observed G-CSF mediated neutrophil mobilization, a cooperative study with 
the lab of Nancy Hogg (London) was established. With their help it was possible to 
set up immunohistological analyses of BM sections, showing that both KC and 
MIP-2 were strongly produced by megakaryocytes located next to sinus vessels 
that were also positive for both chemokines. 2 h after G-CSF injection, the detect-
able megakaryocyte and endothelial expression of KC and MIP-2 was strongly 
reduced (data not shown). The hypothesis of megakaryocytes as the physiological 
source of neutrophil attracting chemokines was further supported by the demon-
stration that isolated primary mouse megakaryocytes in cell culture constitutively 
released KC and MIP-2 into the supernatant under in vitro conditions. Notably the 
addition of G-CSF to the cell culture had no further impact on the cytokine release, 
suggesting that megakaryocytes themselves are also not the direct targets for G-
CSF (data not shown). Further immunohistological studies revealed that neither 
the majority of neutrophils nor Mac-2-positive macrophages in the BM expressed 
the receptor for G-CSF, CD114. However, a population of cells exhibiting a stro-
mal cell like morphology was strongly G-CSF receptor positive (data not shown). 
These cells were predicted to produce factors that would influence the megakar-
yocytic release of chemokines and should therefore constitute the missing link be-
tween G-CSF-treatment, megakaryocytes and PMN mobilization. Megakaryocytes 
are best known for their function as platelet producers and the hematopoietic cyto-
kine thrombopoietin (TPO) has been described as the major stimulant of this pro-
cess. Encouraged by this hypothesis we investigated, if the stromal cells might be 
able to communicate with megakaryocytes via the secretion of TPO and indeed, 
while the expression level of TPO was found to be very low in unstimulated BM a 
strong upregulation was detectable upon systemic stimulation with G-CSF within 2 
h (data not shown). 
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a) 
 
b) 
 
Figure 52  Role of TPO in neutrophil mobilization. a) 2 h after retro orbital injection of TPO a 
significantly elevated neutrophil number was found in blood circulation. b) After injection of G-CSF 
or control PBS in TPOR-/-
 
mice, G-CSF still led to neutrophil mobilization, but compared to WT 
animals the mobilization was diminished. For a) n = 4 – 5 animals were analyzed, for b) between  
5 – 7 animals were analyzed. 
 
To finally clarify the potential influence of TPO on neutrophil mobilization in vivo 
TPO was injected i.v. into mice and the mobilization of neutrophils was assessed 2 
h later. Confirming the histological and cell-culture observations, a single injection 
of TPO already led to a significant recruitment of neutrophils into the blood stream 
(Figure 52 a)). This result further proved that the acute release of TPO constitutes 
the missing link in the context of G-CSF mediated release of KC and MIP-2 by 
megakaryocytes. To additionally proof the role of TPO in neutrophil mobilization 
we injected G-CSF or a PBS control into TPOR-/- mice. Interestingly, neutrophils 
in TPOR-/- mice were mobilized after G-CSF injection compared to TPOR-/- mice 
treated with PBS. However, in comparison to WT animals that received G-CSF the 
mobilization seemed to be slightly but not significantly decreased (Figure 52 b)). 
 
4.2.12 Summary - Part II 
In the course of the thesis we further improved our 2-photon microscopy approach 
and established the staining of blood vessels with rhodamine-dextran. A protocol 
for mouse injections was developed which allowed the double injection of sub-
stances without an interfering pre-stimulation of neutrophils during the mobilization 
experiments. FACS analysis revealed a strong increase of neutrophils and also of 
macrophages in the peripheral blood 2 h after G-CSF injection. Additionally we 
determined the influence of G-CSF on neutrophils via 2-photon microscopy directly 
in the murine long bones and observed an increase in cell motility with a peak dur-
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ing 1 – 2 h after treatment. Interestingly also the entry of neutrophils in the circula-
tion was observable. This increase of motility seems to be a special ability of neu-
trophils as macrophages and dendritic cells did not show this behavior in response 
to G-CSF. To figure out the mechanism of G-CSF mobilization we proved the in-
volvement of the chemokines KC and MIP-2 which are known to play a role in neu-
trophil mobilization during many infection models. Surprisingly the inhibition of 
neutrophil mobilization with monoclonal antibodies against both chemokines was 
not successful but blocking the main receptor CXCR2 of the chemokines with a 
polyclonal antiserum led to a strong reduction of neutrophils in the peripheral blood 
whereas, interestingly, the number of macrophages was slightly increased. To ex-
clude that the CXCR2 antiserum led to a neutrophil depletion, mice were also 
treated with a Gr-1 antibody which definitely leads to neutrophil depletion and the 
bone marrow was analyzed. Our data suggest that the CXCR2 antiserum does not 
simply deplete neutrophils. Injection of the CXCR2 antiserum 48 h before perform-
ing intravital 2-photon microscopy also completely suppressed the neutrophil motil-
ity upon G-CSF injection 2 h before starting the imaging. Moreover, we investigat-
ed the injection of the CXCR4 antagonist AMD3100 into mice as the important role 
of CXCR4 in neutrophil mobilization is known for many years. AMD3100 led to a 
significant increase of neutrophils in the circulation and notably this effect was also 
blocked by administration of CXCR2 antiserum. Together with our cooperation 
partners we identified megakaryocytes to be a source of KC and MIP-2 in the bone 
marrow and the release of both was triggered by TPO. The important role of TPO 
was also confirmed by the finding that injection of TPO alone led to neutrophil mo-
bilization into the peripheral blood and that G-CSF mobilization of TPOR-/- mice 
showed a diminished even though not significantly reduced number of neutrophils 
in the peripheral blood. Taken together, these data reveal a completely new 
mechanism how G-CSF might induce neutrophil mobilization and suggest for the 
first time an involvement of megakaryocytes and TPO in this process. 
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5. Discussion 
5.1 Localization and motility of HPCs und eHPCs from 
young and aged mice in murine long bones 
Migratory dynamics and localization relative to the functional structures of the 
bone matrix are critical for the regulation of stem cell physiology in the bone mar-
row. This is due to the fact that cell behavior is strongly influenced by the adjacen-
cies, composed of special niche cells either at the calcified bone surface [Adams 
et al. 2006a] or at the blood vessels. It was recently postulated that aged stem 
cells compared to young cells present with altered, less favorable and stable inter-
actions with their special niche. This might in part explain impaired hematopoiesis 
in aged individuals [Xing et al. 2006; Geiger et al. 2007], because the necessary 
microenvironment for hematopoiesis might no longer be available for the more 
detached aged cells.  
To test this hypothesis directly, we employed intravital 2-photon microscopy to in-
vestigate both, the in vivo short-term dynamics of young and aged HPCs, eHPCs 
and differentiated hematopoietic cells as well as the distance of these cells from 
the endosteal surface in the marrow of long bones. This study was the first analy-
sis that was performed in long bones. Other in vivo studies using intravital micros-
copy observations of stem cells had so far been done only in the murine calvarium 
[Lo et al. 2009], which is interesting due to the fact that HSCs are normally isolated 
from the marrow of long bones for different studies. Furthermore marrow of the 
long bones and jaws is generated from cartilage-based constructions by a process 
called endochondral ossification [Blumer et al. 2008], while flat bones like the cal-
varium contain marrow that has been formed by intra-membranous ossification, 
occurring without an intermediate cartilage form [Chan et al. 2009]. This has se-
vere functional consequences, e.g. on the functioning of hematopoietic stem cells 
and the formation of bone with functional niches [Xie et al. 2009; Chan et al. 2009]. 
In terms of direct imaging of cells or the blood vessel system in the bone marrow 
in vivo the previously available method for imaging in the calvarium [Mazo et al. 
1998] will suffer from a possible error made by investigating the not optimal envi-
ronment. 
In our approach, HPCs and eHPCs in long bones resided solitary and were com-
pletely immobile after they reached a location in close vicinity to the endosteum. 
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This is consistent with observations made for HPCs and eHPCs lodging in the 
bone marrow of the calvarium [Lo et al. 2009] and also to HSCs, detected by ex 
vivo real time imaging in bone marrow [Xie et al. 2009]. Although the observed 
cells displayed no locomotion, young primitive hematopoietic cells presented with 
active cell protrusion movements (“running on the spot”) in long bones. Moreover, 
sustained and very dynamic interactions with the microenvironment were observed 
that seemed to show some similarities to the movements of T cells during mainte-
nance of the well characterized immunologic synapse (IS) [Reichardt et al. 2007]. 
The IS is the contact plane between T cells and antigen-presenting cells and has 
been well defined in vitro [Gunzer et al. 2000; Friedl et al. 2005; Gunzer et al. 
2004] as well as in vivo [Henrickson et al. 2008; Mempel et al. 2004a; Barcia et al. 
2006]. Because the contact plane of primitive hematopoietic cells with the niche 
cells in the microenvironment seems to be functionally similar to the IS, it is has 
been named stem cell synapse [Yin et al. 2006; Adams et al. 2006b; Scadden 
2006b]. Interestingly, eHPCs seem to be located closer to the endosteal surface in 
the diaphysis of long bones compared with their position to the endosteal region in 
the calvarium [Lo et al. 2009]. This finding might indicate the presence of a special 
niche architecture in long bones, which is somehow altered in comparison to nich-
es in the calvarium and thus further underscores the functional difference between 
these two compartments.  
By comparing eHPCs and HPCs with respect to their localization and motility it 
was conspicuous that the HPCs, which resided more distantly from the endosteum 
showed increased motility compared to eHPCs. The same picture was found by 
comparing eHPCs from young and old mice for the same parameters. More dis-
tantly located cells from old animals displayed a much higher motility than cells 
from young animals, which had closer contact to the endosteum. This might indi-
cate that the close interaction of cells with their endosteal niche supports the 
maintenance of quiescence in cells, whereas a larger distance to the endosteal 
layer leads to a more active cell phenotype. Other studies dealing with the different 
interactions of stem cells with their several niches support these in vivo findings 
[Arai et al. 2007; Scadden 2006a; Adams et al. 2006c; Suda et al. 2005; Wilson et 
al. 2006b]. Now the question came up, whether the zone close to the endosteum 
is an area of generally reduced cell migration. First, imaging in CX3CR1-EGFP 
knock-in mice [Jung et al. 2000] could demonstrate that this specific region is not 
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only engaged by undifferentiated hematopoietic stem cells, a finding that further 
underline the complexity of the bone marrow microenvironment. In addition, be-
cause both EGFP-labeled cell types in these mice, macrophages as well as DCs, 
were highly motile in comparison to HPCs and eHPCs, it could be concluded that 
active cell migration near the endosteal surface is possible and thus the lack of 
locomotion in primitive hematopoietic cells was cell intrinsic rather than hampered 
by a physical migration barrier in this zone. The data obtained later for neutrophils, 
which were even more motile in the near-endosteal environment, further strength-
ens this point. However, interestingly also macrophages and DCs displayed a 
clear correlation between their motility and localization to the inner bone surface. 
So this phenomenon seems not to be restricted to primitive hematopoietic cells but 
applies also for differentiated hematopoietic cell types. The molecular explanation 
for this observation has remained enigmatic so far. 
The complete immobility of eHPCs and HPCs suggest that these cells might have 
an ability to actively suppress migration once they have reached their destination. 
Another possibility might be that the activity of several cytokines which should 
support eHPC migration, like the stromal cell–derived factor 1 (SDF-1), might be 
restricted to very distinct locations of the endosteal layer in vivo. The latter hypoth-
esis is strongly supported by the finding, that stroma cells expressing SDF-1, 
which can induce migration in primitive hematopoietic cells [Dar et al. 2006] are 
distributed on single distinct spots inside the bone [Sugiyama et al. 2006]. 
Several models try to explain the aging of hematopoietic stem cells. The under-
standing for this process is of prime importance because it is involved in the im-
paired tissue homeostasis of different organs that rely on stem cell activity [Rando 
2006]. Aging of stem cells is characterized by a reduced proliferative and regener-
ative capacity, including DNA damage, action of reactive oxygen species and/or 
telomere attrition [Geiger et al. 2002; Geiger et al. 2007; Chambers et al. 2007; 
Kamminga et al. 2006]. Our results add a model to this list of potential defects in 
aged stem cells in which localization and in addition altered cell-cell interactions of 
aged eHPCs with their respective niche in the bone marrow might alter the ability 
to maintain functionality for a longer period of time. This could lead to the special 
phenotypes associated with aged eHPCs. Altered interactions of stem cells with 
the stroma will most likely result in altered differentiation and self-renewal out-
comes.  
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On a molecular level our co-workers found that elevated levels of the α5 integrin 
chain (CD49e) correlated with reduced adhesion to stroma cells, leading to a more 
distant localization of young and aged cells from the endosteum [Kohler et al. 
2009]. This suggested that the level of expression of α5 integrin can modify the 
localization of primitive hematopoietic cells with respect to the endosteal layer. 
Moreover it might regulate in which microenvironment a cell will reside in upon 
transplantation. There are several publications, which are consistent with the find-
ing, that α5 integrins have an influence on stem cell niche interactions. For exam-
ple the blocking of α5 integrins on HSCs leads to a reduced homing to the BM, but 
not to the spleen, which does not have endosteal structures [Kiel et al. 2005; Kiel 
et al. 2006; Wierenga et al. 2006]. Additionally, α5 integrins also regulate engraft-
ment of human hematopoietic stem and progenitor cells [Carstanjen et al. 2005] 
and during the mobilization with G-CSF the cell surface expression level of α5 in-
tegrins is increased in bone marrow resident HSCs [Wagers et al. 2002]. Unfortu-
nately, our results do not answer the question, which cells in the bone marrow are 
directly contacted by eHPCs. Using new animal strains in which additional types of 
hematopoietic [Chiang et al. 2007] or stroma cells are fluorescently labeled will 
result in more profound information about cell-cell interactions of stem cells in long 
bones. Hopefully, this approach will also allow the monitoring of the endosteal as 
well as of the perivascular endothelial region within long bones and their influence 
on aging. This might help to clarify the role and influence of functional stem cell 
niches in the femur and reveal similarities to recent published ex vivo analyses 
[Xie et al. 2009]. 
To summarize the first part of the thesis, the use of intravital 2-photon microscopy 
to visualize hematopoietic cells inside the bone marrow cavity of long bones al-
lowed providing the first direct experimental evidence for the existence of eHPC 
synapses within the niche. In addition, the data implied distinct primitive hemato-
poietic stem cell stroma interactions for aged eHPCs relative to their analogues 
from young animals that might impact on both their self-renewal and differentiation 
potential, probably similar to mechanisms recently described for aged germline 
stem cells in Drosophila [Cheng et al. 2008]. These data thus show, how intravital 
2-photon microscopy in the bone marrow of long bones can open new insights for 
the investigation of mammalian stem cell biology in vivo [Sakaue-Sawano et al. 
2008]. 
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5.2 Investigation of bone structure and blood flow in mu-
rine long bones 
In the second part of the study a novel explanation how G-CSF mobilizes neutro-
phils from bone marrow was established, which appears to be much more con-
sistent with all available data on neutrophil mobilization by G-CSF than previous 
models. Additionally the 3-D bone structure and the blood flow in murine long 
bones were analyzed in detail for the first time. It was found, that the inner bone 
surface displays a “crisp bread” structure with lots of emarginations and pores. 
Many, but not all of these pores were nerved by vessels and blood flow could be 
observed within. However, the blood flow in long bones is still not fully understood. 
It is remarkably difficult to investigate the circulation inside the compact bone thor-
oughly owing to its hard calcified matrix. Methods to study circulation have repre-
sented either the bone morphology and the architecture of the canal system [CO-
HEN et al. 1958; Smith 1960; VASCIAVEO et al. 1961; Albu et al. 1973] or the 
injected vessel network [Brookes et al. 1961; HERT et al. 1961; Trias et al. 1979; 
Marotti et al. 1980]. There is previous evidence that the highly sensitive and com-
plicated bone marrow compartment is not the same in murine long bones and cal-
varium with respect to hematopoiesis [Xie et al. 2009]. Additionally, our 2-photon 
microscopy data detected remarkable differences between blood vessels in long 
bones compared to vessels in the calvarium. Murine long bones display big ves-
sels slightly distant from the endosteal layer. Close to the endosteal layer these 
vessels suddenly branch into a dense network of very small vessels that line the 
complete inner bone surface. In contrast, in the calvarium the complex structure of 
small vessels seems to be completely missing and only bigger vessels are visible 
[Lo et al. 2009; Mazo et al. 1998]. To which extent this fact might influence cell 
behavior and if there are other remarkable differences between both distinct bone 
marrow environments need to be further investigated in the future. Also the overall 
3-D architecture of incoming and outgoing vessels in the murine long bone is an 
important issue worth of in depth investigation in the future. 
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5.3 Important role for the chemokines KC and MIP-2 and 
their receptor CXCR2 in neutrophil mobilization from 
the bone marrow 
Neutrophils in murine long bones react on systemic G-CSF administration with a 
dramatic increase of cell motility. Interestingly the number of migrating cells in-
crease from 35 % to almost 60 % when observed 1 - 3 h after G-CSF injection by 
intravital 2-photon microscopy. This observation fits to the known fact that G-CSF 
disrupts the main anchor for neutrophils that provide their retention in the bone 
marrow, the CXCR4-SDF-1 axis. Notably, neutrophils seem to cluster to distinct 
places at the blood vessels, where they can immigrate into the circulation (Figure 
37). Those special sites are already described for the endothelium [Nourshargh et 
al. 2010; Voisin et al. 2010; Wang et al. 2006] so it could be speculated that a sit-
uation like a traffic jam occurs at these places because too many neutrophils try to 
leave the bone marrow simultaneously. Usually a few clusters were observed in 
every microscopy area but exclusively after mobilization. Also the phenomenon 
that neutrophils aggregate to big clusters was observed in the past and this behav-
ior was named swarming [Peters et al. 2008]). 
Within this work we discovered that after G-CSF administration the neutrophil-
attracting chemokines KC and MIP-2 are produced in the BM. We could also 
demonstrate that the chemokine receptor CXCR2 which is triggered by these 
chemokines is required for the induction of profound neutrophil motility in the bone 
marrow as well as their entry into local blood sinuses after systemic application of 
G-CSF. During the finalization of this thesis and the submission process of the 
associated publication the principal finding that CXCR2 is important for G-CSF-
mediated neutrophil mobilization was also made by others, thus has now been 
independently confirmed [Eash et al. 2010]. 
Surprisingly, while a polyclonal anti-CXCR2 antiserum was very effective in block-
ing increased neutrophil motility in vivo, both anti-KC and anti-MIP-2 antibodies did 
not influence the G-CSF mediated neutrophil motility or their release from bone 
marrow. This was despite the clear repressing effect of both antibodies on neutro-
phil mobilization and recruitment, which has been shown in a model of acute peri-
tonitis [Wengner et al. 2008]. Also in our hands the anti KC and anti MIP-2 anti-
bodies displayed a significant decrease of neutrophils in the peripheral blood as 
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well as in the peritoneal lavage 2h after induction of an LPS mediated peritonitis. 
Why the antibodies did not function within the BM might be explained with the fact, 
that the LPS-peritonitis model represents a distinct local inflammation, whereas a 
systemic neutrophil mobilization through G-CSF induces an overall reaction of 
neutrophils. Possibly this leads to a much stronger neutrophil response, where the 
dose of antibodies that was chosen in our experiments was not capable to over-
come the resulting effect. Another possibility might be that for unknown reasons 
the antibodies did not reach the BM stroma to interfere with neutrophil motility. Un-
fortunately from our experiments we also cannot fully exclude that the anti CXCR2 
antiserum might deplete neutrophils from blood or peripheral organs. However, in 
the light of our data on CXCR2 deficient mice which cannot mobilize neutrophils by 
G-CSF, the recent publication by Eash et al, which confirms a key role of CXCR2 
as well as the fact that the CXCR2 antiserum does not bind complement and thus 
does not kill neutrophils in vitro (personal communication, T. Lane, UCI), we might 
at least assume that the antibody works properly without depletion. An ultimate 
proof of this concept can only come from additional studies using novel transgenic 
animal models 
 
5.4 Megakaryocytes produce and release KC and MIP-2 in 
response to thrombopoietin 
There is previous evidence that the receptor for G-CSF does not need to be ex-
pressed on neutrophils for efficient mobilization but instead that a trans-acting sig-
nal is generated by receptor-expressing bystander cells [Semerad et al. 2002]. 
The nature of this signal has however, remained elusive. Our data fully support 
these previous findings and identified this trans-acting signal as a combination of 
thrombopoietin produced by G-CSFR-expressing stromal cells and KC/MIP-2 re-
leased at least in parts by megakaryocytes. Other cells important in this respect 
might be endothelial cells [Eash et al. 2010]. This concept also gives new perspec-
tives to the function of megakaryocytes. They are well known as platelet producers 
[Junt et al. 2007] and until now this has remained their sole activity. Our findings 
suggest a new central role for megakaryocytes as gatekeepers of neutrophil mobi-
lization.  
It could be shown that primary mouse BM megakaryocytes secrete KC/MIP-2 
without further stimulus in culture and that the baseline levels of circulating neutro-
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phils are severely reduced after blockade of the KC/MIP-2-receptor CXCR2. 
Therefore it could be proposed that megakaryocytes constitutively release small 
amounts of KC/MIP-2 as a "tonic" signal that maintains steady-state levels of neu-
trophils in the blood. Consistent with this, our data show the production of the 
KC/MIP-2 homologue IL-8 by a human megakaryocyte cell line as well as other 
reports using megakaryocytes derived from human CD34+ progenitor cells [Emadi 
et al. 2005; Higuchi et al. 1997]. “Tonic” signalling via chemokine receptors has 
been demonstrated for neutrophils before in a model of peritoneal inflammation 
[Zhang et al. 2005]. Importantly megakaryocytes can greatly boost the production 
of CXCR2-binding chemokines following a systemic increase of G-CSF, thereby 
constituting a hyper-signal capable of mobilizing the large numbers of neutrophils 
that are needed to fight peripheral infections [Behnsen et al. 2007]. Therefore dif-
ferent levels of stimulation via the same chemokine receptor, in this case CXCR2 
on neutrophils, might control the circulating levels of a central leukocyte type under 
both steady state and inflammatory conditions, based on the fact that the CXCR2 
antibody does not deplete neutrophils which was already discussed in 4.3. Our 
demonstration that monocytes were also mobilized via G-CSF but independently 
of CXCR2 suggests that leukocyte specific receptor-ligand systems might be ac-
tive for each type of circulating leukocytes to maintain its baseline and trigger-
induced levels. The CXCR2-independent mobilization of monocytes by G-CSF 
also implies that the cytokine will induce the release of factors distinct from neu-
trophil specific KC/MIP2 which however, are not yet identified. A further complexity 
is that the rapid release of KC/MIP-2 from megakaryocytes is not a direct effect of 
G-CSF. Among BM cells, stromal cells and a subtype of F4/80+ macrophages but 
not neutrophils were identified to express the G-CSFR by our cooperation partners 
from the group of Nancy Hogg. Based on their localization within the BM it ap-
peared that at least some of the same cells were strong expressors of thrombo-
poietin following in vivo G-CSF treatment. Thrombopoietin has a potent influence 
on megakaryocyte maturation and function. Its roles extend from acting as main 
colony-stimulating factor in megakaryopoiesis to controlling the number of mature 
megakaryocytes able to form pro-platelets [de Sauvage et al. 1996]. 
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Figure 53  A model summarizing the con-
cept of neutrophil mobilization by G-CSF 
in keeping with the data of this study.  a) 
(1) A G-CSFR-expressing cell (potentially a 
F4/80 positive bone marrow macrophage) 
recognizes G-CSF. (2) As a result this cell 
produces TPO. (3) TPO enhances the capac-
ity of megakaryocytes to secrete CXCR2 
ligands such as KC and MIP-2. b) Neutro-
phils are mobilized via stimulation of their 
receptor CXCR2 to find a way out of the 
bone marrow into blood vessels.  
a) 
 
 
b) 
 
 
 
In terms of human stromal cells, high levels of thrombopoietin mRNA are ex-
pressed by BM stromal cells from several categories of thrombocytopenic patients 
but not normal controls [Sungaran et al. 1997]. Evidence that thrombopoietin was 
the link between G-CSF-responsive macrophages and megakaryocyte function 
came from the finding, that thrombopoietin caused primary mouse megakaryo-
cytes as well as the human MEG-01 cell line, to make enhanced amounts of the 
neutrophil attracting chemokines. Importantly, thrombopoietin was able to bypass 
the need for G-CSF and caused neutrophil mobilization directly when injected in 
 5. Discussion 
 109 
vivo. In fact long term exposure to thrombopoietin via a retroviral vector infection 
gave rise to a fatal myeloproliferative syndrome making the link between thrombo-
poietin and neutrophils in another way [Villeval et al. 1997]. Moreover also osteo-
blasts that line the endosteal wall within bone marrow are G-CSF receptor posi-
tive, are thrombopoietin producers and are intimately involved in retention of qui-
escent stem cells [Yoshihara et al. 2007]. Notably, TPOR-/- mice are still able to 
mobilize a slightly significant number of neutrophils into the peripheral blood after 
G-CSF treatment, although the number is decreased compared to wild-type ani-
mals. A possible explanation might be that TPO might be just able to induce the 
release of KC and MIP-2 from megakaryocytes. There are other cell types that 
also produce both chemokines but which are not known to react to a TPO stimu-
lus, for example endothelial cells in the bone marrow in which we could demon-
strate high expression of both chemokines with immunohistochemistry. Other still 
unknown mechanisms may lead to their release so that we conclude an important 
but not unique role for TPO in chemokine release which would perfectly explain 
the given but not fully established neutrophil mobilization in TPOR-/- mice. Fur-
thermore, in terms of stem cell release there is evidence that G-CSF may act out-
side the bone marrow on the sympathetic nervous system in a network that in-
volves suppression of osteoblast activity and reduction of CXCL12 levels and al-
tering of stem cell release [Katayama et al. 2006]. Whether osteoblasts also have 
a role in the stromal cell/megakaryocyte/neutrophil network what is proposed here 
is a topic for future investigation. In any case our study demonstrates that CXCR2 
is a critical chemokine receptor that mediates stress granulopoiesis induced by G-
CSF as meanwhile also confirmed by others [Eash et al. 2010]. 
 
5.5 Role of the CXCR4 antagonist AMD3100 in neutrophil 
mobilization 
Previous work has highlighted the essential nature of the CXCR4-CXCL12 bond 
that serves to retain neutrophils in the BM and the disrupting effect of G-CSF on 
this interaction [Link 2005]. AMD3100 is a major CXCR4 antagonist that can inter-
fere with this chemokine-receptor pair causing neutrophil release from BM 
[Wengner et al. 2008]. In our study we demonstrated that the action of AMD3100 
is prevented by CXCR2 blockade thus placing the role of KC/MIP-2 and their 
CXCR2 receptor downstream of CXCR4-CXCL12. This finding immediately pro-
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vides a rational explanation for the well-known synergism of G-CSF and 
AMD3100, which has been lacking so far [di Persio et al. 2009; Flomenberg et al. 
2005; Pelus 2008]. Our data suggest that AMD3100 breaks the CXCR4-CXCL12 
bonds of neutrophils fast and efficiently within the BM but once released, neutro-
phils need to detect the CXCR2 signal to initiate migration and to be directed to-
wards the BM sinuses. This would be in full accordance with the study of Eash et 
al [Eash et al. 2010] who also observe lack of mobilization by AMD3100 in the ab-
sence of CXCR2 on neutrophils. In this concept G-CSF acts synergistically with 
AMD3100 because it strongly increases the amount of neutrophil mobilising 
chemokines in the blood thereby enhancing their release into the circulation in 
much greater numbers than AMD3100 alone. The findings have implications for 
the clinical treatment of neutropenic patients.  
Finally our novel technical approach now allows imaging of BM resident cells in 
the tibia in vivo, a long bone compartment from where both mature neutrophils as 
well as hematopoietic stem cells are normally isolated for experimental studies in 
mice. This is a helpful addition to approaches for imaging BM resident cells which 
have so far concentrated on the bone marrow of the calvarium [Lo et al. 2009; Ma-
zo et al. 1998]. Using this approach it was possible to provide the first view into the 
enormous dynamics of neutrophil mobilization in its natural environment in vivo.  
In summary, the data show that a megakaryocyte/stromal cell axis operates in a 
finely controlled cooperative fashion to maintain both baseline and emergency lev-
els of neutrophils. Thus, we have identified a network of key signalling molecules, 
chemokines and cells controlling neutrophil release that is strategically positioned 
in the BM cavity adjacent to vessels. For future studies it will be important to con-
sider the impact of this cellular axis in response to external perturbations such as 
peripheral infections requiring immune defense as well as its involvement in the 
release from the BM of other mature leukocytes or cells from the hematopoietic 
stem cell compartment. 
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6. Outlook 
The method of intravital 2-photon microscopy opens up a lot of new possibilities for 
immunologists to directly examine the behavior of immune cells in their natural en-
vironment. Due to the enormous complexity of the immune system, this microscop-
ic visualization seems to be an ideal way to really understand cell behavior in dif-
ferent organs and under different conditions. With our new approach of intravital 2-
photon microscopy we gained access to a so far unapproachable area of the or-
ganism with a tremendous immunological relevance, the long bones.  
In the first part of the present work we have analyzed the localization and motility 
of young and aged eHPCs in this compartment. With our new microscopic tool it 
will be now possible to further analyze stem cell behavior in their niche with respect 
to e.g. contact parameters. We are now able to bring light into cell-niche or cell-cell 
interactions and thereby explaining basic hematopoietic processes. Such experi-
ments could gain further help from a very recent publication in which it has been 
shown that nestin positive mesenchymal stem cells build up a unique niche [Men-
dez-Ferrer et al. 2010]. Isolated and fluorescently labeled stem cells could subse-
quently be transferred into Nes-GFP transgenic mice which would allow an obser-
vation of the interaction between both cell types in vivo. Another approach to fur-
ther investigate this interaction are transgenic mouse models in which different ad-
hesion molecules that are important for stem cells retention could be deeply stud-
ied, e.g. by genetic fluorescent labeling and/or deletion. Moreover, the creation of 
transgenic animals with fluorescently labeled stem cells would be very helpful to 
visualize the endogenous stem cell population in the long bones. In such a model it 
would be of great importance to clarify if the endogenous cells behave the same as 
adoptively transferred entities with respect to localization and motility. For particu-
lar experimental questions it could be of interest to analyze stem cells that have 
been transferred into lethally irradiated recipients. It could well be that in these an-
imals much more stem cells invade the marrow and end up in a closer vicinity to 
the endosteum, as the niches are not occupied by the recipient’s endogenous stem 
cells. Another important and still unknown question is how adoptively transferred 
stem cells reach their niche in the bone marrow. Are they leaving the central bone 
vessel to reach the marrow or are they brought to the marrow in smaller vessels 
entering the bone all along its shaft? Do these stem cells first enter the vascular 
niche and then keep moving to the endosteal niche or is it the other way round? 
 6. Outlook 
 112 
And besides the (re-)population of the bone marrow by stem cells it is also not vis-
ualized so far how cells leave this compartment under certain conditions. This stem 
cell mobilization, for example by G-CSF, can also be studied in detail with our nov-
el intravital 2-photon microscopy approach. Finally, also issues regarding the self-
renewing capacity of stem cells will be amenable to intravital imaging. Where and 
how does asymmetric division occur? At what frequency and which role might play 
the associated niche cell? Such issues will be open for direct investigation now. 
In the second part of the work the mechanisms of neutrophil mobilization after G-
CSF treatment have been investigated. The important role of the chemokines KC 
and MIP-2 and of their receptor CXCR2 was described for the first time in this con-
text. Both chemokines were produced and released by megakaryocytes upon trig-
gering with thrombopoietin. In addition we made the first observations that a sub-
population of macrophages might react to G-CSF stimulation with a release of 
thrombopoietin. This could be a valid hint that macrophages are the source of TPO 
that subsequently stimulates megakaryocytes to release the pro-inflammatory 
chemokines but until now it has not been ultimately shown that macrophages are 
the only source of TPO and thereby are the key mediators of the proposed model. 
To prove their involvement in neutrophil mobilization they have to be removed from 
the system in order to show that this ablation has a direct impact on the mobiliza-
tion. Furthermore, the chemokines KC and MIP-2 were also detected in an endo-
thelial cell layer of the bone marrow and their release from these cells could be 
triggered by G-CSF treatment of animals. As this release might not be triggered by 
TPO a very interesting question for upcoming experiments is to clarify if the endo-
thelial cells, in contrast to megakaryocytes, harbor the G-CSF receptor and thereby 
possess the ability to directly react to G-CSF stimulation with the release of KC 
and MIP-2. Further it would be interesting to assess if our proposed model of TPO 
induced chemokine release also is of relevance under infection conditions. In the 
literature it is widely accepted that KC and MIP-2 levels are up-regulated as re-
sponse to different infections and that, as an example, an inactivation of these 
chemokines by antibody treatment reduces the number of neutrophils in an acute 
peritonitis model [Wengner et al. 2008], but the mediating steps also still remain 
unknown. Another context in which our proposed model for neutrophil mobilization 
could be of interest is the regulation of the constantly circulating neutrophil number 
in the peripheral blood under normal, resting conditions. This steady release of 
 6. Outlook 
 113 
neutrophils from the BM into the circulation is influenced by G-CSF. To what extent 
our described mechanism is also involved in this regulation needs to be further 
investigated. 
 
 
 7. References 
 114 
7. Reference list 
 1.  Abramson S, Miller RG, Phillips RA. The identification in adult bone marrow 
of pluripotent and restricted stem cells of the myeloid and lymphoid sys-
tems. J Exp Med 1977; 145: 1567-1579. 
 2.  Adams GB, Chabner KT, Alley IR et al. Stem cell engraftment at the endos-
teal niche is specified by the calcium-sensing receptor. Nature 2006a; 439: 
599-603. 
 3.  Adams GB, Scadden DT. The hematopoietic stem cell in its place. Nat Im-
munol 2006b; 7: 333-337. 
 4.  Adams GB, Scadden DT. The hematopoietic stem cell in its place. Nat Im-
munol 2006c; 7: 333-337. 
 5.  Albu I, Georgia R, Stoica E, Giurgiu T, Pop V. [The system of canals of the 
diaphysial compact layer of human long bones]. Acta Anat (Basel) 1973; 
84: 43-51. 
 6.  Ara T, Tokoyoda K, Sugiyama T, Egawa T, Kawabata K, Nagasawa T. 
Long-term hematopoietic stem cells require stromal cell-derived factor-1 for 
colonizing bone marrow during ontogeny. Immunity 2003; 19: 257-267. 
 7.  Arai F, Hirao A, Ohmura M et al. Tie2/angiopoietin-1 signaling regulates 
hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 
118: 149-161. 
 8.  Arai F, Suda T. Maintenance of quiescent hematopoietic stem cells in the 
osteoblastic niche. Ann N Y Acad Sci 2007; 1106: 41-53. 
 9.  Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor 
receptor. Blood 1996; 88: 761-777. 
 10.  Avecilla ST, Hattori K, Heissig B et al. Chemokine-mediated interaction of 
hematopoietic progenitors with the bone marrow vascular niche is required 
for thrombopoiesis. Nat Med 2004; 10: 64-71. 
 11.  Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cy-
tokines--CXC and CC chemokines. Adv Immunol 1994; 55: 97-179. 
 12.  Barcia C, Thomas CE, Curtin JF et al. In vivo mature immunological synap-
ses forming SMACs mediate clearance of virally infected astrocytes from 
the brain. J Exp Med 2006; 203: 2095-2107. 
 13.  Behnsen J, Narang P, Hasenberg M et al. Environmental Dimensionality 
Controls the Interaction of Phagocytes with the Pathogenic Fungi Aspergil-
lus fumigatus and Candida albicans. PLoS Pathog 2007; 3: e13. 
 14.  Blumer MJ, Longato S, Fritsch H. Structure, formation and role of cartilage 
canals in the developing bone. Ann Anat 2008; 190: 305-315. 
 15.  Bozic CR, Gerard NP, von Uexkull-Guldenband C et al. The murine inter-
 7. References 
 115 
leukin 8 type B receptor homologue and its ligands. Expression and biologi-
cal characterization. J Biol Chem 1994; 269: 29355-29358. 
 16.  Bozic CR, Kolakowski LF, Jr., Gerard NP et al. Expression and biologic 
characterization of the murine chemokine KC. J Immunol 1995; 154: 6048-
6057. 
 17.  Bradfute SB, Graubert TA, Goodell MA. Roles of Sca-1 in hematopoietic 
stem/progenitor cell function. Exp Hematol 2005; 33: 836-843. 
 18.  Branehog I, Ridell B, Swolin B, Weinfeld A. Megakaryocyte quantifications 
in relation to thrombokinetics in primary thrombocythaemia and allied dis-
eases. Scand J Haematol 1975; 15: 321-332. 
 19.  Brinkmann V, Reichard U, Goosmann C et al. Neutrophil extracellular traps 
kill bacteria. Science 2004; 303: 1532-1535. 
 20.  Brinkmann V, Zychlinsky A. Beneficial suicide: why neutrophils die to make 
NETs. Nat Rev Microbiol 2007; 5: 577-582. 
 21.  Brookes M, Lloyd EG. Marrow vascularization and oestrogen-induced en-
dosteal bone formation in mice. J Anat 1961; 95: 220-228. 
 22.  Broxmeyer HE, Orschell CM, Clapp DW et al. Rapid mobilization of murine 
and human hematopoietic stem and progenitor cells with AMD3100, a 
CXCR4 antagonist. J Exp Med 2005; 201: 1307-1318. 
 23.  Bruns S, Kniemeyer O, Hasenberg M et al. Production of extracellular traps 
against Aspergillus fumigatus in vitro and in infected lung tissue is depend-
ent on invading neutrophils and influenced by hydrophobin RodA. PLoS 
Pathog 2010; 6: e1000873. 
 24.  Bunting S, Widmer R, Lipari T et al. Normal platelets and megakaryocytes 
are produced in vivo in the absence of thrombopoietin. Blood 1997; 90: 
3423-3429. 
 25.  Burdon PC, Martin C, Rankin SM. Migration across the sinusoidal endothe-
lium regulates neutrophil mobilization in response to ELR + CXC chemo-
kines. Br J Haematol 2008; 142: 100-108. 
 26.  Burdon PC, Martin C, Rankin SM. The CXC chemokine MIP-2 stimulates 
neutrophil mobilization from the rat bone marrow in a CD49d-dependent 
manner. Blood 2005; 105: 2543-2548. 
 27.  Burgess AW, Metcalf D. Characterization of a serum factor stimulating the 
differentiation of myelomonocytic leukemic cells. Int J Cancer 1980; 26: 
647-654. 
 28.  Cahalan MD, Parker I, Wei SH, Miller MJ. Two-photon tissue imaging: see-
ing the immune system in a fresh light. Nat Rev Immunol 2002; 2: 872-880. 
 29.  Carlson T, Kroenke M, Rao P, Lane TE, Segal B. The Th17-ELR+ CXC 
chemokine pathway is essential for the development of central nervous sys-
 7. References 
 116 
tem autoimmune disease. J Exp Med 2008b; 205: 811-823. 
 30.  Carlson T, Kroenke M, Rao P, Lane TE, Segal B. The Th17-ELR+ CXC 
chemokine pathway is essential for the development of central nervous sys-
tem autoimmune disease. J Exp Med 2008a; 205: 811-823. 
 31.  Carstanjen D, Gross A, Kosova N, Fichtner I, Salama A. The alpha4beta1 
and alpha5beta1 integrins mediate engraftment of granulocyte-colony-
stimulating factor-mobilized human hematopoietic progenitor cells. Transfu-
sion 2005; 45: 1192-1200. 
 32.  Cataisson C, Pearson AJ, Tsien MZ et al. CXCR2 ligands and G-CSF me-
diate PKCalpha-induced intraepidermal inflammation. J Clin Invest 2006; 
116: 2757-2766. 
 33.  Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA. 
Aging hematopoietic stem cells decline in function and exhibit epigenetic 
dysregulation. PLoS Biol 2007; 5: e201. 
 34.  Chan CK, Chen CC, Luppen CA et al. Endochondral ossification is required 
for haematopoietic stem-cell niche formation. Nature 2009; 457: 490-494. 
 35.  Chen J, Astle CM, Harrison DE. Genetic regulation of primitive hematopoi-
etic stem cell senescence. Exp Hematol 2000; 28: 442-450. 
 36.  Cheng J, Turkel N, Hemati N, Fuller MT, Hunt AJ, Yamashita YM. Centro-
some misorientation reduces stem cell division during ageing. Nature 2008; 
456: 599-604. 
 37.  Cheng T, Rodrigues N, Shen H et al. Hematopoietic stem cell quiescence 
maintained by p21cip1/waf1. Science 2000; 287: 1804-1808. 
 38.  Cheshier SH, Morrison SJ, Liao X, Weissman IL. In vivo proliferation and 
cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc 
Natl Acad Sci U S A 1999; 96: 3120-3125. 
 39.  Chiang EY, Hidalgo A, Chang J, Frenette PS. Imaging receptor microdo-
mains on leukocyte subsets in live mice. Nat Methods 2007; 4: 219-222. 
 40.  Civin CI, Gore SD. Antigenic analysis of hematopoiesis: a review. J Hema-
tother 1993; 2: 137-144. 
 41.  COHEN J, HARRIS WH. The three-dimensional anatomy of haversian sys-
tems. J Bone Joint Surg Am 1958; 40-A: 419-434. 
 42.  Cox G, Kable E, Jones A, Fraser I, Manconi F, Gorrell MD. 3-dimensional 
imaging of collagen using second harmonic generation. J Struct Biol 2003; 
141: 53-62. 
 43.  Crawford J, Ozer H, Stoller R et al. Reduction by granulocyte colony-
stimulating factor of fever and neutropenia induced by chemotherapy in pa-
tients with small-cell lung cancer. N Engl J Med 1991; 325: 164-170. 
 7. References 
 117 
 44.  CUDKOWICZ G, UPTON AC, SHEARER GM, HUGHES WL. LYMPHO-
CYTE CONTENT AND PROLIFERATIVE CAPACITY OF SERIALLY 
TRANSPLANTED MOUSE BONE MARROW. Nature 1964; 201: 165-167. 
 45.  Curry JL, Trentin JJ, Wolf N. Hemopoietic spleen colony studies. II. Eryth-
ropoiesis. J Exp Med 1967; 125: 703-720. 
 46.  Cutler C, Antin JH. Peripheral blood stem cells for allogeneic transplanta-
tion: a review. Stem Cells 2001; 19: 108-117. 
 47.  Dar A, Kollet O, Lapidot T. Mutual, reciprocal SDF-1/CXCR4 interactions 
between hematopoietic and bone marrow stromal cells regulate human 
stem cell migration and development in NOD/SCID chimeric mice. Exp 
Hematol 2006; 34: 967-975. 
 48.  De Clercq E, Yamamoto N, Pauwels R et al. Potent and selective inhibition 
of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class 
of bicyclams interacting with a viral uncoating event. Proc Natl Acad Sci U S 
A 1992; 89: 5286-5290. 
 49.  de Haan G, Van ZG. Dynamic changes in mouse hematopoietic stem cell 
numbers during aging. Blood 1999; 93: 3294-3301. 
 50.  de Sauvage FJ, Carver-Moore K, Luoh SM et al. Physiological regulation of 
early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp 
Med 1996; 183: 651-656. 
 51.  Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its recep-
tor. Blood 1991; 78: 2791-2808. 
 52.  Demetri GD, Zenzie BW, Rheinwald JG, Griffin JD. Expression of colony-
stimulating factor genes by normal human mesothelial cells and human ma-
lignant mesothelioma cells lines in vitro. Blood 1989; 74: 940-946. 
 53.  Denk W, Strickler JH, Webb WW. Two-photon laser scanning fluorescence 
microscopy. Science 1990; 248: 73-76. 
 54.  Deutsch VR, Tomer A. Megakaryocyte development and platelet produc-
tion. Br J Haematol 2006; 134: 453-466. 
 55.  di Persio JF, Uy GL, Yasothan U, Kirkpatrick P. Plerixafor. Nat Rev Drug 
Discov 2009; 8: 105-106. 
 56.  Dick JE, Magli MC, Huszar D, Phillips RA, Bernstein A. Introduction of a 
selectable gene into primitive stem cells capable of long-term reconstitution 
of the hemopoietic system of W/Wv mice. Cell 1985; 42: 71-79. 
 57.  Dilulio NA, Engeman T, Armstrong D, Tannenbaum C, Hamilton TA, 
Fairchild RL. Groalpha-mediated recruitment of neutrophils is required for 
elicitation of contact hypersensitivity. Eur J Immunol 1999; 29: 3485-3495. 
 58.  Eash KJ, Greenbaum AM, Gopalan PK, Link DC. CXCR2 and CXCR4 an-
tagonistically regulate neutrophil trafficking from murine bone marrow. J 
 7. References 
 118 
Clin Invest 2010. 
 59.  Emadi S, Clay D, Desterke C et al. IL-8 and its CXCR1 and CXCR2 recep-
tors participate in the control of megakaryocytic proliferation, differentiation, 
and ploidy in myeloid metaplasia with myelofibrosis. Blood 2005; 105: 464-
473. 
 60.  Ernst TJ, Ritchie AR, Demetri GD, Griffin JD. Regulation of granulocyte- 
and monocyte-colony stimulating factor mRNA levels in human blood mon-
ocytes is mediated primarily at a post-transcriptional level. J Biol Chem 
1989; 264: 5700-5703. 
 61.  Fahey TJ, III, Sherry B, Tracey KJ et al. Cytokine production in a model of 
wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. 
Cytokine 1990; 2: 92-99. 
 62.  Faust N, Varas F, Kelly LM, Heck S, Graf T. Insertion of enhanced green 
fluorescent protein into the lysozyme gene creates mice with green fluores-
cent granulocytes and macrophages. Blood 2000; 96: 719-726. 
 63.  Fibbe WE, van DJ, Billiau A et al. Interleukin 1 induces human marrow 
stromal cells in long-term culture to produce granulocyte colony-stimulating 
factor and macrophage colony-stimulating factor. Blood 1988; 71: 430-435. 
 64.  Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL. 
Functional heterogeneity is associated with the cell cycle status of murine 
hematopoietic stem cells. J Cell Biol 1993; 122: 897-902. 
 65.  Flomenberg N, Devine SM, DiPersio JF et al. The use of AMD3100 plus G-
CSF for autologous hematopoietic progenitor cell mobilization is superior to 
G-CSF alone. Blood 2005; 106: 1867-1874. 
 66.  Friedl P, den Boer AT, Gunzer M. Tuning immune responses: diversity and 
adaptation of the immunological synapse. Nat Rev Immunol 2005; 5: 532-
545. 
 67.  Friedl P, Wolf K, von Andrian UH, Harms G. Biological second and third 
harmonic generation microscopy. Curr Protoc Cell Biol 2007; Chapter 4: 
Unit. 
 68.  Furze RC, Rankin SM. Neutrophil mobilization and clearance in the bone 
marrow. Immunology 2008; 125: 281-288. 
 69.  Gabrilove JL, Jakubowski A, Fain K et al. Phase I study of granulocyte col-
ony-stimulating factor in patients with transitional cell carcinoma of the 
urothelium. J Clin Invest 1988a; 82: 1454-1461. 
 70.  Gabrilove JL, Jakubowski A, Scher H et al. Effect of granulocyte colony-
stimulating factor on neutropenia and associated morbidity due to chemo-
therapy for transitional-cell carcinoma of the urothelium. N Engl J Med 
1988b; 318: 1414-1422. 
 71.  Geiger H, Koehler A, Gunzer M. Stem cells, aging, niche, adhesion and 
 7. References 
 119 
Cdc42: a model for changes in cell-cell interactions and hematopoietic stem 
cell aging. Cell Cycle 2007; 6: 884-887. 
 72.  Geiger H, Rennebeck G, Van ZG. Regulation of hematopoietic stem cell 
aging in vivo by a distinct genetic element. Proc Natl Acad Sci U S A 2005; 
102: 5102-5107. 
 73.  Geiger H, Van ZG. The aging of lympho-hematopoietic stem cells. Nat Im-
munol 2002; 3: 329-333. 
 74.  Göppert-Mayer M. Über Elementarakte mit zwei Quantensprüngen. Ann 
Phys 1931; 273-295. 
 75.  Gordon JR, Li F, Zhang X, Wang W, Zhao X, Nayyar A. The combined 
CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil in-
filtration, pyrexia, and pulmonary vascular pathology in endotoxemic ani-
mals. J Leukoc Biol 2005; 78: 1265-1272. 
 76.  Gregory AD, Hogue LA, Ferkol TW, Link DC. Regulation of systemic and 
local neutrophil responses by G-CSF during pulmonary Pseudomonas ae-
ruginosa infection. Blood 2007; 109: 3235-3243. 
 77.  Gunzer M, Schafer A, Borgmann S et al. Antigen presentation in extracellu-
lar matrix: interactions of T cells with dendritic cells are dynamic, short lived, 
and sequential. Immunity 2000; 13: 323-332. 
 78.  Gunzer M, Weishaupt C, Hillmer A et al. A spectrum of biophysical interac-
tion modes between T cells and different antigen-presenting cells during 
priming in 3-D collagen and in vivo. Blood 2004; 104: 2801-2809. 
 79.  Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW. Thrombocytope-
nia in c-mpl-deficient mice. Science 1994; 265: 1445-1447. 
 80.  Hanson P, Mathews V, Marrus SH, Graubert TA. Enhanced green fluores-
cent protein targeted to the Sca-1 (Ly-6A) locus in transgenic mice results 
in efficient marking of hematopoietic stem cells in vivo. Exp Hematol 2003; 
31: 159-167. 
 81.  Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ 
effector T cells develop via a lineage distinct from the T helper type 1 and 2 
lineages. Nat Immunol 2005; 6: 1123-1132. 
 82.  Hauser AE, Junt T, Mempel TR et al. Definition of germinal-center B cell 
migration in vivo reveals predominant intrazonal circulation patterns. Im-
munity 2007; 26: 655-667. 
 83.  Hendrix CW, Flexner C, MacFarland RT et al. Pharmacokinetics and safety 
of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in 
human volunteers. Antimicrob Agents Chemother 2000; 44: 1667-1673. 
 84.  Henrickson SE, Mempel TR, Mazo IB et al. T cell sensing of antigen dose 
governs interactive behavior with dendritic cells and sets a threshold for T 
cell activation. Nat Immunol 2008; 9: 282-291. 
 7. References 
 120 
 85.  Herrmann F, Cannistra SA, Griffin JD. T cell-monocyte interactions in the 
production of humoral factors regulating human granulopoiesis in vitro. J 
Immunol 1986; 136: 2856-2861. 
 86.  HERT J, HLADIKOVA J. [The vascular supply of the Haversian bones.]. 
Acta Anat (Basel) 1961; 45: 344-361. 
 87.  Higuchi T, Koike K, Sawai N et al. Megakaryocytes derived from CD34-
positive cord blood cells produce interleukin-8. Br J Haematol 1997; 99: 
509-516. 
 88.  Hill CP, Johnston NL, Cohen RE. Crystal structure of a ubiquitin-dependent 
degradation substrate: a three-disulfide form of lysozyme. Proc Natl Acad 
Sci U S A 1993a; 90: 4136-4140. 
 89.  Hill CP, Osslund TD, Eisenberg D. The structure of granulocyte-colony-
stimulating factor and its relationship to other growth factors. Proc Natl 
Acad Sci U S A 1993b; 90: 5167-5171. 
 90.  Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive 
immunity. Nat Immunol 2004; 5: 971-974. 
 91.  Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI. Structure and functional 
expression of a human interleukin-8 receptor. Science 1991; 253: 1278-
1280. 
 92.  Horuk R. Chemokine receptors. Cytokine Growth Factor Rev 2001; 12: 313-
335. 
 93.  Hosking MP, Liu L, Ransohoff RM, Lane TE. A Protective Role for ELR+ 
Chemokines during Acute Viral Encephalomyelitis. PLoS Pathog 2009; 5: 
e1000648. 
 94.  Huang S, Paulauskis JD, Godleski JJ, Kobzik L. Expression of macrophage 
inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am J 
Pathol 1992; 141: 981-988. 
 95.  Ito CY, Li CY, Bernstein A, Dick JE, Stanford WL. Hematopoietic stem cell 
and progenitor defects in Sca-1/Ly-6A-null mice. Blood 2003; 101: 517-523. 
 96.  Jagels MA, Chambers JD, Arfors KE, Hugli TE. C5a- and tumor necrosis 
factor-alpha-induced leukocytosis occurs independently of beta 2 integrins 
and L-selectin: differential effects on neutrophil adhesion molecule expres-
sion in vivo. Blood 1995; 85: 2900-2909. 
 97.  Jagels MA, Hugli TE. Neutrophil chemotactic factors promote leukocytosis. 
A common mechanism for cellular recruitment from bone marrow. J Immu-
nol 1992; 148: 1119-1128. 
 98.  Janzen V, Forkert R, Fleming HE et al. Stem-cell ageing modified by the 
cyclin-dependent kinase inhibitor p16INK4a. Nature 2006; 443: 421-426. 
 99.  Jordan CT, Lemischka IR. Clonal and systemic analysis of long-term hema-
 7. References 
 121 
topoiesis in the mouse. Genes Dev 1990; 4: 220-232. 
 100.  Ju ST, Panka DJ, Cui H et al. Fas(CD95)/FasL interactions required for 
programmed cell death after T-cell activation. Nature 1995; 373: 444-448. 
 101.  Jung S, Aliberti J, Graemmel P et al. Analysis of fractalkine receptor 
CX(3)CR1 function by targeted deletion and green fluorescent protein re-
porter gene insertion. Mol Cell Biol 2000; 20: 4106-4114. 
 102.  Jung Y, Wang J, Havens A et al. Cell-to-cell contact is critical for the surviv-
al of hematopoietic progenitor cells on osteoblasts. Cytokine 2005; 32: 155-
162. 
 103.  Junquiera LC, Carneiro J. Histologie. Heidelberg: Springer Medizin Verlag; 
2005. 
 104.  Junt T, Schulze H, Chen Z et al. Dynamic visualization of thrombopoiesis 
within bone marrow. Science 2007; 317: 1767-1770. 
 105.  Kagi D, Vignaux F, Ledermann B et al. Fas and perforin pathways as major 
mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528-530. 
 106.  Kalajzic I, Kalajzic Z, Kaliterna M et al. Use of type I collagen green fluores-
cent protein transgenes to identify subpopulations of cells at different stag-
es of the osteoblast lineage. J Bone Miner Res 2002; 17: 15-25. 
 107.  Kamminga LM, de HG. Cellular memory and hematopoietic stem cell aging. 
Stem Cells 2006; 24: 1143-1149. 
 108.  Katayama Y, Battista M, Kao WM et al. Signals from the sympathetic nerv-
ous system regulate hematopoietic stem cell egress from bone marrow. 
Cell 2006; 124: 407-421. 
 109.  Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J 
Med 2006; 354: 2034-2045. 
 110.  Keller G, Paige C, Gilboa E, Wagner EF. Expression of a foreign gene in 
myeloid and lymphoid cells derived from multipotent haematopoietic pre-
cursors. Nature 1985; 318: 149-154. 
 111.  Kiel MJ, Morrison SJ. Maintaining hematopoietic stem cells in the vascular 
niche. Immunity 2006; 25: 862-864. 
 112.  Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. SLAM 
family receptors distinguish hematopoietic stem and progenitor cells and 
reveal endothelial niches for stem cells. Cell 2005; 121: 1109-1121. 
 113.  Kielian T, Barry B, Hickey WF. CXC chemokine receptor-2 ligands are re-
quired for neutrophil-mediated host defense in experimental brain abscess-
es. J Immunol 2001; 166: 4634-4643. 
 114.  Kim HK, De La Luz SM, Williams CK, Gulino AV, Tosato G. G-CSF down-
regulation of CXCR4 expression identified as a mechanism for mobilization 
 7. References 
 122 
of myeloid cells. Blood 2006; 108: 812-820. 
 115.  King AG, Horowitz D, Dillon SB et al. Rapid mobilization of murine hemato-
poietic stem cells with enhanced engraftment properties and evaluation of 
hematopoietic progenitor cell mobilization in rhesus monkeys by a single in-
jection of SB-251353, a specific truncated form of the human CXC chemo-
kine GRObeta. Blood 2001; 97: 1534-1542. 
 116.  Knapp S, Hareng L, Rijneveld AW et al. Activation of neutrophils and inhibi-
tion of the proinflammatory cytokine response by endogenous granulocyte 
colony-stimulating factor in murine pneumococcal pneumonia. J Infect Dis 
2004; 189: 1506-1515. 
 117.  Kobayashi Y. Neutrophil infiltration and chemokines. Crit Rev Immunol 
2006; 26: 307-316. 
 118.  Koch AE, Polverini PJ, Kunkel SL et al. Interleukin-8 as a macrophage-
derived mediator of angiogenesis. Science 1992; 258: 1798-1801. 
 119.  Koeffler HP, Gasson J, Ranyard J, Souza L, Shepard M, Munker R. Re-
combinant human TNF alpha stimulates production of granulocyte colony-
stimulating factor. Blood 1987; 70: 55-59. 
 120.  Koeffler HP, Gasson J, Tobler A. Transcriptional and posttranscriptional 
modulation of myeloid colony-stimulating factor expression by tumor necro-
sis factor and other agents. Mol Cell Biol 1988; 8: 3432-3438. 
 121.  Kohler A, Schmithorst V, Filippi MD et al. Altered cellular dynamics and en-
dosteal location of aged early hematopoietic progenitor cells revealed by 
time-lapse intravital imaging in long bones. Blood 2009; 114: 290-298. 
 122.  Kondo M, Wagers AJ, Manz MG et al. Biology of hematopoietic stem cells 
and progenitors: implications for clinical application. Annu Rev Immunol 
2003; 21: 759-806. 
 123.  Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage en-
graftment by a single bone marrow-derived stem cell. Cell 2001; 105: 369-
377. 
 124.  Lally F, Smith E, Filer A et al. A novel mechanism of neutrophil recruitment 
in a coculture model of the rheumatoid synovium. Arthritis Rheum 2005; 52: 
3460-3469. 
 125.  Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 
2005; 106: 1901-1910. 
 126.  Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles 
of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and 
stromal cells. Exp Hematol 2002; 30: 973-981. 
 127.  Laterveer L, Lindley IJ, Hamilton MS, Willemze R, Fibbe WE. Interleukin-8 
induces rapid mobilization of hematopoietic stem cells with radioprotective 
capacity and long-term myelolymphoid repopulating ability. Blood 1995; 85: 
 7. References 
 123 
2269-2275. 
 128.  Le Beau MM, Lemons RS, Carrino JJ et al. Chromosomal localization of the 
human G-CSF gene to 17q11 proximal to the breakpoint of the t(15;17) in 
acute promyelocytic leukemia. Leukemia 1987; 1: 795-799. 
 129.  Le Y, Zhou Y, Iribarren P, Wang J. Chemokines and chemokine receptors: 
their manifold roles in homeostasis and disease. Cell Mol Immunol 2004; 1: 
95-104. 
 130.  Leeuwenberg JF, Smeets EF, Neefjes JJ et al. E-selectin and intercellular 
adhesion molecule-1 are released by activated human endothelial cells in 
vitro. Immunology 1992; 77: 543-549. 
 131.  Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption 
of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem 
cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 
2003a; 111: 187-196. 
 132.  Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption 
of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem 
cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 
2003b; 111: 187-196. 
 133.  Liang Y, Van ZG, Szilvassy SJ. Effects of aging on the homing and en-
graftment of murine hematopoietic stem and progenitor cells. Blood 2005; 
106: 1479-1487. 
 134.  Liles WC, Broxmeyer HE, Rodger E et al. Mobilization of hematopoietic 
progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. 
Blood 2003; 102: 2728-2730. 
 135.  Link DC. Neutrophil homeostasis: a new role for stromal cell-derived factor-
1. Immunol Res 2005; 32: 169-178. 
 136.  Lo CC, Fleming HE, Wu JW et al. Live-animal tracking of individual haema-
topoietic stem/progenitor cells in their niche. Nature 2009; 457: 92-96. 
 137.  Ma Q, Jones D, Borghesani PR et al. Impaired B-lymphopoiesis, myelopoi-
esis, and derailed cerebellar neuron migration in C. Proc Natl Acad Sci U S 
A 1998; 95: 9448-9453. 
 138.  Marotti G, Zallone AZ. Changes in the vascular network during the for-
mation of Haversian systems. Acta Anat (Basel) 1980; 106: 84-100. 
 139.  Mazo IB, Gutierrez-Ramos JC, Frenette PS, Hynes RO, Wagner DD, von 
Andrian UH. Hematopoietic progenitor cell rolling in bone marrow mi-
crovessels: parallel contributions by endothelial selectins and vascular cell 
adhesion molecule 1. J Exp Med 1998; 188: 465-474. 
 140.  McColl SR, Clark-Lewis I. Inhibition of murine neutrophil recruitment in vivo 
by CXC chemokine receptor antagonists. J Immunol 1999; 163: 2829-2835. 
 7. References 
 124 
 141.  McDonald B, Pittman K, Menezes GB et al. Intravascular danger signals 
guide neutrophils to sites of sterile inflammation. Science 2010; 330: 362-
366. 
 142.  Mempel TR, Henrickson SE, von Andrian UH. T-cell priming by dendritic 
cells in lymph nodes occurs in three distinct phases. Nature 2004a; 427: 
154-159. 
 143.  Mempel TR, Scimone ML, Mora JR, von Andrian UH. In vivo imaging of 
leukocyte trafficking in blood vessels and tissues. Curr Opin Immunol 
2004b; 16: 406-417. 
 144.  Mempel TR, Scimone ML, Mora JR, von Andrian UH. In vivo imaging of 
leukocyte trafficking in blood vessels and tissues. Curr Opin Immunol 
2004c; 16: 406-417. 
 145.  Mendez-Ferrer S, Michurina TV, Ferraro F et al. Mesenchymal and haema-
topoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 
829-834. 
 146.  Metcalf D. Hematopoietic cytokines. Blood 2008; 111: 485-491. 
 147.  Metcalf D, Robb L, Dunn AR, Mifsud S, Di RL. Role of granulocyte-
macrophage colony-stimulating factor and granulocyte colony-stimulating 
factor in the development of an acute neutrophil inflammatory response in 
mice. Blood 1996; 88: 3755-3764. 
 148.  Miura M, Fu X, Zhang QW, Remick DG, Fairchild RL. Neutralization of Gro 
alpha and macrophage inflammatory protein-2 attenuates renal ische-
mia/reperfusion injury. Am J Pathol 2001; 159: 2137-2145. 
 149.  Morrison SJ, Hemmati HD, Wandycz AM, Weissman IL. The purification 
and characterization of fetal liver hematopoietic stem cells. Proc Natl Acad 
Sci U S A 1995; 92: 10302-10306. 
 150.  Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL. The ag-
ing of hematopoietic stem cells. Nat Med 1996; 2: 1011-1016. 
 151.  Morstyn G, Campbell L, Souza LM et al. Effect of granulocyte colony stimu-
lating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 
1988; 1: 667-672. 
 152.  Murdoch C, Finn A. Chemokine receptors and their role in inflammation and 
infectious diseases. Blood 2000; 95: 3032-3043. 
 153.  Murone M, Carpenter DA, de Sauvage FJ. Hematopoietic deficiencies in c-
mpl and TPO knockout mice. Stem Cells 1998; 16: 1-6. 
 154.  Murphy K, Travers P, Walport M. Janeway`s Immunobiology. 2008. 
 155.  Murphy PM. Neutrophil receptors for interleukin-8 and related CXC chemo-
kines. Semin Hematol 1997; 34: 311-318. 
 7. References 
 125 
 156.  Murphy PM. Chemokines and the molecular basis of cancer metastasis. N 
Engl J Med 2001; 345: 833-835. 
 157.  Murphy PM. The molecular biology of leukocyte chemoattractant receptors. 
Annu Rev Immunol 1994; 12: 593-633. 
 158.  Murphy PM, Baggiolini M, Charo IF et al. International union of pharmacol-
ogy. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000; 
52: 145-176. 
 159.  Nagata S, Tsuchiya M, Asano S et al. Molecular cloning and expression of 
cDNA for human granulocyte colony-stimulating factor. Nature 1986a; 319: 
415-418. 
 160.  Nagata S, Tsuchiya M, Asano S et al. The chromosomal gene structure and 
two mRNAs for human granulocyte colony-stimulating factor. EMBO J 
1986b; 5: 575-581. 
 161.  Nagata S, Tsuchiya M, Asano S et al. The chromosomal gene structure and 
two mRNAs for human granulocyte colony-stimulating factor. EMBO J 
1986c; 5: 575-581. 
 162.  Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction 
of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171: 
6173-6177. 
 163.  Neiva K, Sun YX, Taichman RS. The role of osteoblasts in regulating hema-
topoietic stem cell activity and tumor metastasis. Braz J Med Biol Res 2005; 
38: 1449-1454. 
 164.  Nilsson SK, Haylock DN, Johnston HM, Occhiodoro T, Brown TJ, Simmons 
PJ. Hyaluronan is synthesized by primitive hemopoietic cells, participates in 
their lodgment at the endosteum following transplantation, and is involved in 
the regulation of their proliferation and differentiation in vitro. Blood 2003; 
101: 856-862. 
 165.  Nilsson SK, Johnston HM, Coverdale JA. Spatial localization of transplant-
ed hemopoietic stem cells: inferences for the localization of stem cell nich-
es. Blood 2001; 97: 2293-2299. 
 166.  Nilsson SK, Johnston HM, Whitty GA et al. Osteopontin, a key component 
of the hematopoietic stem cell niche and regulator of primitive hematopoiet-
ic progenitor cells. Blood 2005; 106: 1232-1239. 
 167.  Nilsson SK, Simmons PJ. Transplantable stem cells: home to specific nich-
es. Curr Opin Hematol 2004; 11: 102-106. 
 168.  Nourshargh S, Hordijk PL, Sixt M. Breaching multiple barriers: leukocyte 
motility through venular walls and the interstitium. Nat Rev Mol Cell Biol 
2010; 11: 366-378. 
 169.  Ohmori Y, Hamilton TA. Cell type and stimulus specific regulation of chem-
okine gene expression. Biochem Biophys Res Commun 1994a; 198: 590-
 7. References 
 126 
596. 
 170.  Ohmori Y, Hamilton TA. IFN-gamma selectively inhibits lipopolysaccharide-
inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma 
growth-stimulating activity gene expression in mouse peritoneal macro-
phages. J Immunol 1994b; 153: 2204-2212. 
 171.  Opdenakker G, Fibbe WE, van DJ. The molecular basis of leukocytosis. 
Immunol Today 1998; 19: 182-189. 
 172.  Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohemato-
poietic reconstitution by a single CD34-low/negative hematopoietic stem 
cell. Science 1996; 273: 242-245. 
 173.  Oster W, Lindemann A, Mertelsmann R, Herrmann F. Granulocyte-
macrophage colony-stimulating factor (CSF) and multilineage CSF recruit 
human monocytes to express granulocyte CSF. Blood 1989; 73: 64-67. 
 174.  P.A.Franken AEHCWPaGW. Generation of Optical Harmonics. Phys Rev 
Lett 1961; 7: 118. 
 175.  Pannarale L, Morini S, D'Ubaldo E, Gaudio E, Marinozzi G. SEM corrosion-
casts study of the microcirculation of the flat bones in the rat. Anat Rec 
1997; 247: 462-471. 
 176.  Papayannopoulou T. Current mechanistic scenarios in hematopoietic 
stem/progenitor cell mobilization. Blood 2004; 103: 1580-1585. 
 177.  Papayannopoulou T. Bone marrow homing: the players, the playfield, and 
their evolving roles. Curr Opin Hematol 2003; 10: 214-219. 
 178.  Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tis-
sue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-
1141. 
 179.  Pelus LM. Peripheral blood stem cell mobilization: new regimens, new cells, 
where do we stand. Curr Opin Hematol 2008; 15: 285-292. 
 180.  Peters NC, Egen JG, Secundino N et al. In vivo imaging reveals an essen-
tial role for neutrophils in leishmaniasis transmitted by sand flies. Science 
2008; 321: 970-974. 
 181.  Petit I, Szyper-Kravitz M, Nagler A et al. G-CSF induces stem cell mobiliza-
tion by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat 
Immunol 2002; 3: 687-694. 
 182.  Ponomaryov T, Peled A, Petit I et al. Induction of the chemokine stromal-
derived factor-1 following DNA damage improves human stem cell function. 
J Clin Invest 2000; 106: 1331-1339. 
 183.  Rando TA. Stem cells, ageing and the quest for immortality. Nature 2006; 
441: 1080-1086. 
 7. References 
 127 
 184.  Reichardt P, Gunzer F, Gunzer M. Analyzing the physicodynamics of im-
mune cells in a three-dimensional collagen matrix. Methods Mol Biol 2007; 
380: 253-269. 
 185.  Rossi DJ, Bryder D, Zahn JM et al. Cell intrinsic alterations underlie hema-
topoietic stem cell aging. Proc Natl Acad Sci U S A 2005; 102: 9194-9199. 
 186.  Rovai LE, Herschman HR, Smith JB. The murine neutrophil-
chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction ki-
netics, tissue distributions, and tissue-specific sensitivities to glucocorticoid 
regulation in endotoxemia. J Leukoc Biol 1998; 64: 494-502. 
 187.  Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 
2002; 20: 323-370. 
 188.  Safirstein R, Megyesi J, Saggi SJ et al. Expression of cytokine-like genes 
JE and KC is increased during renal ischemia. Am J Physiol 1991; 261: 
F1095-F1101. 
 189.  Sakaue-Sawano A, Kurokawa H, Morimura T et al. Visualizing spatiotem-
poral dynamics of multicellular cell-cycle progression. Cell 2008; 132: 487-
498. 
 190.  Scadden DT. The stem-cell niche as an entity of action. Nature 2006b; 441: 
1075-1079. 
 191.  Scadden DT. The stem-cell niche as an entity of action. Nature 2006a; 441: 
1075-1079. 
 192.  Schiebler TH. Anatomie. 2005. 
 193.  Schofield R. The relationship between the spleen colony-forming cell and 
the haemopoietic stem cell. Blood Cells 1978; 4: 7-25. 
 194.  Semerad CL, Christopher MJ, Liu F et al. G-CSF potently inhibits osteoblast 
activity and CXCL12 mRNA expression in the bone marrow. Blood 2005a; 
106: 3020-3027. 
 195.  Semerad CL, Christopher MJ, Liu F et al. G-CSF potently inhibits osteoblast 
activity and CXCL12 mRNA expression in the bone marrow. Blood 2005b; 
106: 3020-3027. 
 196.  Semerad CL, Liu F, Gregory AD, Stumpf K, Link DC. G-CSF is an essential 
regulator of neutrophil trafficking from the bone marrow to the blood. Im-
munity 2002; 17: 413-423. 
 197.  Shahbazian LM, Quinton LJ, Bagby GJ, Nelson S, Wang G, Zhang P. 
Escherichia coli pneumonia enhances granulopoiesis and the mobilization 
of myeloid progenitor cells into the systemic circulation. Crit Care Med 
2004; 32: 1740-1746. 
 198.  Sharpless NE, DePinho RA. Telomeres, stem cells, senescence, and can-
cer. J Clin Invest 2004; 113: 160-168. 
 7. References 
 128 
 199.  Sherry B, Horii Y, Manogue KR, Widmer U, Cerami A. Macrophage inflam-
matory proteins 1 and 2: an overview. Cytokines 1992; 4: 117-130. 
 200.  SIMINOVITCH L, TILL JE, MCCULLOCH EA. DECLINE IN COLONY-
FORMING ABILITY OF MARROW CELLS SUBJECTED TO SERIAL 
TRANSPLANTATION INTO IRRADIATED MICE. J Cell Physiol 1964; 64: 
23-31. 
 201.  Simmers RN, Webber LM, Shannon MF et al. Localization of the G-CSF 
gene on chromosome 17 proximal to the breakpoint in the t(15;17) in acute 
promyelocytic leukemia. Blood 1987; 70: 330-332. 
 202.  Smith JW. Collagen fibre patterns in mammalian bone. J Anat 1960; 94: 
329-344. 
 203.  Souza LM, Boone TC, Gabrilove J et al. Recombinant human granulocyte 
colony-stimulating factor: effects on normal and leukemic myeloid cells. 
Science 1986; 232: 61-65. 
 204.  Spangrude GJ, Johnson GR. Resting and activated subsets of mouse mul-
tipotent hematopoietic stem cells. Proc Natl Acad Sci U S A 1990; 87: 7433-
7437. 
 205.  Stegemann S, Dahlberg S, Kröger A et al. Increased susceptibility for su-
perinfection with Streptococcus pneumoniae during influenza virus infection 
is not caused by TLR7-mediated lymphopenia. PLoS one 2009; 4: e4840. 
 206.  Strieter RM, Kunkel SL, Elner VM et al. Interleukin-8. A corneal factor that 
induces neovascularization. Am J Pathol 1992; 141: 1279-1284. 
 207.  Suda T, Arai F, Hirao A. Hematopoietic stem cells and their niche. Trends 
Immunol 2005; 26: 426-433. 
 208.  Sudo K, Ema H, Morita Y, Nakauchi H. Age-associated characteristics of 
murine hematopoietic stem cells. J Exp Med 2000; 192: 1273-1280. 
 209.  Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hemato-
poietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone 
marrow stromal cell niches. Immunity 2006; 25: 977-988. 
 210.  Sumen C, Mempel TR, Mazo IB, von Andrian UH. Intravital microscopy: 
visualizing immunity in context. Immunity 2004; 21: 315-329. 
 211.  Sungaran R, Markovic B, Chong BH. Localization and regulation of throm-
bopoietin mRNa expression in human kidney, liver, bone marrow, and 
spleen using in situ hybridization. Blood 1997; 89: 101-107. 
 212.  Suratt BT, Petty JM, Young SK et al. Role of the CXCR4/SDF-1 chemokine 
axis in circulating neutrophil homeostasis. Blood 2004; 104: 565-571. 
 213.  Szilvassy SJ. The biology of hematopoietic stem cells. Arch Med Res 2003; 
34: 446-460. 
 7. References 
 129 
 214.  Szilvassy SJ, Cory S. Efficient retroviral gene transfer to purified long-term 
repopulating hematopoietic stem cells. Blood 1994; 84: 74-83. 
 215.  Tachibana K, Hirota S, Iizasa H et al. The chemokine receptor CXCR4 is 
essential for vascularization of the gastrointestinal tract. Nature 1998; 393: 
591-594. 
 216.  Terashima T, English D, Hogg JC, van Eeden SF. Release of polymorpho-
nuclear leukocytes from the bone marrow by interleukin-8. Blood 1998; 92: 
1062-1069. 
 217.  Thomas J, Liu F, Link DC. Mechanisms of mobilization of hematopoietic 
progenitors with granulocyte colony-stimulating factor. Curr Opin Hematol 
2002; 9: 183-189. 
 218.  Torella D, Rota M, Nurzynska D et al. Cardiac stem cell and myocyte aging, 
heart failure, and insulin-like growth factor-1 overexpression. Circ Res 
2004; 94: 514-524. 
 219.  Trias A, Fery A. Cortical circulation of long bones. J Bone Joint Surg Am 
1979; 61: 1052-1059. 
 220.  Tromberg BJ, Shah N, Lanning R et al. Non-invasive in vivo characteriza-
tion of breast tumors using photon migration spectroscopy. Neoplasia 2000; 
2: 26-40. 
 221.  Tsuchiya M, Asano S, Kaziro Y, Nagata S. Isolation and characterization of 
the cDNA for murine granulocyte colony-stimulating factor. Proc Natl Acad 
Sci U S A 1986; 83: 7633-7637. 
 222.  Uchida N, Fleming WH, Alpern EJ, Weissman IL. Heterogeneity of hemato-
poietic stem cells. Curr Opin Immunol 1993; 5: 177-184. 
 223.  van Zant G, Liang Y. The role of stem cells in aging. Exp Hematol 2003; 31: 
659-672. 
 224.  VASCIAVEO F, BARTOLI E. Vascular channels and resorption cavities in 
the long bone cortex. The bovine bone. Acta Anat (Basel) 1961; 47: 1-33. 
 225.  Vellenga E, Rambaldi A, Ernst TJ, Ostapovicz D, Griffin JD. Independent 
regulation of M-CSF and G-CSF gene expression in human monocytes. 
Blood 1988; 71: 1529-1532. 
 226.  Villeval JL, Cohen-Solal K, Tulliez M et al. High thrombopoietin production 
by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. 
Blood 1997; 90: 4369-4383. 
 227.  Visnjic D, Kalajzic I, Gronowicz G et al. Conditional ablation of the osteo-
blast lineage in Col2.3deltatk transgenic mice. J Bone Miner Res 2001; 16: 
2222-2231. 
 228.  Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aguila HL. Hemato-
poiesis is severely altered in mice with an induced osteoblast deficiency. 
 7. References 
 130 
Blood 2004; 103: 3258-3264. 
 229.  Visser JW, Van Bekkum DW. Purification of pluripotent hemopoietic stem 
cells: past and present. Exp Hematol 1990; 18: 248-256. 
 230.  Voisin MB, Probstl D, Nourshargh S. Venular basement membranes ubiqui-
tously express matrix protein low-expression regions: characterization in 
multiple tissues and remodeling during inflammation. Am J Pathol 2010; 
176: 482-495. 
 231.  von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. 
Nat Rev Immunol 2003; 3: 867-878. 
 232.  von Vietinghoff S, Ley K. Homeostatic regulation of blood neutrophil counts. 
J Immunol 2008; 181: 5183-5188. 
 233.  Wagers AJ, Allsopp RC, Weissman IL. Changes in integrin expression are 
associated with altered homing properties of Lin(-/lo)Thy1.1(lo)Sca-1(+)c-
kit(+) hematopoietic stem cells following mobilization by cyclophospha-
mide/granulocyte colony-stimulating factor. Exp Hematol 2002; 30: 176-
185. 
 234.  Wang JM, Deng X, Gong W, Su S. Chemokines and their role in tumor 
growth and metastasis. J Immunol Methods 1998; 220: 1-17. 
 235.  Wang S, Voisin MB, Larbi KY et al. Venular basement membranes contain 
specific matrix protein low expression regions that act as exit points for em-
igrating neutrophils. J Exp Med 2006; 203: 1519-1532. 
 236.  Weissman IL. Stem cells: units of development, units of regeneration, and 
units in evolution. Cell 2000; 100: 157-168. 
 237.  Wengner AM, Pitchford SC, Furze RC, Rankin SM. The coordinated action 
of G-CSF and ELR + CXC chemokines in neutrophil mobilization during 
acute inflammation. Blood 2008; 111: 42-49. 
 238.  Wierenga PK, Weersing E, Dontje B, de HG, van OR. Differential role for 
very late antigen-5 in mobilization and homing of hematopoietic stem cells. 
Bone Marrow Transplant 2006; 38: 789-797. 
 239.  Wieser M, Bonifer R, Oster W, Lindemann A, Mertelsmann R, Herrmann F. 
Interleukin-4 induces secretion of CSF for granulocytes and CSF for mac-
rophages by peripheral blood monocytes. Blood 1989; 73: 1105-1108. 
 240.  Williams B.Swaim. Overview over Confocal microscopy. 2010. 
 241.  Wilson A, Murphy MJ, Oskarsson T et al. c-Myc controls the balance be-
tween hematopoietic stem cell self-renewal and differentiation. Genes Dev 
2004; 18: 2747-2763. 
 242.  Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat 
Rev Immunol 2006b; 6: 93-106. 
 7. References 
 131 
 243.  Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat 
Rev Immunol 2006a; 6: 93-106. 
 244.  Witowski J, Ksiazek K, Warnecke C et al. Role of mesothelial cell-derived 
granulocyte colony-stimulating factor in interleukin-17-induced neutrophil 
accumulation in the peritoneum. Kidney Int 2007; 71: 514-525. 
 245.  Wright DE, Bowman EP, Wagers AJ, Butcher EC, Weissman IL. Hemato-
poietic stem cells are uniquely selective in their migratory response to 
chemokines. J Exp Med 2002; 195: 1145-1154. 
 246.  Xie Y, Yin T, Wiegraebe W et al. Detection of functional haematopoietic 
stem cell niche using real-time imaging. Nature 2009; 457: 97-101. 
 247.  Xing Z, Ryan MA, Daria D et al. Increased hematopoietic stem cell mobili-
zation in aged mice. Blood 2006; 108: 2190-2197. 
 248.  Yin T, Li L. The stem cell niches in bone. J Clin Invest 2006; 116: 1195-
1201. 
 249.  Yoshihara H, Arai F, Hosokawa K et al. Thrombopoietin/MPL signaling reg-
ulates hematopoietic stem cell quiescence and interaction with the osteo-
blastic niche. Cell Stem Cell 2007; 1: 685-697. 
 250.  Zhang H, Meng F, Chu CL, Takai T, Lowell CA. The Src family kinases Hck 
and Fgr negatively regulate neutrophil and dendritic cell chemokine signal-
ing via PIR-B. Immunity 2005; 22: 235-246. 
 251.  Zhang J, Niu C, Ye L et al. Identification of the haematopoietic stem cell 
niche and control of the niche size. Nature 2003; 425: 836-841. 
 252.  Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the 
chemokine receptor CXCR4 in haematopoiesis and in cerebellar develop-
ment. Nature 1998; 393: 595-599. 
 253.  Zsebo KM, Yuschenkoff VN, Schiffer S et al. Vascular endothelial cells and 
granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF. 
Blood 1988; 71: 99-103. 
 
 
 8. Appendix 
 132 
8. Appendix – DVD-Content 
Supplemental movie 1  Behavior of eHPCs from young mice in long bones.  
eHPCS were isolated from 8 weeks old C57Bl/6 mice, stained with CFSE and 
adoptively transferred into a naÏve 8 weeks old recipient. 2-photon microscopy was 
carried out in the tibia at a total magnification of 200x, 18 h after cell transfer. The 
recording time was 10 min, one z-stack consisted of 31 steps with an interval of 3 
µm and the repetition time for each z-stack acquisition was 80 s. The bone struc-
ture, displayed in brown was detected by its SHG signal.  
 
Supplemental movie 2  Behavior of eHPCs from old mice in long bones.  
eHPCS were isolated from 18-20 months old C57Bl/6 mice, stained with CFSE 
and adoptively transferred into a naÏve 8 weeks old recipient. 2-photon microscopy 
was carried out in the tibia at a total magnification of 200x, 18 h after cell transfer. 
The recording time was 9 min, one z-stack consisted of 31 steps with an interval of 
4 µm and the repetition time for each z-stack acquisition was 60 s. The bone struc-
ture, displayed in brown was detected by its SHG signal.  
 
Supplemental movie 3  Behavior of HPCs from young mice in long bones.  
HPCS were isolated from 8 weeks old C57Bl/6 mice, stained with CFSE and adop-
tively transferred into a naÏve 8 weeks old recipient. 2-photon microscopy was car-
ried out in the tibia at a total magnification of 200x, 40 h after cell transfer. The re-
cording time was 14 min, one z-stack consisted of 31 steps with an interval of 
4 µm and the repetition time for each z-stack acquisition was 80 s. The bone struc-
ture, displayed in brown was detected by its SHG signal.  
 
Supplemental movie 4  Behavior of HPCs from old mice in long bones.  
HPCS were isolated from old 18-20 months old C57Bl/6 mice, stained with CFSE 
and adoptively transferred into a naÏve 8 weeks old recipient. 2-photon microscopy 
was carried out in the tibia at a total magnification of 200x, 40 h after cell transfer. 
The recording time was 10 min, one z-stack consisted of 31 steps with an interval 
of 4 µm and the repetition time for each z-stack acquisition was 60 s. The bone 
structure, displayed in brown was detected by its SHG signal.  
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Supplemental movie 5  High resolution z-stack of murine tibia.  The z-stack 
was recorded in a Lys-EGFP mouse. Blood vessels were stained with rhodamine-
dextran and displayed in red, cells were detected via their green fluorescence and 
the bone structure by its SHG signal which was displayed in brown. The z-stack 
consisted of 99 steps with an interval of 2 µm and was recorded at a magnification 
of 200x. 
 
Supplemental movie 6  Neutrophil observation in a Lys-EGFP mouse under 
steady-state conditions.  Blood vessels were stained with rhodamine-dextran 
and displayed in red, cells were detected via their green fluorescence and the 
bone structure by its SHG signal which was displayed in brown. The recording 
time was 59 min, one z-stack consisted of 31 steps with an interval of 4 µm and 
the repetition time for each z-stack acquisition was 60 s. Pictures were taken at a 
magnification of 200x. 
 
Supplemental movie 7  Neutrophil observation in a Lys-EGFP mouse 2 h af-
ter G-CSF mobilization.  Blood vessels were stained with rhodamine-dextran and 
displayed in red, cells were detected via their green fluorescence and the bone 
structure by its SHG signal which was displayed in brown. The recording time was 
39 min, one z-stack consisted of 31 steps with an interval of 4 µm and the repeti-
tion time for each z-stack acquisition was 60 s. Pictures were taken at a magnifica-
tion of 200x. 
 
Supplemental movie 8  Neutrophils of a Lys-EGFP mouse entering blood 
vessels after G-CSF treatment.  Blood vessels were stained with rhodamine-
dextran and displayed in red, cells were detected via their green fluorescence and 
the bone structure by its SHG signal which was displayed in brown. The recording 
time was 44 min, one z-stack consisted of 31 steps with an interval of 4 µm and 
the repetition time for each z-stack acquisition was 60 s. Pictures were taken at a 
magnification of 200x. 
 
Supplemental movie 9  Macrophage and DC observation in a CX3CR1-EGFP 
mouse 2 h after mobilization with G-CSF.  Blood vessels were stained with rho-
damine-dextran and displayed in red, cells were detected via their green fluores-
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cence and the bone structure by its SHG signal which was displayed in brown. 
The recording time was 29 min, one z-stack consisted of 31 steps with an interval 
of 4 µm and the repetition time for each z-stack acquisition was 60 s. Pictures 
were taken at a magnification of 200x. 
 
Supplemental movie 10  Neutrophil behavior in a Lys-EGFP mouse treated 
with anti-KC/anti-MIP-2 antibodies and subsequently with G-CSF.  G-CSF was 
applied 46 h after simultaneous i.p. antibody administration. Blood vessels were 
stained with rhodamine-dextran and displayed in red, cells were detected via their 
green fluorescence and the bone structure by its SHG signal which was displayed 
in brown. The recording time was 29 min, one z-stack consisted of 31 steps with 
an interval of 4 µm and the repetition time for each z-stack acquisition was 60 s. 
Pictures were taken at a magnification of 200x. 
 
Supplemental movie 11  Neutrophil behavior in a Lys-EGFP mouse treated 
with an anti-CXCR2 antiserum and subsequently with G-CSF.  G-CSF was 
applied 46 h after i.p. injection of the antiserum. Blood vessels were stained with 
rhodamine-dextran and displayed in red, cells were detected via their green fluo-
rescence and the bone structure by its SHG signal which was displayed in brown. 
The recording time was 38 min, one z-stack consisted of 31 steps with an interval 
of 4 µm and the repetition time for each z-stack acquisition was 60 s. Pictures 
were taken at a magnification of 200x. 
 
Supplemental movie 12  Neutrophil behavior in a Lys-EGFP mouse before 
treatment with AMD3100.  Blood vessels were stained with rhodamine-dextran 
and displayed in red, cells were detected via their green fluorescence and the 
bone structure by its SHG signal which was displayed in brown. The recording 
time was 14 min, one z-stack consisted of 31 steps with an interval of 4 µm and 
the repetition time for each z-stack acquisition was 60 s. Pictures were taken at a 
magnification of 200x. 
 
Supplemental movie 13  Neutrophil behavior in a Lys-EGFP mouse 2 h after 
i.v. treatment with AMD3100.  Blood vessels were stained with rhodamine-
dextran and displayed in red, cells were detected via their green fluorescence and 
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the bone structure by its SHG signal which was displayed in brown. The recording 
time was 14 min, one z-stack consisted of 31 steps with an interval of 4 µm and 
the repetition time for each z-stack acquisition was 60 s. Pictures were taken at a 
magnification of 200x. 
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